data_1ezp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ezp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.827 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 18.0 t-20 -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.728 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' HG21 ' A' ' 23' ' ' VAL . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.781 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.644 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.781 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.827 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.621 ' H ' HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' HD22 ' A' ' 12' ' ' ASN . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' HA ' ' HZ2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.81 ' HZ2' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 46' ' ' LYS . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.947 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.787 ' HB2' HG22 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.695 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.645 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.699 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.699 HD11 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.566 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.753 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.566 ' CG2' ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.919 ' HA ' HG11 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.684 ' O ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.729 HD12 ' HA2' ' A' ' 68' ' ' GLY . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 301' ' ' ALA . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 320' ' ' THR . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.569 HG13 ' HG1' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.659 ' CD1' HD12 ' A' ' 122' ' ' LEU . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.791 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.791 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.426 ' CD2' ' HZ2' ' A' ' 144' ' ' LYS . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.899 HD21 ' HB3' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.565 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 1.054 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' CB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.648 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.054 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.801 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.753 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.463 ' OE2' HD21 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HZ2' ' CD2' ' A' ' 121' ' ' LEU . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.421 ' C ' ' HG1' ' A' ' 222' ' ' THR . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.558 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.675 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.502 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HD13 ' A' ' 226' ' ' ILE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.721 ' N ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.679 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.893 ' CE1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.555 ' CB ' HD23 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.539 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.679 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.893 HD13 ' CE1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.829 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.557 ' HB1' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.574 ' HB2' ' HB3' ' A' ' 250' ' ' PHE . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.889 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.873 ' HH ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.873 ' HA2' ' HH ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.555 HG22 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.772 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.444 ' O ' HD13 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.782 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.605 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.829 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.555 HD23 ' CB ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 1.026 ' HB ' HD13 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.897 ' HB2' HD11 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.67 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.718 ' HA ' HG23 ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.899 ' HB3' HD21 ' A' ' 122' ' ' LEU . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.675 ' HB2' ' CB ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.765 HD13 ' CE2' ' A' ' 149' ' ' PHE . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.69 ' HB3' ' HZ ' ' A' ' 217' ' ' PHE . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.74 0.305 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.616 ' OG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.648 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.574 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.557 ' OG ' ' HB1' ' A' ' 162' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.645 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.787 HG22 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.516 ' HG ' ' CG2' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 50.4 m-80 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.771 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.795 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.553 HD13 HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.513 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.891 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.829 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.6 HD22 ' CD2' ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.891 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.829 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.599 ' O ' HD21 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.599 HD21 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.631 HD11 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.737 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.704 HG23 ' HB2' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.509 ' HE2' HG12 ' A' ' 317' ' ' ILE . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.425 HD22 HG21 ' A' ' 320' ' ' THR . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 64' ' ' HIS . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.515 ' HB3' ' HE2' ' A' ' 336' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.808 HG23 ' HD2' ' A' ' 334' ' ' PRO . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.808 ' HD2' HG23 ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.515 ' HE2' ' HB3' ' A' ' 331' ' ' PRO . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.566 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.634 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.825 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.842 HD21 ' HG3' ' A' ' 355' ' ' GLN . 0.6 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.842 ' HG3' HD21 ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.772 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.762 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' HD11 ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.708 ' HB3' HG13 ' A' ' 60' ' ' ILE . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' CG ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.863 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.757 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.757 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.755 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.603 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.755 ' CB ' ' HB3' ' A' ' 27' ' ' PHE . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' CD ' HD11 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.785 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.785 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' CD ' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.694 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.708 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.821 ' HB3' HD23 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.845 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.724 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.465 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.845 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.595 ' HB3' HG21 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.748 HG22 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.746 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.746 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.667 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.554 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 94' ' ' TRP . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 103' ' ' LEU . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HB3' HG23 ' A' ' 261' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.627 ' N ' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 261' ' ' VAL . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.442 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.615 ' CB ' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.669 ' HB2' ' CD1' ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.825 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.452 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.848 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.452 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.687 HG12 HD21 ' A' ' 147' ' ' LEU . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.697 HD23 ' HB1' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 145' ' ' SER . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.702 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.697 ' HB1' HD23 ' A' ' 135' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.693 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 1.074 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.681 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HG ' ' HB2' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.681 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.402 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.764 HG22 HD11 ' A' ' 161' ' ' ILE . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.477 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.719 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.515 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' H ' ' A' ' 164' ' ' ASP . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.401 ' H ' ' HB1' ' A' ' 163' ' ' ALA . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.437 ' HB2' HD11 ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG11 HE21 ' A' ' 365' ' ' GLN . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.4 HD21 ' H ' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.4 ' H ' HD21 ' A' ' 185' ' ' ASN . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.771 ' HA ' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.735 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.65 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.626 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.683 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.683 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.789 ' HB2' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.9 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.9 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.545 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.991 ' HD2' ' HA ' ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.651 ' C ' HG22 ' A' ' 222' ' ' THR . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 221' ' ' GLU . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 1.074 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.991 ' HA ' ' HD2' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.684 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.494 ' H ' HH12 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.953 0.406 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.565 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.519 ' N ' HG21 ' A' ' 246' ' ' VAL . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.848 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 1.025 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 1.025 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.719 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.499 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.437 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.565 ' HA ' HD22 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.748 ' HE3' HG22 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.818 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.818 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.662 HD12 HG12 ' A' ' 293' ' ' VAL . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 1.071 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 296' ' ' ASP . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.863 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.596 HD21 HD12 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 1.071 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 292' ' ' ALA . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.687 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.687 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.661 ' CB ' HG13 ' A' ' 317' ' ' ILE . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 302' ' ' VAL . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 1.014 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.812 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 1.035 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 1.035 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 319' ' ' ALA . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.684 HH12 ' HA ' ' A' ' 229' ' ' PRO . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.661 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 315' ' ' PRO . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.615 HG23 ' CB ' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.565 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.676 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.554 HD11 ' HB1' ' A' ' 96' ' ' ALA . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.738 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 333' ' ' ILE . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.432 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.479 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.681 ' H ' HG13 ' A' ' 348' ' ' ILE . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.599 HD12 ' CG2' ' A' ' 357' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.624 HE21 HG11 ' A' ' 181' ' ' VAL . 1.2 tm0? -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 365' ' ' GLN . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.481 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.842 ' HB3' HD13 ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.834 HG11 ' CB ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.642 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.711 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.544 HG22 ' OD2' ' A' ' 14' ' ' ASP . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.55 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.758 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.605 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 7' ' ' LEU . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' OE2' HD22 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' CZ2' ' A' ' 10' ' ' TRP . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.681 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.705 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.834 ' CB ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.842 HD13 ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.816 ' HB3' HD23 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.856 ' O ' ' HG ' ' A' ' 262' ' ' LEU . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 67' ' ' PHE . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.98 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' C ' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.856 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.769 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.856 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.769 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 93' ' ' THR . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.59 ' HD2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.59 ' CD1' ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HB2' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 301' ' ' ALA . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 229' ' ' PRO . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.71 ' HB2' HG22 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.747 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.862 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.862 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.767 ' HB2' HD22 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.634 ' C ' HD23 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.63 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.751 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.902 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.751 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.714 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.444 ' HG1' ' H ' ' A' ' 158' ' ' TRP . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.557 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.714 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.915 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.684 HD13 HD23 ' A' ' 192' ' ' LEU . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.537 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.659 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.633 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.659 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HB ' ' CD ' ' A' ' 365' ' ' GLN . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.549 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.684 HD23 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.787 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.539 ' O ' HD21 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 196' ' ' VAL . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.774 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.774 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.695 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.526 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.82 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.816 ' HA ' HG21 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.705 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 113' ' ' LEU . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.801 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 231' ' ' ALA . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.801 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.471 HD22 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.747 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.72 HG23 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.915 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 1.001 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 1.001 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.658 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.727 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.856 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.942 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.754 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 77' ' ' ALA . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.584 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.717 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.636 HG22 ' H ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.808 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 293' ' ' VAL . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.62 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.808 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HA ' ' A' ' 109' ' ' ALA . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.431 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.98 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.765 ' HA ' ' CD1' ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.765 ' CD1' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.563 ' CB ' HD12 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.737 HG22 ' HA2' ' A' ' 300' ' ' GLY . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.426 ' HG1' HG11 ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.615 ' HE2' ' OE2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 257' ' ' PRO . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.734 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.701 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.687 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.619 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 336' ' ' MET . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.753 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 353' ' ' GLY . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 352' ' ' SER . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 352' ' ' SER . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.753 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 11.5 mm100 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.838 HG22 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.838 ' HB2' HG22 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.508 ' O ' ' HB1' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 192' ' ' LEU . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 360' ' ' ALA . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.591 ' HA ' HG23 ' A' ' 368' ' ' ILE . 0.4 OUTLIER -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.462 ' NH1' ' HB2' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.863 HD11 ' HB2' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.636 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.822 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.677 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.545 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.759 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' H ' HD11 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.73 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' OD2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.822 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.636 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 8' ' ' VAL . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.802 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HD2' HD13 ' A' ' 108' ' ' ILE . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.679 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 105' ' ' ALA . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.894 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.679 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.943 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.82 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 72' ' ' GLN . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.403 HG23 ' NZ ' ' A' ' 273' ' ' LYS . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.653 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.653 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CE2' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HA ' ' HZ3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 90' ' ' TYR . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.604 ' CE2' HD12 ' A' ' 89' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.82 HD12 ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.757 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.637 ' C ' HG22 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.898 HD22 HG23 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.804 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.493 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.747 ' CD2' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.493 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.417 ' CH2' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.852 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.852 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.936 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.936 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.487 ' HB2' HD13 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.666 ' HE1' ' HB2' ' A' ' 216' ' ' ALA . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.728 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.404 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.45 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.627 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.621 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.515 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.627 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.417 HD12 ' CH2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.832 HD12 ' HB2' ' A' ' 192' ' ' LEU . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.408 ' HB3' ' H ' ' A' ' 164' ' ' ASP . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.608 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.591 HG21 ' H ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.591 ' H ' HG21 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.897 ' HZ2' ' HB3' ' A' ' 362' ' ' LYS . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.965 ' HA ' ' HZ2' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.456 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.627 ' CB ' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.627 HD13 ' CB ' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.856 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.856 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.753 ' O ' HG21 ' A' ' 222' ' ' THR . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.753 HG21 ' O ' ' A' ' 221' ' ' GLU . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.714 ' HE3' HD12 ' A' ' 226' ' ' ILE . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.804 ' HB ' HG12 ' A' ' 116' ' ' ILE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.898 HG23 HD22 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.673 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.433 ' HD3' HD12 ' A' ' 113' ' ' LEU . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.533 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.545 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.506 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.776 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.964 HG11 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.722 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.943 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.913 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 272' ' ' ASN . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 270' ' ' SER . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.735 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.73 ' HA ' ' CD1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.73 ' CD1' ' HA ' ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.66 ' HG ' HD11 ' A' ' 290' ' ' LEU . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.611 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.66 HD11 ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.638 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 1.001 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.604 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 1.001 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.785 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.785 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.681 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.439 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.712 ' CA ' HG23 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.637 HG22 ' C ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.842 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.615 ' HZ3' ' HA ' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.883 ' HA ' HD11 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.883 HD11 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.786 HD13 ' HB3' ' A' ' 311' ' ' LEU . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.776 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.964 ' HA ' HG11 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.643 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.894 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.664 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.664 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.608 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.699 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.844 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.844 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.757 HE21 ' HB1' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.757 ' HB1' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.764 HD11 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.897 ' HB3' ' HZ2' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.853 ' HG2' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.623 0.249 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 279' ' ' PHE . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.641 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.677 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.79 ' HB3' HG22 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TRP . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.502 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.608 HG23 ' HA3' ' A' ' 289' ' ' GLY . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.563 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG23 ' HA3' ' A' ' 24' ' ' GLY . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.764 ' HA ' HD13 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.641 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 9' ' ' ILE . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG22 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' HG23 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.651 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.651 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.626 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 104' ' ' ILE . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.566 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.606 ' HB1' HD22 ' A' ' 89' ' ' LEU . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.606 HD22 ' HB1' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.568 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 90' ' ' TYR . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.787 HG12 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.527 ' CD1' HD13 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB3' HG11 ' A' ' 97' ' ' VAL . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.787 ' HD3' HG12 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' PRO . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.875 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.547 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.859 HD23 ' HG1' ' A' ' 245' ' ' THR . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.561 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.508 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.64 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.561 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 1.06 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 1.06 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.791 ' HB3' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.713 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 1.062 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.5 ' CB ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.409 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 208' ' ' THR . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.551 ' CE2' HD12 ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 158' ' ' TRP . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.54 ' H ' HG23 ' A' ' 157' ' ' THR . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.779 ' HB3' HD23 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 158' ' ' TRP . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.475 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 177' ' ' ASP . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.61 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 180' ' ' ASP . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.731 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.536 ' OD1' ' HE2' ' A' ' 204' ' ' MET . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.758 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.758 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.5 ' HB1' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.915 ' CD2' HG21 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 1.062 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.915 HG21 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.875 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.973 0.416 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 319' ' ' ALA . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.859 ' HG1' HD23 ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.589 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.511 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.468 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.664 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.704 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.605 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.714 ' HB2' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.645 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.405 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.636 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 21.5 m120 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.65 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.613 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.706 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 283' ' ' TYR . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.608 ' HA3' HG23 ' A' ' 23' ' ' VAL . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.892 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.782 ' HB ' HD22 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.782 HD22 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.736 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.699 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.66 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.709 ' HB ' ' HB1' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.571 ' HB3' HG11 ' A' ' 244' ' ' VAL . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.589 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.473 HD13 ' HB1' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.434 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 14.4 m120 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.473 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.479 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 351' ' ' ALA . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 345' ' ' THR . 0.3 OUTLIER -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 347' ' ' VAL . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 1.056 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.758 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.758 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.533 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.849 0.356 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.953 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 59' ' ' ILE . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.637 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.82 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.845 ' HZ3' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.747 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 7' ' ' LEU . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.621 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.669 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.953 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.638 ' HB2' HG21 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.934 HD13 ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.637 ' CD1' ' HB3' ' A' ' 10' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 108' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 67' ' ' PHE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.84 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.625 ' HA ' HG21 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.52 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' LYS . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.656 ' CB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.842 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' CB ' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.842 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 105' ' ' ALA . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.657 HD11 ' OE1' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 97' ' ' VAL . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 108' ' ' ILE . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 107' ' ' PRO . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.566 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.749 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.719 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.668 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.717 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.733 ' CH2' ' HE1' ' A' ' 224' ' ' MET . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.687 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.717 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 147' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.459 HD23 ' CD ' ' A' ' 138' ' ' GLU . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 139' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.713 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.622 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.713 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 132' ' ' ILE . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.702 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 156' ' ' PHE . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.599 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.633 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.613 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.599 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.874 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 171' ' ' TYR . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.528 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.427 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.502 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 182' ' ' GLY . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.731 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.475 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.799 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.899 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.899 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.808 ' O ' HG22 ' A' ' 222' ' ' THR . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 221' ' ' GLU . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.733 ' HE1' ' CH2' ' A' ' 129' ' ' TRP . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.98 HG22 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.758 HG21 HD23 ' A' ' 113' ' ' LEU . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.749 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.71 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.823 HG23 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 1.033 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 1.033 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.861 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.701 ' O ' ' HE1' ' A' ' 330' ' ' MET . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 58' ' ' ASP . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.535 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.897 ' HG ' HD11 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.68 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.897 HD11 ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.024 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.63 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.845 ' HG2' ' HZ3' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.874 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.827 ' HB3' HD12 ' A' ' 290' ' ' LEU . 16.8 t-20 -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.874 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.792 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.579 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.748 ' HB1' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 1.024 HD13 HD23 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.881 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 318' ' ' ALA . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.706 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.807 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 315' ' ' PRO . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.542 HD22 HG23 ' A' ' 246' ' ' VAL . 2.1 m-80 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.861 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.415 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.566 ' O ' HG13 ' A' ' 343' ' ' VAL . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.514 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.559 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.872 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB3' ' CD2' ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 343' ' ' VAL . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.722 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.722 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.66 ' O ' ' HB2' ' A' ' 360' ' ' ALA . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.86 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 356' ' ' THR . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.86 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.731 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.0 tm0? -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.626 ' O ' HG21 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 369' ' ' THR . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.58 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.919 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.983 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.79 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.785 ' H ' HD13 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.653 ' OD2' HD12 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 23' ' ' VAL . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.915 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.625 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.915 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.794 ' O ' HG23 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.983 HG11 HG21 ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.713 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.705 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' HG1' ' A' ' 53' ' ' THR . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.919 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.512 ' HE2' HG23 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.733 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.733 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.909 ' HB3' ' HE3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.916 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.728 ' C ' ' HB2' ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.542 ' N ' HD21 ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.728 ' HB2' ' C ' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.631 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 305' ' ' LYS . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.924 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.764 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 92' ' ' PHE . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.512 HG23 ' HE2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 1.018 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.635 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.796 ' HB3' HG21 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.464 ' CD2' HD21 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 243' ' ' GLY . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.634 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 121' ' ' LEU . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.462 ' HD2' HD13 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.415 HD21 ' HD2' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' HD21 ' A' ' 124' ' ' ASN . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.833 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.887 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.49 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.939 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.939 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.462 HD13 ' HD2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.723 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.882 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.653 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.524 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.796 ' CE2' HG22 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.796 HG22 ' CE2' ' A' ' 156' ' ' PHE . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.743 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.743 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 164' ' ' ASP . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE2' HD11 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.56 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.861 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.861 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.556 HG22 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.536 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.413 ' O ' HG21 ' A' ' 196' ' ' VAL . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' HG23 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 193' ' ' THR . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.602 HG12 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.62 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.604 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.672 ' HB ' HG22 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.701 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 222' ' ' THR . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 221' ' ' GLU . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.653 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.816 ' H ' HG22 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.613 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.796 HG21 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 247' ' ' LEU . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.625 ' HA ' HD11 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 160' ' ' LEU . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.728 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.599 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.607 ' HZ3' ' N ' ' A' ' 328' ' ' GLU . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 1.018 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.916 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.773 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.788 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.788 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.667 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.736 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.667 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 286' ' ' THR . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 285' ' ' LEU . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 1.057 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.413 HG11 HD21 ' A' ' 294' ' ' ASN . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.819 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 1.4 m-80 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 1.057 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.749 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.871 ' HB3' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.933 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.924 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.652 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.837 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.652 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.879 ' HB3' HG22 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.701 ' HB3' HD12 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.534 ' O ' ' HB1' ' A' ' 319' ' ' ALA . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.749 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.879 HG22 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 315' ' ' PRO . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.553 ' HA ' HD22 ' A' ' 323' ' ' ASN . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.553 HD22 ' HA ' ' A' ' 320' ' ' THR . 6.2 p30 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.607 ' N ' ' HZ3' ' A' ' 256' ' ' LYS . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.909 ' HE3' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.912 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.912 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.556 ' NE2' HD13 ' A' ' 333' ' ' ILE . 38.5 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.526 ' O ' HG21 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.59 HH11 ' HG3' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 351' ' ' ALA . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.802 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 347' ' ' VAL . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.691 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.835 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.691 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.835 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.668 ' O ' HD13 ' A' ' 368' ' ' ILE . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.556 ' OE1' HG22 ' A' ' 183' ' ' VAL . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.598 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 1.105 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 1.105 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.546 ' C ' HG22 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.786 ' HB3' HD12 ' A' ' 59' ' ' ILE . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.945 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.989 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 10' ' ' TRP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.69 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.483 ' CB ' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 24' ' ' GLY . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 23' ' ' VAL . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HA ' ' A' ' 6' ' ' LYS . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HA ' HD22 ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.658 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.49 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' THR . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' C ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.5 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.557 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.945 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 ' HB3' ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.989 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HE1' ' CG2' ' A' ' 108' ' ' ILE . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 1.055 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.633 ' CD2' HG22 ' A' ' 261' ' ' VAL . 0.4 OUTLIER -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.992 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.708 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' HD21 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 HD21 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.754 ' CB ' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.637 HG21 ' HE3' ' A' ' 277' ' ' LYS . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.634 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.57 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.634 ' CZ2' ' HB3' ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 92' ' ' PHE . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.708 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.992 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.834 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' HG21 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.778 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.534 HD23 HD21 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.778 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.505 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.747 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 1.012 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 1.012 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.74 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.495 ' CD1' ' HB1' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HB1' ' CD1' ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.555 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.517 HD12 ' ND1' ' A' ' 203' ' ' HIS . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.639 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.57 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.981 ' HB3' HD13 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 157' ' ' THR . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.521 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.65 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.542 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.732 ' HA2' HD22 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.868 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.591 ' CZ ' HG23 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.854 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.541 HD11 ' C ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 178' ' ' ILE . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.507 HG12 ' OE1' ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.614 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.732 HD22 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.996 ' HA ' ' HZ3' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.996 ' HZ3' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.534 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.642 ' CD2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.981 HD13 ' HB3' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.517 ' ND1' HD12 ' A' ' 151' ' ' LEU . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.573 ' OD1' HD13 ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.573 HD13 ' OD1' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.956 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.956 ' CE2' ' HA ' ' A' ' 214' ' ' GLU . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.693 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.445 ' C ' HG22 ' A' ' 222' ' ' THR . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.729 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.92 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.496 HG21 ' N ' ' A' ' 247' ' ' LEU . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.496 ' N ' HG21 ' A' ' 246' ' ' VAL . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.747 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.849 HG23 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.542 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.849 ' HD3' HG23 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.65 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.633 HG22 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 1.055 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 67' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.921 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.601 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.949 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.949 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.77 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.77 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.718 ' O ' HD21 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.727 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.495 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.727 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 1.097 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.767 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.539 ' HB3' HD22 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 1.097 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.767 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.594 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.594 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.894 ' HA ' HG23 ' A' ' 317' ' ' ILE . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.472 HG22 ' N ' ' A' ' 303' ' ' ALA . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.472 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CE2' HD12 ' A' ' 304' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.885 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.71 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.885 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 301' ' ' ALA . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.428 ' HA ' ' OD1' ' A' ' 323' ' ' ASN . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.568 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.767 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.854 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.414 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.521 HE22 HG13 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.686 ' HB2' HG21 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 346' ' ' ALA . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.608 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.648 ' O ' ' HB1' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.608 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.973 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 346' ' ' ALA . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.837 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 4.7 mm100 -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' A' ' 360' ' ' ALA . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 356' ' ' THR . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.614 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.54 ' O ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 365' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.656 ' C ' HG21 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 1.159 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.594 ' C ' HG13 ' A' ' 11' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 17' ' ' TYR . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.708 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.656 HG21 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.708 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 7' ' ' LEU . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.936 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 1.159 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.679 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HB ' ' HZ ' ' A' ' 67' ' ' PHE . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.675 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.762 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 1.083 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 16.3 t-80 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.685 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.709 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.809 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.767 HE21 HG21 ' A' ' 104' ' ' ILE . 1.2 tt0 -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.809 ' HG ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.695 ' HG2' ' HG2' ' A' ' 102' ' ' LYS . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 88' ' ' LYS . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.826 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.481 ' HH2' ' CZ ' ' A' ' 85' ' ' PHE . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' HD2' HD22 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.695 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.767 HG21 HE21 ' A' ' 72' ' ' GLN . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HH ' HD13 ' A' ' 285' ' ' LEU . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.977 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.598 ' H ' ' CG2' ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.504 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.493 ' C ' HD21 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.494 HD21 ' N ' ' A' ' 113' ' ' LEU . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' HG21 ' A' ' 226' ' ' ILE . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.624 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.64 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.516 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.433 HG22 ' HG3' ' A' ' 130' ' ' GLU . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.852 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.524 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.732 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.748 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.586 ' HZ3' ' HZ3' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.685 ' HG3' HD21 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.726 ' CB ' HD11 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.718 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.795 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.586 ' HB1' ' H ' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' HD1' ' A' ' 169' ' ' PHE . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.555 ' HD1' ' HB1' ' A' ' 168' ' ' ALA . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.629 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.629 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' NE2' ' A' ' 365' ' ' GLN . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.795 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.641 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.658 ' CD1' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.695 ' HA ' ' HD3' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.531 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.417 ' HD2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 203' ' ' HIS . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.581 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.816 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.919 ' CE1' HG21 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.574 ' HB2' ' HG2' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.483 ' C ' HG22 ' A' ' 222' ' ' THR . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 145' ' ' SER . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.735 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.919 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.473 ' H ' ' HE1' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.571 ' ND2' HG22 ' A' ' 225' ' ' THR . 3.9 m-80 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.504 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.638 0.256 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.641 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.401 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.842 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.588 ' NZ ' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.743 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.977 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 1.083 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.709 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 75' ' ' LEU . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.471 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.845 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.741 HD13 ' HH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.874 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.727 ' O ' HG21 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.699 ' O ' HD11 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.679 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 110' ' ' VAL . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.813 ' HG3' HD21 ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 1.01 HD23 HG23 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 1.01 HG23 HD23 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.467 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.445 HD22 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.57 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 344' ' ' ARG . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.469 ' N ' HG11 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.691 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 360' ' ' ALA . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 361' ' ' LEU . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.737 ' O ' ' HB1' ' A' ' 364' ' ' ALA . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 357' ' ' VAL . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.677 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.923 ' HG3' HG22 ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 369' ' ' THR . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 366' ' ' THR . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.467 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.892 0.377 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.901 ' HB3' HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.845 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.681 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.515 HD22 ' HZ3' ' A' ' 62' ' ' TRP . 1.6 p30 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.497 ' CA ' ' HH ' ' A' ' 283' ' ' TYR . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.599 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.605 ' CG2' HG21 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 7' ' ' LEU . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.845 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.566 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.507 HD13 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HE3' HD13 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.715 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 50' ' ' VAL . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.766 ' HB3' HG13 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.803 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.533 ' CB ' ' HB2' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.881 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.881 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.604 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.666 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.862 HD22 HD21 ' A' ' 267' ' ' ASN . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.522 HG21 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.522 ' HD2' HG21 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' O ' ' HZ2' ' A' ' 94' ' ' TRP . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.528 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 94' ' ' TRP . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.604 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.478 HD13 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.66 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.882 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 1.05 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.653 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.799 HG23 ' N ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.48 ' HH ' ' HD3' ' A' ' 125' ' ' PRO . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' N ' HD21 ' A' ' 118' ' ' ASN . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.671 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.716 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.646 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.684 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.716 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.856 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.856 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.954 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.954 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.628 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.839 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.947 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.535 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.741 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.832 ' H ' ' HG ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.595 ' HD2' HG21 ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.595 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.659 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HG2' ' HZ3' ' A' ' 189' ' ' LYS . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.465 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.64 ' HZ1' ' ND1' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.64 ' ND1' ' HZ1' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' HIS . 5.6 p30 -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.762 HG23 ' HB1' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.797 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.576 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.986 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.986 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 20.5 t-20 -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.569 HG23 ' C ' ' A' ' 221' ' ' GLU . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.947 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.799 ' N ' HG23 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.444 ' ND2' ' HB1' ' A' ' 231' ' ' ALA . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 1.05 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.635 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 227' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.653 ' CG2' ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.509 HG23 ' ND2' ' A' ' 323' ' ' ASN . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.776 HG21 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.748 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.447 ' HG2' ' C ' ' A' ' 252' ' ' GLY . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.776 ' HD3' HG21 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.832 ' HG ' ' H ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.418 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.862 HD21 HD22 ' A' ' 75' ' ' LEU . 13.6 m120 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 15.1 m120 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.81 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.48 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.549 ' HD1' ' CD2' ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.549 ' CD2' ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.772 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.406 ' O ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.837 ' HA ' HD22 ' A' ' 294' ' ' ASN . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 290' ' ' LEU . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.837 HD22 ' HA ' ' A' ' 291' ' ' GLU . 12.7 p30 -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.725 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.678 HD11 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.715 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 302' ' ' VAL . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.761 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.761 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.726 ' OE2' ' HE2' ' A' ' 321' ' ' MET . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.839 HD21 HG22 ' A' ' 317' ' ' ILE . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.663 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.711 ' CG ' ' HA ' ' A' ' 311' ' ' LEU . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 311' ' ' LEU . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.726 ' HE2' ' OE2' ' A' ' 308' ' ' GLU . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.509 ' ND2' HG23 ' A' ' 246' ' ' VAL . 12.4 m120 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.545 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.454 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 347' ' ' VAL . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.692 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 343' ' ' VAL . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.692 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.656 ' O ' ' HB1' ' A' ' 360' ' ' ALA . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.835 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 356' ' ' THR . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.763 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.74 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.9 mm100 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.24 153.02 49.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.72 157.46 41.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.53 174.18 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.827 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 18.0 t-20 -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.728 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' HG21 ' A' ' 23' ' ' VAL . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.781 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.644 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.415 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.781 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.827 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.621 ' H ' HG21 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' HD22 ' A' ' 12' ' ' ASN . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' HA ' ' HZ2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.81 ' HZ2' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 46' ' ' LYS . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.947 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.787 ' HB2' HG22 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.695 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.645 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.699 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.699 HD11 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.566 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.753 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.566 ' CG2' ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.919 ' HA ' HG11 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.684 ' O ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.729 HD12 ' HA2' ' A' ' 68' ' ' GLY . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 301' ' ' ALA . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 320' ' ' THR . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.569 HG13 ' HG1' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.659 ' CD1' HD12 ' A' ' 122' ' ' LEU . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.791 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.791 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.426 ' CD2' ' HZ2' ' A' ' 144' ' ' LYS . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.899 HD21 ' HB3' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.565 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 1.054 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HE3' ' CB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.648 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.054 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.801 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.753 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' OE2' HD21 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HZ2' ' CD2' ' A' ' 121' ' ' LEU . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.421 ' C ' ' HG1' ' A' ' 222' ' ' THR . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.558 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.675 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.502 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HD13 ' A' ' 226' ' ' ILE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.721 ' N ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.679 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.893 ' CE1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.555 ' CB ' HD23 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.539 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.679 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.893 HD13 ' CE1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.829 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.557 ' HB1' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.574 ' HB2' ' HB3' ' A' ' 250' ' ' PHE . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.889 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.873 ' HH ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.873 ' HA2' ' HH ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.555 HG22 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.889 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.772 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.782 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.444 ' O ' HD13 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.782 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.605 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.829 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.555 HD23 ' CB ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.411 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 1.026 ' HB ' HD13 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.897 ' HB2' HD11 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.67 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.718 ' HA ' HG23 ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.899 ' HB3' HD21 ' A' ' 122' ' ' LEU . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.675 ' HB2' ' CB ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.718 HG23 ' HA ' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.765 HD13 ' CE2' ' A' ' 149' ' ' PHE . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.912 HD21 ' HE1' ' A' ' 232' ' ' TRP . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.811 ' HA ' ' CH2' ' A' ' 232' ' ' TRP . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.79 24.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.912 ' HE1' HD21 ' A' ' 227' ' ' ASN . 12.5 m0 -99.05 128.47 45.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.27 115.58 27.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.181 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 60.99 114.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 236' ' ' ASP . 0.9 OUTLIER -62.53 -76.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.753 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.499 ' H ' ' CG1' ' A' ' 235' ' ' ILE . 3.1 m-20 60.41 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.895 0.378 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 13.5 p -71.78 78.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.468 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 179.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.109 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 27.2 2.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 242' ' ' TYR . 21.8 t -110.37 130.37 63.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.055 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -81.56 137.26 35.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.613 ' HE1' ' HB ' ' A' ' 240' ' ' VAL . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.616 ' OG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.648 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.574 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.557 ' OG ' ' HB1' ' A' ' 162' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.787 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.645 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.787 HG22 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.516 ' HG ' ' CG2' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 50.4 m-80 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.771 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.795 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.795 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.553 HD13 HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.547 ' HA ' HD11 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.513 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.891 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.829 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.6 HD22 ' CD2' ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.891 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.829 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.599 ' O ' HD21 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.599 HD21 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.631 HD11 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.737 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.704 HG23 ' HB2' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.509 ' HE2' HG12 ' A' ' 317' ' ' ILE . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.425 HD22 HG21 ' A' ' 320' ' ' THR . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 64' ' ' HIS . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.515 ' HB3' ' HE2' ' A' ' 336' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.808 HG23 ' HD2' ' A' ' 334' ' ' PRO . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.808 ' HD2' HG23 ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.515 ' HE2' ' HB3' ' A' ' 331' ' ' PRO . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.566 ' O ' ' HB ' ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.634 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.825 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.842 HD21 ' HG3' ' A' ' 355' ' ' GLN . 0.6 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.842 ' HG3' HD21 ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.772 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.762 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.762 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.757 0.313 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 p -136.48 87.66 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.013 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -116.17 111.51 20.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -178.87 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.705 ' HB3' HD11 ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG11 ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.708 ' HB3' HG13 ' A' ' 60' ' ' ILE . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' CG ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.863 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.757 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.757 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.755 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.603 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.755 ' CB ' ' HB3' ' A' ' 27' ' ' PHE . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' CD ' HD11 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.785 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.785 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' CD ' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.694 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.708 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.821 ' HB3' HD23 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.845 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.724 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.465 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.845 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.595 ' HB3' HG21 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.748 HG22 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.746 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.746 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.426 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.667 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.554 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 94' ' ' TRP . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 103' ' ' LEU . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.595 HG21 ' HB3' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HB3' HG23 ' A' ' 261' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.627 ' N ' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 261' ' ' VAL . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.442 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.615 ' CB ' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.757 ' HB2' ' CZ3' ' A' ' 232' ' ' TRP . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.669 ' HB2' ' CD1' ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.825 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.452 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.848 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.452 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.687 HG12 HD21 ' A' ' 147' ' ' LEU . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.697 HD23 ' HB1' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 145' ' ' SER . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.702 ' O ' HD22 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.697 ' HB1' HD23 ' A' ' 135' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.693 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 1.074 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.681 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HG ' ' HB2' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.681 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.402 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.764 HG22 HD11 ' A' ' 161' ' ' ILE . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.477 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.719 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.515 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' H ' ' A' ' 164' ' ' ASP . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.401 ' H ' ' HB1' ' A' ' 163' ' ' ALA . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.437 ' HB2' HD11 ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG11 HE21 ' A' ' 365' ' ' GLN . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.462 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.4 HD21 ' H ' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.4 ' H ' HD21 ' A' ' 185' ' ' ASN . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.771 ' HA ' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.735 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.65 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.626 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.683 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.683 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.789 ' HB2' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.482 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.9 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.9 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.545 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.991 ' HD2' ' HA ' ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.651 ' C ' HG22 ' A' ' 222' ' ' THR . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 221' ' ' GLU . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 1.074 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.991 ' HA ' ' HD2' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.684 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.494 ' H ' HH12 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.96 -60.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.757 ' CZ3' ' HB2' ' A' ' 114' ' ' SER . 1.4 p90 -91.31 -2.49 57.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.264 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.31 68.84 10.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.441 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 64.35 154.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.753 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.618 HD12 ' N ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -135.61 -24.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.913 -179.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.402 ' C ' ' HG1' ' A' ' 237' ' ' THR . 1.8 p30 -172.16 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.2 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 236' ' ' ASP . 5.1 m -151.52 150.41 30.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.63 0.252 . . . . 0.0 110.858 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.9 m -66.72 105.53 1.59 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.73 ' O ' HG12 ' A' ' 240' ' ' VAL . 2.6 mmmm -107.39 -24.01 12.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.212 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 239' ' ' LYS . 14.7 p 42.44 59.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.34 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.97 65.26 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.565 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.519 ' N ' HG21 ' A' ' 246' ' ' VAL . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.848 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 1.025 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 1.025 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.719 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.697 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.499 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.437 ' C ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.565 ' HA ' HD22 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.748 ' HE3' HG22 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.818 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.818 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.662 HD12 HG12 ' A' ' 293' ' ' VAL . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 1.071 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 296' ' ' ASP . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.863 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.596 HD21 HD12 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 1.071 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 292' ' ' ALA . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.687 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.687 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.661 ' CB ' HG13 ' A' ' 317' ' ' ILE . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 302' ' ' VAL . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 1.014 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.812 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.812 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 1.035 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 1.035 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 319' ' ' ALA . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.684 HH12 ' HA ' ' A' ' 229' ' ' PRO . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.661 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 315' ' ' PRO . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.615 HG23 ' CB ' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.565 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.676 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.554 HD11 ' HB1' ' A' ' 96' ' ' ALA . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.738 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 333' ' ' ILE . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.432 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.479 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.681 ' H ' HG13 ' A' ' 348' ' ' ILE . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.631 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.599 ' CG2' HD12 ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.599 HD12 ' CG2' ' A' ' 357' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.624 HE21 HG11 ' A' ' 181' ' ' VAL . 1.2 tm0? -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 365' ' ' GLN . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.481 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.738 0.304 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -127.37 101.25 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.591 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.39 155.87 35.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.518 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -128.26 126.25 40.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.8 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.842 ' HB3' HD13 ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.834 HG11 ' CB ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.642 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.711 ' HB2' ' HB ' ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.544 HG22 ' OD2' ' A' ' 14' ' ' ASP . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.55 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.758 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.605 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 7' ' ' LEU . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' OE2' HD22 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' CZ2' ' A' ' 10' ' ' TRP . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.681 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.705 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.834 ' CB ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.842 HD13 ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.816 ' HB3' HD23 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.856 ' O ' ' HG ' ' A' ' 262' ' ' LEU . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.942 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.754 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 67' ' ' PHE . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 0.1 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.98 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' C ' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.856 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.769 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.49 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.856 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.769 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 93' ' ' THR . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.59 ' HD2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.59 ' CD1' ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HB2' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 301' ' ' ALA . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 229' ' ' PRO . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.71 ' HB2' HG22 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.747 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.862 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.862 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.767 ' HB2' HD22 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.634 ' C ' HD23 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.63 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.767 HD22 ' HB2' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.751 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.902 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.751 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.714 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.444 ' HG1' ' H ' ' A' ' 158' ' ' TRP . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.557 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.714 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.915 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.684 HD13 HD23 ' A' ' 192' ' ' LEU . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.537 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.659 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.633 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.659 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.494 ' HB ' ' CD ' ' A' ' 365' ' ' GLN . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.549 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.684 HD23 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.787 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.539 ' O ' HD21 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 196' ' ' VAL . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.774 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.774 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.695 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.526 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.82 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.816 ' HA ' HG21 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.63 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.705 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 113' ' ' LEU . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.801 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 231' ' ' ALA . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.801 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . -98.07 -38.66 9.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.524 ' HB3' ' OD1' ' A' ' 234' ' ' ASN . 75.7 m95 -87.43 -80.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.671 0.272 . . . . 0.0 110.651 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.48 31.01 19.59 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.763 0.316 . . . . 0.0 111.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 232' ' ' TRP . 6.4 p-10 -108.37 167.67 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.869 HD11 ' O ' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -152.92 48.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.834 0.826 . . . . 0.0 110.564 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -157.99 157.17 32.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.671 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.23 115.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.12 120.23 21.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.95 156.69 16.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 240' ' ' VAL . 12.2 p -170.96 -21.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.968 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.28 56.55 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 240' ' ' VAL . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.471 HD22 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.747 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.72 HG23 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.915 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 1.001 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 1.001 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.658 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.727 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.856 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.942 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.754 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 77' ' ' ALA . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.584 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.717 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.636 HG22 ' H ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.808 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 293' ' ' VAL . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.62 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.808 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.737 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.804 ' HB3' ' HA ' ' A' ' 109' ' ' ALA . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.431 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.98 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.765 ' HA ' ' CD1' ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.765 ' CD1' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.563 ' CB ' HD12 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.808 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.737 HG22 ' HA2' ' A' ' 300' ' ' GLY . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.426 ' HG1' HG11 ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.615 ' HE2' ' OE2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 257' ' ' PRO . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.734 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.701 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.687 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.619 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.863 ' HB2' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 336' ' ' MET . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.753 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' A' ' 353' ' ' GLY . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . 0.624 ' N ' ' HG ' ' A' ' 352' ' ' SER . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 352' ' ' SER . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.753 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 11.5 mm100 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.838 HG22 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.838 ' HB2' HG22 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.508 ' O ' ' HB1' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 192' ' ' LEU . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 360' ' ' ALA . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.591 ' HA ' HG23 ' A' ' 368' ' ' ILE . 0.4 OUTLIER -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.462 ' NH1' ' HB2' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.863 HD11 ' HB2' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.762 0.315 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -116.01 145.14 43.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.574 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -121.72 129.7 52.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -166.83 130.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.636 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.822 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.759 HG12 ' O ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.677 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.545 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.672 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.759 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' H ' HD11 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.73 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' OD2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.822 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.636 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 8' ' ' VAL . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.802 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.431 ' HD2' HD13 ' A' ' 108' ' ' ILE . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.679 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 105' ' ' ALA . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.894 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.679 ' HG2' ' HB2' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.943 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.663 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.675 ' HB3' HD11 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.82 ' HG3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.695 ' HB3' ' HA ' ' A' ' 72' ' ' GLN . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.403 HG23 ' NZ ' ' A' ' 273' ' ' LYS . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.653 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.653 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CE2' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HA ' ' HZ3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 90' ' ' TYR . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.604 ' CE2' HD12 ' A' ' 89' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.602 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.82 HD12 ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.757 ' HB2' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.637 ' C ' HG22 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.898 HD22 HG23 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.804 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.493 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.747 ' CD2' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.493 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.417 ' CH2' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.852 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.852 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.936 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.936 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.487 ' HB2' HD13 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.666 ' HE1' ' HB2' ' A' ' 216' ' ' ALA . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.728 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.404 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.45 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.627 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.621 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.515 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.627 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.417 HD12 ' CH2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.832 HD12 ' HB2' ' A' ' 192' ' ' LEU . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.408 ' HB3' ' H ' ' A' ' 164' ' ' ASP . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.745 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.608 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.591 HG21 ' H ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.591 ' H ' HG21 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.853 HG23 ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.897 ' HZ2' ' HB3' ' A' ' 362' ' ' LYS . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.965 ' HA ' ' HZ2' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.456 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.577 HG21 HD11 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.627 ' CB ' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.627 HD13 ' CB ' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.856 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.856 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.753 ' O ' HG21 ' A' ' 222' ' ' THR . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.753 HG21 ' O ' ' A' ' 221' ' ' GLU . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.714 ' HE3' HD12 ' A' ' 226' ' ' ILE . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.804 ' HB ' HG12 ' A' ' 116' ' ' ILE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.898 HG23 HD22 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.673 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.433 ' HD3' HD12 ' A' ' 113' ' ' LEU . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.533 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.19 -67.89 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.931 ' HZ3' HD12 ' A' ' 235' ' ' ILE . 1.2 m95 -102.18 -17.66 15.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.366 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.24 35.67 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.14 -49.11 0.46 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.754 0.311 . . . . 0.0 110.755 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.931 HD12 ' HZ3' ' A' ' 232' ' ' TRP . 10.4 pt -107.02 -5.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.03 163.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.286 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.5 p -77.3 170.47 16.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.053 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.61 -30.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.421 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.91 -177.49 6.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.779 0.323 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.4 t -132.82 -34.52 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.922 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -79.64 84.75 5.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.545 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.745 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.506 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.776 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.964 HG11 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.722 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.943 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.913 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 272' ' ' ASN . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 270' ' ' SER . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.735 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.796 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.73 ' HA ' ' CD1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.73 ' CD1' ' HA ' ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.66 ' HG ' HD11 ' A' ' 290' ' ' LEU . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.611 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.66 HD11 ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.638 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 1.001 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.604 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 1.001 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.785 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.785 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.681 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.439 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.712 ' CA ' HG23 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.637 HG22 ' C ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.842 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.615 ' HZ3' ' HA ' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.687 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.883 ' HA ' HD11 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.883 HD11 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.786 HD13 ' HB3' ' A' ' 311' ' ' LEU . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.628 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.776 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.964 ' HA ' HG11 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.643 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.894 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.664 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.664 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.608 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.699 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.595 ' HA ' HD13 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.844 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 351' ' ' ALA . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.844 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.757 HE21 ' HB1' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.651 ' O ' ' HG2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.605 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.757 ' HB1' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.764 HD11 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.897 ' HB3' ' HZ2' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.853 ' HG2' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.8 m -105.0 135.46 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 160.23 25.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.332 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.77 151.65 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.819 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 ' CD2' ' A' ' 279' ' ' PHE . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.641 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.677 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.79 ' HB3' HG22 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 10' ' ' TRP . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.502 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.608 HG23 ' HA3' ' A' ' 289' ' ' GLY . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG23 ' HA3' ' A' ' 24' ' ' GLY . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.764 ' HA ' HD13 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.612 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.641 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 9' ' ' ILE . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG22 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' HG23 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.651 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.651 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.626 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.711 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.456 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.683 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 104' ' ' ILE . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.566 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.606 ' HB1' HD22 ' A' ' 89' ' ' LEU . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD22 ' HB1' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.568 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 90' ' ' TYR . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.787 HG12 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.527 ' CD1' HD13 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.608 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB3' HG11 ' A' ' 97' ' ' VAL . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.787 ' HD3' HG12 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' PRO . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.875 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.547 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.859 HD23 ' HG1' ' A' ' 245' ' ' THR . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.528 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.561 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.508 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.64 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.561 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 1.06 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 1.06 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.791 ' HB3' HD22 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.713 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 1.062 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.5 ' CB ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.409 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.618 ' HB2' HG23 ' A' ' 208' ' ' THR . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.58 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.551 ' CE2' HD12 ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 158' ' ' TRP . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.54 ' H ' HG23 ' A' ' 157' ' ' THR . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.779 ' HB3' HD23 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 158' ' ' TRP . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.475 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 177' ' ' ASP . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.61 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 180' ' ' ASP . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.731 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.536 ' OD1' ' HE2' ' A' ' 204' ' ' MET . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.758 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.758 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.5 ' HB1' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.915 ' CD2' HG21 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 1.062 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.915 HG21 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.502 HG22 ' HB2' ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.875 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.98 11.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -97.79 103.23 15.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.49 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.1 m -76.55 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -62.89 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 235' ' ' ILE . 15.9 tt -73.43 116.26 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.069 0.462 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.54 103.57 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 m -66.66 136.45 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 77.5 p -134.88 113.93 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.9 170.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.326 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.69 92.84 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.291 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -170.18 40.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.257 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 319' ' ' ALA . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.859 ' HG1' HD23 ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.589 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.633 ' HA ' HD11 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.511 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.468 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.664 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.704 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.605 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.714 ' HB2' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.645 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.405 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.636 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 21.5 m120 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.653 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.709 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.65 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.613 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.706 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.65 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 283' ' ' TYR . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.608 ' HA3' HG23 ' A' ' 23' ' ' VAL . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.892 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.709 ' HB1' ' HB ' ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.782 ' HB ' HD22 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.782 HD22 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.736 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.699 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.66 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.709 ' HB ' ' HB1' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.571 ' HB3' HG11 ' A' ' 244' ' ' VAL . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 324' ' ' ALA . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.589 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 320' ' ' THR . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.473 HD13 ' HB1' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.434 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 14.4 m120 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.473 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.479 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.65 ' O ' ' HB1' ' A' ' 351' ' ' ALA . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 345' ' ' THR . 0.3 OUTLIER -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 347' ' ' VAL . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 1.056 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.603 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.758 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.758 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.533 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.479 ' N ' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -119.23 -178.76 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.074 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -110.41 166.36 11.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.15 122.06 34.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.201 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.934 ' HB3' HD13 ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.953 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 59' ' ' ILE . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.637 ' HB3' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.82 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 ' HA ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.845 ' HZ3' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.747 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.747 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 7' ' ' LEU . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.621 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.669 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 47' ' ' PHE . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.953 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.638 ' HB2' HG21 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.934 HD13 ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.637 ' CD1' ' HB3' ' A' ' 10' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 108' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 67' ' ' PHE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.84 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.625 ' HA ' HG21 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.52 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' LYS . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.656 ' CB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.842 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' CB ' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.842 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 105' ' ' ALA . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.657 HD11 ' OE1' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 97' ' ' VAL . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 108' ' ' ILE . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 107' ' ' PRO . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.566 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.749 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 226' ' ' ILE . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.719 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.668 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.668 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.717 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.733 ' CH2' ' HE1' ' A' ' 224' ' ' MET . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.687 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.717 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.683 HG23 HD22 ' A' ' 147' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.459 HD23 ' CD ' ' A' ' 138' ' ' GLU . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 139' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.713 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.622 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.713 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 132' ' ' ILE . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.702 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CD2' HD13 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 156' ' ' PHE . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.599 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.633 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.613 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.599 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.874 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HE1' ' HB3' ' A' ' 171' ' ' TYR . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.528 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.427 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.502 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 182' ' ' GLY . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.731 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.874 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.475 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.799 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 209' ' ' ASP . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.899 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.899 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.808 ' O ' HG22 ' A' ' 222' ' ' THR . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 221' ' ' GLU . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.733 ' HE1' ' CH2' ' A' ' 129' ' ' TRP . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.98 HG22 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.758 HG21 HD23 ' A' ' 113' ' ' LEU . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.749 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.28 -71.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.21 89.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.091 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.28 162.25 17.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 110.496 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.82 171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.087 0.47 . . . . 0.0 111.138 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.554 HD13 ' C ' ' A' ' 235' ' ' ILE . 2.7 pp -128.44 159.95 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.003 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.15 -174.53 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 t -137.66 -44.42 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.175 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -51.35 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.882 0.373 . . . . 0.0 110.957 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -154.74 -73.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.167 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 240' ' ' VAL . 12.0 p -176.26 123.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 111.409 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -126.18 51.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.71 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.823 HG23 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 1.033 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 1.033 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.861 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.701 ' O ' ' HE1' ' A' ' 330' ' ' MET . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.742 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.747 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.638 HG21 ' HB2' ' A' ' 58' ' ' ASP . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.535 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.68 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.897 ' HG ' HD11 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.68 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.897 HD11 ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.024 HD23 HD13 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.63 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.845 ' HG2' ' HZ3' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.874 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.827 ' HB3' HD12 ' A' ' 290' ' ' LEU . 16.8 t-20 -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.874 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.792 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.579 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.748 ' HB1' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 1.024 HD13 HD23 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.881 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 318' ' ' ALA . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.706 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.807 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 315' ' ' PRO . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.542 HD22 HG23 ' A' ' 246' ' ' VAL . 2.1 m-80 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.861 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.415 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.566 ' O ' HG13 ' A' ' 343' ' ' VAL . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.514 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.559 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.872 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB3' ' CD2' ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 343' ' ' VAL . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.722 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.722 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.66 ' O ' ' HB2' ' A' ' 360' ' ' ALA . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.86 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 356' ' ' THR . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.86 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.731 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.0 tm0? -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.626 ' O ' HG21 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 369' ' ' THR . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.58 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.666 0.27 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 2' ' ' THR . 7.8 t -106.17 76.06 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.929 0.395 . . . . 0.0 110.929 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.96 125.15 50.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.29 134.42 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.261 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.919 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.983 HG21 HG11 ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.79 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.785 ' H ' HD13 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.653 ' OD2' HD12 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' HG13 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 23' ' ' VAL . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.915 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.625 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' CG2' ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.915 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.794 ' O ' HG23 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.983 HG11 HG21 ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.705 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' HG1' ' A' ' 53' ' ' THR . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.919 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.512 ' HE2' HG23 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.733 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.733 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.909 ' HB3' ' HE3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.605 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.916 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.728 ' C ' ' HB2' ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.542 ' N ' HD21 ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.728 ' HB2' ' C ' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' C ' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 305' ' ' LYS . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.924 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.764 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 92' ' ' PHE . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 64' ' ' HIS . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.512 HG23 ' HE2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 1.018 ' HB2' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.635 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.796 ' HB3' HG21 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.464 ' CD2' HD21 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 243' ' ' GLY . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.634 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 121' ' ' LEU . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.462 ' HD2' HD13 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.415 HD21 ' HD2' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' HD21 ' A' ' 124' ' ' ASN . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.49 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.833 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.887 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.49 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.939 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.939 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.462 HD13 ' HD2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.723 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.524 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.882 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.653 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.524 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.796 ' CE2' HG22 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.796 HG22 ' CE2' ' A' ' 156' ' ' PHE . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.743 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.686 HD23 ' CE2' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.743 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 164' ' ' ASP . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.441 ' CE2' HD11 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.56 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.773 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.861 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.861 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.556 HG22 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.536 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.413 ' O ' HG21 ' A' ' 196' ' ' VAL . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' HG23 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 193' ' ' THR . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.602 HG12 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.575 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.62 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.604 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.672 ' HB ' HG22 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.706 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.701 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 222' ' ' THR . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 221' ' ' GLU . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.653 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.816 ' H ' HG22 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.613 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 233' ' ' SER . . . -122.83 -42.69 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.5 t90 71.57 -18.64 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.597 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 231' ' ' ALA . 2.5 t 60.73 169.34 0.09 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.901 0.381 . . . . 0.0 111.058 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 235' ' ' ILE . 6.0 m-20 -174.39 165.36 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.222 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -153.2 179.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.015 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.83 -39.62 83.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -101.02 91.03 4.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 90.3 p -68.22 143.24 55.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.12 177.71 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.508 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 242' ' ' TYR . 9.3 p -139.69 146.57 25.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.79 44.41 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.759 ' CE1' HG22 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.796 HG21 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 247' ' ' LEU . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.625 ' HA ' HD11 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 160' ' ' LEU . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.728 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.599 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.607 ' HZ3' ' N ' ' A' ' 328' ' ' GLU . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 1.018 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.916 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.773 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.55 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.788 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.788 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.667 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.736 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.667 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 286' ' ' THR . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 285' ' ' LEU . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 303' ' ' ALA . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 1.057 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.413 HG11 HD21 ' A' ' 294' ' ' ASN . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.819 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 1.4 m-80 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 1.057 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.749 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.728 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.871 ' HB3' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.681 HG13 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.933 ' HB2' HD22 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.924 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.652 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.837 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.652 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.879 ' HB3' HG22 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.701 ' HB3' HD12 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.534 ' O ' ' HB1' ' A' ' 319' ' ' ALA . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.749 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.879 HG22 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 315' ' ' PRO . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.553 ' HA ' HD22 ' A' ' 323' ' ' ASN . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.553 HD22 ' HA ' ' A' ' 320' ' ' THR . 6.2 p30 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.607 ' N ' ' HZ3' ' A' ' 256' ' ' LYS . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.909 ' HE3' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.912 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.912 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.556 ' NE2' HD13 ' A' ' 333' ' ' ILE . 38.5 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.526 ' O ' HG21 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.59 HH11 ' HG3' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.798 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.827 ' O ' ' HB1' ' A' ' 351' ' ' ALA . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.802 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 347' ' ' VAL . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.691 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.835 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.691 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.835 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.668 ' O ' HD13 ' A' ' 368' ' ' ILE . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.556 ' OE1' HG22 ' A' ' 183' ' ' VAL . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.598 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 1.105 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 1.105 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.787 0.327 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 p -131.68 148.02 52.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.92 116.95 32.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.56 -68.66 0.57 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.546 ' C ' HG22 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.786 ' HB3' HD12 ' A' ' 59' ' ' ILE . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.945 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.989 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 10' ' ' TRP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.69 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.483 ' CB ' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 24' ' ' GLY . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 23' ' ' VAL . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.736 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.542 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HA ' ' A' ' 6' ' ' LYS . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HA ' HD22 ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.658 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.49 ' CZ ' HD13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 53' ' ' THR . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' C ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.5 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.557 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.945 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.786 HD12 ' HB3' ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.989 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HE1' ' CG2' ' A' ' 108' ' ' ILE . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.478 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 1.055 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.633 ' CD2' HG22 ' A' ' 261' ' ' VAL . 0.4 OUTLIER -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.992 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.708 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' HD21 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD21 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.754 ' CB ' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.637 HG21 ' HE3' ' A' ' 277' ' ' LYS . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.634 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.57 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.634 ' CZ2' ' HB3' ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 92' ' ' PHE . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.708 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.992 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.834 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' HG21 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.778 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.534 HD23 HD21 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.778 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.505 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.747 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 1.012 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 1.012 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.74 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.74 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.495 ' CD1' ' HB1' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HB1' ' CD1' ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.555 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.517 HD12 ' ND1' ' A' ' 203' ' ' HIS . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.639 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.57 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.981 ' HB3' HD13 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 157' ' ' THR . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.521 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.65 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.542 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.732 ' HA2' HD22 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.868 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.591 ' CZ ' HG23 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.854 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.541 HD11 ' C ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 178' ' ' ILE . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.507 HG12 ' OE1' ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.614 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.732 HD22 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.996 ' HA ' ' HZ3' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.996 ' HZ3' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.534 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.642 ' CD2' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.981 HD13 ' HB3' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.517 ' ND1' HD12 ' A' ' 151' ' ' LEU . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.573 ' OD1' HD13 ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.721 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.573 HD13 ' OD1' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.956 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.956 ' CE2' ' HA ' ' A' ' 214' ' ' GLU . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.693 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.445 ' C ' HG22 ' A' ' 222' ' ' THR . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.729 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.92 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -161.52 85.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.55 -37.76 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.836 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.1 t 61.47 160.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -136.91 165.68 25.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.503 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 235' ' ' ILE . 0.9 OUTLIER -168.23 117.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.36 67.49 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -140.93 -57.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.45 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.05 51.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.36 116.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.975 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.57 126.1 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -171.33 120.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.496 HG21 ' N ' ' A' ' 247' ' ' LEU . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.496 ' N ' HG21 ' A' ' 246' ' ' VAL . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.747 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.849 HG23 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.542 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.849 ' HD3' HG23 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.65 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.672 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.633 HG22 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 1.055 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.402 ' O ' ' CZ ' ' A' ' 67' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.921 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.754 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.601 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.949 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.949 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 276' ' ' ALA . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 272' ' ' ASN . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.77 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.77 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.718 ' O ' HD21 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.727 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.495 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.727 ' HB2' ' O ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 1.097 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.767 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.539 ' HB3' HD22 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 1.097 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.767 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.594 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.594 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.894 ' HA ' HG23 ' A' ' 317' ' ' ILE . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.472 HG22 ' N ' ' A' ' 303' ' ' ALA . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.472 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.654 ' CE2' HD12 ' A' ' 304' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.885 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.71 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.885 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 301' ' ' ALA . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.428 ' HA ' ' OD1' ' A' ' 323' ' ' ASN . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.568 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.767 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.854 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.414 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.521 HE22 HG13 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.686 ' HB2' HG21 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 346' ' ' ALA . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.608 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.648 ' O ' ' HB1' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.608 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.973 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 346' ' ' ALA . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.837 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 4.7 mm100 -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.749 ' O ' ' HB3' ' A' ' 360' ' ' ALA . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 356' ' ' THR . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.614 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.54 ' O ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 365' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.059 0.457 . . . . 0.0 111.421 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -85.79 169.24 13.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.27 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.66 151.91 37.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.39 76.37 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.656 ' C ' HG21 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.159 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.594 ' C ' HG13 ' A' ' 11' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.675 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 17' ' ' TYR . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.708 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.656 HG21 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.708 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 7' ' ' LEU . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.936 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 1.159 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.679 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HB ' ' HZ ' ' A' ' 67' ' ' PHE . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.675 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.762 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 1.083 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 16.3 t-80 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.685 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.709 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.809 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.767 HE21 HG21 ' A' ' 104' ' ' ILE . 1.2 tt0 -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 267' ' ' ASN . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.809 ' HG ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.695 ' HG2' ' HG2' ' A' ' 102' ' ' LYS . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 88' ' ' LYS . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' CB ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.826 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.481 ' HH2' ' CZ ' ' A' ' 85' ' ' PHE . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' HD2' HD22 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.695 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.767 HG21 HE21 ' A' ' 72' ' ' GLN . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HH ' HD13 ' A' ' 285' ' ' LEU . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.977 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.598 ' H ' ' CG2' ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.504 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.493 ' C ' HD21 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.494 HD21 ' N ' ' A' ' 113' ' ' LEU . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' HG21 ' A' ' 226' ' ' ILE . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.624 ' HB3' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.64 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.516 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.433 HG22 ' HG3' ' A' ' 130' ' ' GLU . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.852 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.524 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.732 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.748 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.748 HD12 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.586 ' HZ3' ' HZ3' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.685 ' HG3' HD21 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.726 ' CB ' HD11 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.735 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.718 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.795 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.586 ' HB1' ' H ' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' HD1' ' A' ' 169' ' ' PHE . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.555 ' HD1' ' HB1' ' A' ' 168' ' ' ALA . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.629 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.629 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' NE2' ' A' ' 365' ' ' GLN . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.795 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.641 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.658 ' CD1' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.695 ' HA ' ' HD3' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.531 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.417 ' HD2' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 203' ' ' HIS . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.581 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.816 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.581 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.919 ' CE1' HG21 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.574 ' HB2' ' HG2' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.483 ' C ' HG22 ' A' ' 222' ' ' THR . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 145' ' ' SER . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.735 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.919 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.473 ' H ' ' HE1' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.571 ' ND2' HG22 ' A' ' 225' ' ' THR . 3.9 m-80 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HD2' ' CE3' ' A' ' 230' ' ' TRP . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.504 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.03 32.97 2.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -122.93 110.97 16.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 110.49 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.3 p -126.41 165.37 19.19 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.013 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.24 147.87 45.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.76 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -156.12 78.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 111.069 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.09 28.03 15.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.39 -179.58 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 91.0 p -168.6 -32.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.313 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.437 ' O ' HG22 ' A' ' 240' ' ' VAL . 6.7 mttt -148.79 132.09 16.52 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.764 0.316 . . . . 0.0 111.235 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 239' ' ' LYS . 25.8 t -143.26 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -91.29 90.78 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.641 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.401 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.842 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.588 ' NZ ' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.743 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.977 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 1.083 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.709 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 75' ' ' LEU . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.471 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.845 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.741 HD13 ' HH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.874 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.727 ' O ' HG21 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.699 ' O ' HD11 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.679 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.615 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 110' ' ' VAL . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.813 ' HG3' HD21 ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 1.01 HD23 HG23 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.529 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 1.01 HG23 HD23 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.467 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.445 HD22 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.57 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 344' ' ' ARG . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.469 ' N ' HG11 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.691 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 360' ' ' ALA . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 361' ' ' LEU . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.737 ' O ' ' HB1' ' A' ' 364' ' ' ALA . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 357' ' ' VAL . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.677 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.923 ' HG3' HG22 ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 369' ' ' THR . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 366' ' ' THR . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.467 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.805 0.336 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.5 p -130.94 -176.75 4.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.683 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.13 166.85 10.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -134.95 -75.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.449 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.901 ' HB3' HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.845 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.681 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.515 HD22 ' HZ3' ' A' ' 62' ' ' TRP . 1.6 p30 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.497 ' CA ' ' HH ' ' A' ' 283' ' ' TYR . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.599 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.863 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.605 ' CG2' HG21 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 7' ' ' LEU . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.845 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.566 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.507 HD13 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HE3' HD13 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.715 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 50' ' ' VAL . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.766 ' HB3' HG13 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.803 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.533 ' CB ' ' HB2' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.881 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.881 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.604 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.666 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.862 HD22 HD21 ' A' ' 267' ' ' ASN . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.66 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.522 HG21 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.522 ' HD2' HG21 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' O ' ' HZ2' ' A' ' 94' ' ' TRP . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.474 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.528 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 94' ' ' TRP . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.604 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.478 HD13 HG23 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.66 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.882 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 1.05 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.653 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.799 HG23 ' N ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.48 ' HH ' ' HD3' ' A' ' 125' ' ' PRO . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' N ' HD21 ' A' ' 118' ' ' ASN . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.671 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.716 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.646 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.684 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.646 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.716 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.856 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.856 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.954 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.954 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.628 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.839 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.947 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.69 HD11 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.535 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.741 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.616 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.832 ' H ' ' HG ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.595 ' HD2' HG21 ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.595 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.659 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HG2' ' HZ3' ' A' ' 189' ' ' LYS . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.465 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.64 ' HZ1' ' ND1' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.64 ' ND1' ' HZ1' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' HIS . 5.6 p30 -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.762 HG23 ' HB1' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.797 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.576 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.762 ' HB1' HG23 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.986 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.986 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 20.5 t-20 -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.569 HG23 ' C ' ' A' ' 221' ' ' GLU . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.947 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.799 ' N ' HG23 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.444 ' ND2' ' HB1' ' A' ' 231' ' ' ALA . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 1.05 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.635 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 227' ' ' ASN . . . -110.22 103.04 11.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.42 155.58 48.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.6 t -99.42 -38.35 8.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.025 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.3 m120 61.15 118.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.87 -38.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.613 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.12 115.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.156 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m 59.92 167.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.67 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 21.1 m 70.8 -56.55 0.61 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.664 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.615 ' O ' HG12 ' A' ' 240' ' ' VAL . 1.4 ttmt -141.8 113.47 7.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.866 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 239' ' ' LYS . 5.1 m -152.87 29.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.37 100.66 11.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.653 ' CG2' ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.509 HG23 ' ND2' ' A' ' 323' ' ' ASN . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.684 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.776 HG21 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.748 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.447 ' HG2' ' C ' ' A' ' 252' ' ' GLY . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.776 ' HD3' HG21 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.832 ' HG ' ' H ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.882 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.418 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.862 HD21 HD22 ' A' ' 75' ' ' LEU . 13.6 m120 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.664 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 15.1 m120 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.81 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.48 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.409 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.549 ' HD1' ' CD2' ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.549 ' CD2' ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.772 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.406 ' O ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.837 ' HA ' HD22 ' A' ' 294' ' ' ASN . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 290' ' ' LEU . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.837 HD22 ' HA ' ' A' ' 291' ' ' GLU . 12.7 p30 -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.725 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.678 HD11 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.715 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 302' ' ' VAL . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.761 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.761 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.726 ' OE2' ' HE2' ' A' ' 321' ' ' MET . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.839 HD21 HG22 ' A' ' 317' ' ' ILE . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.663 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.711 ' CG ' ' HA ' ' A' ' 311' ' ' LEU . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 311' ' ' LEU . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.726 ' HE2' ' OE2' ' A' ' 308' ' ' GLU . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.509 ' ND2' HG23 ' A' ' 246' ' ' VAL . 12.4 m120 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.545 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.454 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 343' ' ' VAL . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 347' ' ' VAL . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.692 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 343' ' ' VAL . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.692 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.656 ' O ' ' HB1' ' A' ' 360' ' ' ALA . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.835 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 356' ' ' THR . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.763 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.74 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.9 mm100 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.595 HG21 ' HD2' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.842 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CB ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' A' ' 292' ' ' ALA . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.696 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.763 HG11 ' HA2' ' A' ' 289' ' ' GLY . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.743 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 279' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 9' ' ' ILE . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.842 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' O ' HG22 ' A' ' 53' ' ' THR . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 1.006 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.9 ' HB2' HG23 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HB3' HD23 ' A' ' 262' ' ' LEU . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.707 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 2.0 p-80 -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.657 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.584 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.899 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.658 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.95 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.95 HG23 ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 1.024 ' HA ' HG12 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.024 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 78' ' ' GLU . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.83 ' HD2' ' HG1' ' A' ' 245' ' ' THR . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.494 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.757 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 19.0 p-10 -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 1.096 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.649 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.096 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.779 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' OE2' HD23 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.509 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' HD2' ' HD2' ' A' ' 156' ' ' PHE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.544 ' H ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.711 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.624 ' CD1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.624 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.85 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 255' ' ' SER . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.926 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.738 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.738 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.926 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.782 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.833 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.85 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.431 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB2' ' CG2' ' A' ' 199' ' ' ILE . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.015 ' HB ' HD11 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.744 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.696 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.744 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.737 ' CD2' ' HB ' ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.714 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.737 ' HB ' ' CD2' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.723 ' HB3' ' HZ ' ' A' ' 217' ' ' PHE . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.74 0.305 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.83 ' HG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.649 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.657 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.9 HG23 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 50.4 m-80 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.814 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.853 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.447 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.682 HD11 HG11 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.483 ' CA ' HD13 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.541 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA2' HG11 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.715 HD23 HD21 ' A' ' 294' ' ' ASN . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.919 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.839 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.715 HD21 HD23 ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.919 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.608 ' O ' HD23 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.968 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.753 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.968 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.405 ' HB3' ' HD2' ' A' ' 331' ' ' PRO . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 330' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 335' ' ' GLN . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.534 ' H ' HG22 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.614 ' HD2' HG23 ' A' ' 345' ' ' THR . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.5 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.613 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.613 ' CB ' ' HA ' ' A' ' 350' ' ' ALA . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 359' ' ' GLU . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.72 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.543 HD11 HG22 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.782 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.77 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 363' ' ' ASP . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.77 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.739 ' CG1' ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.513 HD12 HG21 ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 40' ' ' PRO . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.598 HD11 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' CG ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.941 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.733 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.784 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.818 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 20' ' ' LEU . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE1' HD13 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.822 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' OE1' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.808 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' C ' HG13 ' A' ' 59' ' ' ILE . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.987 ' HB3' HD21 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.884 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.884 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.83 ' CB ' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' OE1' HG21 ' A' ' 104' ' ' ILE . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.657 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.657 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.83 HD12 ' CB ' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.705 HG23 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.687 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 107' ' ' PRO . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.747 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.824 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 97' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.452 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.857 HD12 ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.612 HG23 ' HB2' ' A' ' 131' ' ' GLU . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.873 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.612 ' HB2' HG23 ' A' ' 128' ' ' THR . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 132' ' ' ILE . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 146' ' ' ALA . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.802 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.681 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.009 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.722 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 1.051 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.692 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.692 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.419 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 195' ' ' LEU . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.716 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.965 HD13 ' HG ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.542 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.43 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.593 ' CG1' HG23 ' A' ' 183' ' ' VAL . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.965 ' HG ' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.493 HD21 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.668 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.674 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.917 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.917 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 1.107 ' HB3' HG23 ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 145' ' ' SER . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 1.051 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . 1.107 HG23 ' HB3' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.759 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.541 ' H ' HH22 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.953 0.406 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 244' ' ' VAL . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.51 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 1.056 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 1.056 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.987 HD21 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.509 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.678 ' HA ' HD23 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.705 ' HE3' HG23 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.83 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.83 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.647 ' HA ' HD23 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.691 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.714 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 294' ' ' ASN . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 1.125 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.941 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.73 ' HB2' HD13 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 1.125 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.715 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.715 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.464 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.586 HG11 ' OD1' ' A' ' 294' ' ' ASN . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.738 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.833 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 305' ' ' LYS . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.833 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 1.086 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 1.086 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 317' ' ' ILE . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.51 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.71 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.747 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 335' ' ' GLN . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.467 ' H ' HG13 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 343' ' ' VAL . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.636 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 363' ' ' ASP . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' A' ' 345' ' ' THR . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 183' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 359' ' ' GLU . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.489 HE21 ' HB3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.479 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.803 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.648 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.994 ' HE3' HD12 ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.838 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.499 HG12 ' HB ' ' A' ' 9' ' ' ILE . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.717 ' CD1' ' HB2' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 53' ' ' THR . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.657 ' HA ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 267' ' ' ASN . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.994 HD12 ' HE3' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.822 ' HB3' HD21 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.878 ' HZ3' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.568 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.717 ' CG ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.065 HD13 ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 1.027 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.906 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.938 ' HD2' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.938 HD11 ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.567 ' H ' ' HA3' ' A' ' 260' ' ' GLY . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB2' HG23 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 139' ' ' LEU . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.765 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.634 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.885 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.885 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HB2' HD21 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.58 HD22 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.411 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.727 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.693 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.773 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.971 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.971 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 161' ' ' ILE . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.573 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.751 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.944 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.581 HG13 ' HA3' ' A' ' 191' ' ' GLY . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.543 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.681 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 188' ' ' ALA . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.761 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 192' ' ' LEU . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.811 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 195' ' ' LEU . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.811 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.78 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.78 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.591 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.837 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.674 ' HB2' ' CG2' ' A' ' 208' ' ' THR . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.837 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.631 ' HA ' HG23 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.738 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.738 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.693 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.631 HG23 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 156' ' ' PHE . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.826 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.564 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.826 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.435 HD23 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.765 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.729 HG22 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.944 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 1.015 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 1.015 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.685 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.877 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.967 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.771 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 266' ' ' ILE . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.619 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.846 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 284' ' ' LEU . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.664 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.825 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.44 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . 1.027 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.932 HD13 ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.825 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 314' ' ' ASP . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.628 ' HE1' ' HG2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.805 HD22 ' HB1' ' A' ' 112' ' ' ALA . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.736 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.718 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.713 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.713 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.639 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 339' ' ' PHE . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 343' ' ' VAL . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.78 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.78 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 7.8 mm-40 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.659 HG23 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 357' ' ' VAL . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 367' ' ' ARG . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.54 ' NE2' HG11 ' A' ' 183' ' ' VAL . 1.3 mp0 -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.675 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.016 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.715 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.91 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.783 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.91 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 9' ' ' ILE . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.735 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.617 ' OD2' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.016 HG23 ' HA ' ' A' ' 9' ' ' ILE . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 10' ' ' TRP . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.903 ' HB2' HG23 ' A' ' 261' ' ' VAL . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.927 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.988 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.808 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.77 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.641 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.808 HD13 ' HB3' ' A' ' 71' ' ' ALA . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.685 ' HZ3' HD21 ' A' ' 103' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.685 HD21 ' HZ3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.77 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.72 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.82 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.864 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.978 ' HD2' HD22 ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.978 HD22 ' HD2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.49 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.701 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CZ2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.902 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.902 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.959 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.548 ' CB ' HD12 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.547 ' O ' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.698 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.654 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.821 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' H ' ' HD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.458 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.661 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.673 ' HH2' ' HB2' ' A' ' 168' ' ' ALA . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CZ2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 157' ' ' THR . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.599 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HG2' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.808 ' CG2' ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' A' ' 361' ' ' LEU . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 195' ' ' LEU . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.587 ' HA ' ' NZ ' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.718 ' CG2' HD12 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.864 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.645 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.864 HD13 ' HB2' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.967 ' CD1' HG23 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.905 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 145' ' ' SER . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.967 HG23 ' CD1' ' A' ' 217' ' ' PHE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.944 HG22 HD23 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.451 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.671 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.556 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.82 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.655 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HG ' HD13 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.474 HG22 ' HD3' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' ' 162' ' ' ALA . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.785 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 1.085 HG12 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.988 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.84 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.801 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.776 HD23 ' HE1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.743 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.801 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.776 ' HE1' HD23 ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 283' ' ' TYR . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.662 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD1' ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.945 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.611 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.945 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.8 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.8 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.701 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 317' ' ' ILE . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.742 ' N ' HG22 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.716 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.973 ' HA ' HD13 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.701 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 301' ' ' ALA . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.744 ' HB1' HG11 ' A' ' 244' ' ' VAL . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.655 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 321' ' ' MET . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 1.085 ' HA ' HG12 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.656 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.722 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.519 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.629 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.73 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.861 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.861 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.4 m120 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.818 HE21 ' HB2' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 358' ' ' ASP . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.668 ' O ' ' HE2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.818 ' HB2' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.686 ' HB3' ' NZ ' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.808 ' HG2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.623 0.249 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.944 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.772 ' HB3' HG23 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.94 HD13 ' HB3' ' A' ' 15' ' ' LYS . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.94 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.657 HG12 ' HD2' ' A' ' 283' ' ' TYR . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 31' ' ' THR . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 HG13 ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 7' ' ' LEU . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 37' ' ' VAL . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.978 ' HA ' HD12 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 46' ' ' LYS . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.659 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.633 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 58' ' ' ASP . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.694 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.694 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.788 ' HB2' HG23 ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.672 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.895 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 75' ' ' LEU . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.885 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.594 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' N ' ' HG2' ' A' ' 83' ' ' LYS . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CB ' ' HE1' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' THR . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.783 ' O ' HG22 ' A' ' 97' ' ' VAL . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.82 HG11 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.761 ' CG ' HD11 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 72' ' ' GLN . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HD3' HG11 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.899 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.574 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.494 HD22 HG21 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.774 HD12 HD13 ' A' ' 247' ' ' LEU . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 122' ' ' LEU . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.621 ' CG ' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.558 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.551 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.661 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.028 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 1.028 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.621 HD23 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.723 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.723 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.072 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.512 ' CB ' ' HB3' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.604 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.021 ' HB3' HD21 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.633 HG22 ' C ' ' A' ' 191' ' ' GLY . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.636 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.636 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.021 HD21 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.622 HG23 ' CD2' ' A' ' 151' ' ' LEU . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.611 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.773 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.903 ' CD2' HG23 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.426 ' HD2' ' OE1' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 219' ' ' LYS . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.621 ' HB2' ' CG ' ' A' ' 122' ' ' LEU . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 1.072 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.903 HG23 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 217' ' ' PHE . 14.9 p30 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.899 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.973 0.416 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 114' ' ' SER . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.65 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.774 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.551 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.676 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' HIS . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.672 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.997 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.87 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 36.7 m-80 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.73 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.998 HD23 HD22 ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.625 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.998 HD22 HD23 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 304' ' ' LEU . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.906 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.933 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.933 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.844 ' N ' HG21 ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.853 ' HB ' HD23 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.853 HD23 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.771 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.771 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.717 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.621 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.753 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.605 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.65 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.713 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 45.1 m-80 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.544 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 333' ' ' ILE . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.583 ' O ' HG22 ' A' ' 347' ' ' VAL . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 343' ' ' VAL . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.5 m-80 -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 1.064 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 1.064 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 2.2 pp0? -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.849 0.356 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.77 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.954 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 37' ' ' VAL . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.669 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.859 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.636 ' NZ ' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.777 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.655 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.777 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 HD12 ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.702 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.954 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 62' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB2' HG22 ' A' ' 11' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.967 ' HE1' HD11 ' A' ' 60' ' ' ILE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.833 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.861 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HB1' ' A' ' 71' ' ' ALA . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.602 ' HG3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.724 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.86 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.86 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.759 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.775 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 61' ' ' PHE . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.718 ' OE2' ' HB1' ' A' ' 109' ' ' ALA . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.783 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.771 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HD1' ' CD1' ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 121' ' ' LEU . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.499 ' CD1' ' HD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.692 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.725 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' CD ' HD23 ' A' ' 135' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.73 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.635 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.73 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.792 ' O ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.69 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 155' ' ' TYR . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.631 ' O ' HD12 ' A' ' 160' ' ' LEU . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.648 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.631 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.897 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 331' ' ' PRO . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.897 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 196' ' ' VAL . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.722 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.674 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.434 ' HB3' ' H ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 203' ' ' HIS . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 213' ' ' ALA . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.556 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.833 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.556 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.598 ' HB2' ' OG1' ' A' ' 208' ' ' THR . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.959 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 1.09 ' HB2' HG23 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.959 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 145' ' ' SER . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.69 ' HB3' ' H ' ' A' ' 148' ' ' MET . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . 1.09 HG23 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.918 HD12 ' CD2' ' A' ' 149' ' ' PHE . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.783 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.705 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.466 ' CE2' HD23 ' A' ' 160' ' ' LEU . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 1.032 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 1.032 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.777 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.642 ' O ' HD13 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 265' ' ' GLY . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.581 HD21 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.615 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.698 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.619 ' CB ' ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.935 HD21 HD11 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.636 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 290' ' ' LEU . 0.4 OUTLIER -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.893 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.925 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.855 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.925 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.518 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.935 HD11 HD21 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.908 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.704 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.864 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.487 HG21 ' CG1' ' A' ' 110' ' ' VAL . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.542 ' HA ' ' HE3' ' A' ' 326' ' ' LYS . 5.2 m120 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 329' ' ' ILE . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.879 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 335' ' ' GLN . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG12 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.426 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.5 ' HB1' ' CZ ' ' A' ' 341' ' ' TYR . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 158' ' ' TRP . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.533 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.605 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.659 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 348' ' ' ILE . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.751 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.738 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 358' ' ' ASP . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.793 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 356' ' ' THR . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.793 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.428 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 0.8 OUTLIER -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 364' ' ' ALA . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.58 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HB3' ' OD1' ' A' ' 272' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.912 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.856 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.816 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' OD2' HD13 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.945 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.856 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 46' ' ' LYS . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.912 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 58' ' ' ASP . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.816 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.758 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.758 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.944 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.944 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.95 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD13 ' HB3' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.996 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' HD13 ' A' ' 266' ' ' ILE . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.696 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 97' ' ' VAL . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.766 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.842 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.65 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.677 HG23 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.639 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.581 HD23 ' HA3' ' A' ' 228' ' ' GLY . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB3' HG23 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.856 HG21 ' OG1' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.576 ' CD2' HD22 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.512 ' O ' HD12 ' A' ' 122' ' ' LEU . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 119' ' ' LYS . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.589 ' CD2' HD11 ' A' ' 139' ' ' LEU . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.488 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.835 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.902 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.96 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.96 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.75 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.542 ' O ' HG22 ' A' ' 222' ' ' THR . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.842 HD22 HG23 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.854 HG22 HD12 ' A' ' 195' ' ' LEU . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.769 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.419 HD11 ' NE1' ' A' ' 129' ' ' TRP . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.665 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.57 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.853 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.853 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.643 HG21 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.552 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.854 HD12 HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.842 HG23 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.652 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.606 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.717 HG22 HG23 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.734 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 1.027 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 145' ' ' SER . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 122' ' ' LEU . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.647 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . 1.027 HG22 ' HD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 225' ' ' THR . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.628 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.581 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.612 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.49 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 252' ' ' GLY . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.73 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.627 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.577 ' HZ1' ' C ' ' A' ' 327' ' ' GLY . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.944 HG23 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.001 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.944 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 266' ' ' ILE . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.996 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.626 ' ND2' ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.626 ' HB2' ' ND2' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.811 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.834 ' O ' ' HB2' ' A' ' 294' ' ' ASN . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 1.078 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 2.0 m120 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.774 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.737 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.911 ' HB2' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.889 HG11 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.956 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.985 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.797 ' CB ' HD13 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.985 HG21 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.535 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 316' ' ' ARG . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.577 ' C ' ' HZ1' ' A' ' 256' ' ' LYS . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.57 ' HG2' ' OH ' ' A' ' 171' ' ' TYR . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.67 ' CE ' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.895 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.895 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.414 ' OE1' HD11 ' A' ' 333' ' ' ILE . 44.6 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.462 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.61 ' HG3' HH11 ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.804 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.804 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 362' ' ' LYS . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.853 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.632 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.43 ' C ' HD13 ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 367' ' ' ARG . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.701 ' HA ' HD12 ' A' ' 368' ' ' ILE . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 1.101 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 1.101 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.695 ' C ' HG23 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.824 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 6' ' ' LYS . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.962 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.733 ' CD1' HD21 ' A' ' 20' ' ' LEU . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 1.014 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.82 HD12 ' HB2' ' A' ' 14' ' ' ASP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.82 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB2' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.733 HD21 ' CD1' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.764 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.695 HG23 ' C ' ' A' ' 5' ' ' GLY . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG22 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.633 ' HB ' HG13 ' A' ' 8' ' ' VAL . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.829 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' A' ' 50' ' ' VAL . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.962 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' CG1' HD12 ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.014 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 264' ' ' ALA . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.503 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.048 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.655 ' ND1' HG23 ' A' ' 261' ' ' VAL . 2.4 p-80 -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.016 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.741 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' O ' HD22 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.838 HD13 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.054 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.66 HD12 ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 90' ' ' TYR . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.66 ' NE1' HD12 ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 97' ' ' VAL . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.741 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 1.016 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.736 ' HB3' HG23 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 247' ' ' LEU . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.788 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.788 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.768 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.058 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.574 HD23 HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.541 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.644 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.755 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 1.004 HG23 HD22 ' A' ' 195' ' ' LEU . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.663 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.816 ' HA2' HD21 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.904 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.431 HG12 HE22 ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.627 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.816 HD21 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.531 ' HA ' ' NZ ' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.531 ' NZ ' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.004 HD22 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.725 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.979 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 1.045 ' HB2' HG23 ' A' ' 225' ' ' THR . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.76 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . 1.045 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 113' ' ' LEU . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.705 ' C ' HD23 ' A' ' 113' ' ' LEU . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' ' 115' ' ' LEU . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.768 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.876 HG22 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.646 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.56 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.663 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.655 HG23 ' ND1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.048 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.954 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 266' ' ' ILE . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 1.054 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.991 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.789 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.789 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.807 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 1.078 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.832 ' CB ' HD23 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.789 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.634 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.634 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.856 ' HB3' HG21 ' A' ' 110' ' ' VAL . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.807 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 290' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.941 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.712 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.941 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.659 HG21 ' CD2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.628 ' H ' HD13 ' A' ' 317' ' ' ILE . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.496 HG21 ' CG1' ' A' ' 110' ' ' VAL . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.642 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.795 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.712 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 344' ' ' ARG . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.646 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.979 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.646 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.979 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.856 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.627 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.523 ' HA ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 365' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.555 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.771 ' C ' HG23 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.129 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.972 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.716 ' HB3' HG23 ' A' ' 60' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.67 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.753 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.771 HG23 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.753 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.676 ' OG1' HG22 ' A' ' 8' ' ' VAL . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.972 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 11' ' ' ILE . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.45 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 46' ' ' LYS . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 1.129 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 59' ' ' ILE . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 10' ' ' TRP . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.785 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.062 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 23.7 t60 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.73 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 104' ' ' ILE . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.974 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.974 HD23 ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.79 ' HG3' HG22 ' A' ' 104' ' ' ILE . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.691 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.497 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.874 ' HD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.874 ' HB2' ' HD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HD2' HD21 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.79 HG22 ' HG3' ' A' ' 78' ' ' GLU . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.612 ' CD1' ' HD2' ' A' ' 107' ' ' PRO . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.011 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.741 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.517 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 226' ' ' ILE . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.78 HD23 HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.915 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.406 ' OH ' HD12 ' A' ' 122' ' ' LEU . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.64 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.639 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.874 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.765 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.559 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.002 HD23 ' HG3' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 1.002 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.771 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.928 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.915 HD23 ' HG3' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.766 ' HZ ' HD11 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.493 HG22 ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.742 ' HD2' ' C ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 1.103 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.894 ' HB2' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.607 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.644 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.786 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 1.103 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.534 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.657 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.706 ' HA ' ' CD ' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.737 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.737 ' H ' HG13 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.559 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.737 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.521 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.635 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.836 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.836 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.976 ' CD1' HG23 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.534 ' HB ' ' CA ' ' A' ' 146' ' ' ALA . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.915 ' HG3' HD23 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.976 HG23 ' CD1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 225' ' ' THR . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 299' ' ' LEU . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.517 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.705 HD21 ' N ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.638 0.256 . . . . 0.0 110.313 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 HD23 ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 160' ' ' LEU . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.445 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.894 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.923 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.805 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.441 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.735 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.924 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.924 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.882 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.695 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.497 ' H ' HD12 ' A' ' 317' ' ' ILE . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.452 ' HA ' ' OE2' ' A' ' 308' ' ' GLU . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 306' ' ' SER . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.807 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 1.114 HD21 HG21 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 1.114 HG21 HD21 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 110' ' ' VAL . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.515 HD21 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.721 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 359' ' ' GLU . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 355' ' ' GLN . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 361' ' ' LEU . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.699 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.786 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 365' ' ' GLN . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.461 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.892 0.377 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.848 HD22 HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.877 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.678 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.664 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.676 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' CG2' HG23 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 8' ' ' VAL . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.877 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.678 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.842 HD12 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.842 ' HE3' HD12 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.807 ' HB3' HG11 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.814 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.1 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.914 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.83 ' HB1' ' CD2' ' A' ' 76' ' ' LEU . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.62 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.83 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.861 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.58 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.557 ' HE1' ' HH ' ' A' ' 106' ' ' TYR . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.812 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.533 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 93' ' ' THR . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.62 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.685 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.601 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HD2' ' HD1' ' A' ' 106' ' ' TYR . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.787 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.987 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 1.093 ' HB3' HG23 ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.1 t-20 -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.659 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.732 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.735 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.732 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.899 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.899 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.465 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.885 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.945 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.652 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.652 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.56 ' O ' HG23 ' A' ' 178' ' ' ILE . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.584 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.658 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 204' ' ' MET . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.7 OUTLIER -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.593 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.817 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 1.011 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 219' ' ' LYS . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 145' ' ' SER . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 122' ' ' LEU . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.945 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.665 ' H ' HG22 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.655 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 1.093 HG23 ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.735 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.932 HG22 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.448 ' C ' ' HG2' ' A' ' 253' ' ' GLN . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.932 ' HD3' HG22 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.895 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 108' ' ' ILE . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 67' ' ' PHE . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.446 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.814 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 23.8 m-80 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.7 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 26.8 m-80 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.404 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.742 ' HD1' HD23 ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.786 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.707 ' H ' HG23 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.562 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.786 ' HG2' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.681 ' OD1' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.753 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.54 ' CG2' HG21 ' A' ' 317' ' ' ILE . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 304' ' ' LEU . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.783 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.783 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 315' ' ' PRO . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.67 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 318' ' ' ALA . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.753 HG13 ' HA2' ' A' ' 300' ' ' GLY . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.745 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.58 ' HG3' ' HG2' ' A' ' 325' ' ' GLN . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.58 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.441 ' HB3' ' HE3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.55 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . 0.477 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 3.5 mm-40 -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.849 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.792 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.849 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.792 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.658 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.5 mm-40 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.755 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.24 153.02 49.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.72 157.46 41.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.53 174.18 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.842 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CB ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' A' ' 292' ' ' ALA . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.696 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.763 HG11 ' HA2' ' A' ' 289' ' ' GLY . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.743 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 279' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 9' ' ' ILE . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.842 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' O ' HG22 ' A' ' 53' ' ' THR . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 1.006 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.9 ' HB2' HG23 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HB3' HD23 ' A' ' 262' ' ' LEU . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.707 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 2.0 p-80 -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.657 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.584 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.899 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.658 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.95 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.95 HG23 ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 1.024 ' HA ' HG12 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.024 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 78' ' ' GLU . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.83 ' HD2' ' HG1' ' A' ' 245' ' ' THR . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.494 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.757 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 19.0 p-10 -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 1.096 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.649 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.096 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.779 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' OE2' HD23 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.509 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' HD2' ' HD2' ' A' ' 156' ' ' PHE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.544 ' H ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.711 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.624 ' CD1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.624 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.85 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 255' ' ' SER . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.926 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.738 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.738 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.926 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.782 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.833 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.85 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.431 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB2' ' CG2' ' A' ' 199' ' ' ILE . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.015 ' HB ' HD11 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.744 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.696 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.744 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.737 ' CD2' ' HB ' ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.714 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.737 ' HB ' ' CD2' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.851 HD22 ' HE1' ' A' ' 232' ' ' TRP . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HA ' ' CH2' ' A' ' 232' ' ' TRP . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.79 24.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 227' ' ' ASN . 12.5 m0 -99.05 128.47 45.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.27 115.58 27.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.181 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 60.99 114.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 236' ' ' ASP . 0.9 OUTLIER -62.53 -76.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.753 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.598 ' H ' HD12 ' A' ' 235' ' ' ILE . 3.1 m-20 60.41 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.895 0.378 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 13.5 p -71.78 78.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.468 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 179.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.109 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 27.2 2.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.628 ' HB ' ' HE1' ' A' ' 242' ' ' TYR . 21.8 t -110.37 130.37 63.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.055 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -81.56 137.26 35.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' HE1' ' HB ' ' A' ' 240' ' ' VAL . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.83 ' HG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.649 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.657 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.9 HG23 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 15.5 m120 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.814 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.853 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.447 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.682 HD11 HG11 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.483 ' CA ' HD13 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.541 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA2' HG11 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.715 HD23 HD21 ' A' ' 294' ' ' ASN . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.919 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.839 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.715 HD21 HD23 ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.919 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.608 ' O ' HD23 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.968 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.753 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.968 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.405 ' HB3' ' HD2' ' A' ' 331' ' ' PRO . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 330' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 335' ' ' GLN . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.534 ' H ' HG22 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.614 ' HD2' HG23 ' A' ' 345' ' ' THR . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.5 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.613 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.613 ' CB ' ' HA ' ' A' ' 350' ' ' ALA . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 359' ' ' GLU . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.72 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.543 HD11 HG22 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.782 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.77 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 363' ' ' ASP . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.77 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.757 0.313 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 p -136.48 87.66 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.013 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -116.17 111.51 20.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -178.87 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.739 ' CG1' ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.513 HD12 HG21 ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 40' ' ' PRO . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.598 HD11 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' CG ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.941 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.733 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.784 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.818 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 20' ' ' LEU . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE1' HD13 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.822 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' OE1' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.808 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' C ' HG13 ' A' ' 59' ' ' ILE . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.987 ' HB3' HD21 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.884 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.884 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.83 ' CB ' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' OE1' HG21 ' A' ' 104' ' ' ILE . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.657 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.657 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.83 HD12 ' CB ' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.705 HG23 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.687 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 107' ' ' PRO . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.747 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.824 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 97' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.452 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.792 ' HB2' ' CZ3' ' A' ' 232' ' ' TRP . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.857 HD12 ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.612 HG23 ' HB2' ' A' ' 131' ' ' GLU . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.873 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.612 ' HB2' HG23 ' A' ' 128' ' ' THR . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 132' ' ' ILE . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 146' ' ' ALA . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.802 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.681 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.009 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.722 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 1.051 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.692 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.692 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.419 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 195' ' ' LEU . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.716 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.965 HD13 ' HG ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.542 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.43 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.593 ' CG1' HG23 ' A' ' 183' ' ' VAL . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.965 ' HG ' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.493 HD21 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.668 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.674 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.917 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.917 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 1.107 ' HB3' HG23 ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 145' ' ' SER . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 1.051 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 1.107 HG23 ' HB3' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 116' ' ' ILE . 6.4 p30 -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.759 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.541 ' H ' HH22 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.96 -60.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.792 ' CZ3' ' HB2' ' A' ' 114' ' ' SER . 1.4 p90 -91.31 -2.49 57.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.264 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.31 68.84 10.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.441 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 64.35 154.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.753 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -135.61 -24.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.913 -179.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.414 ' OD2' HG12 ' A' ' 235' ' ' ILE . 1.8 p30 -172.16 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.2 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 m -151.52 150.41 30.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.63 0.252 . . . . 0.0 110.858 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.9 m -66.72 105.53 1.59 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -107.39 -24.01 12.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.212 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 240' ' ' VAL . 14.7 p 42.44 59.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.34 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.97 65.26 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 244' ' ' VAL . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.51 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 1.056 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 1.056 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.987 HD21 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.509 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.678 ' HA ' HD23 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.705 ' HE3' HG23 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.83 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.83 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.647 ' HA ' HD23 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.691 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.714 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 294' ' ' ASN . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 1.125 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.941 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.73 ' HB2' HD13 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 1.125 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.715 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.715 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.464 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.586 HG11 ' OD1' ' A' ' 294' ' ' ASN . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.738 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.833 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 305' ' ' LYS . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.833 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 1.086 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 1.086 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 317' ' ' ILE . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.51 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.71 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.747 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 335' ' ' GLN . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.467 ' H ' HG13 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 343' ' ' VAL . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.636 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 363' ' ' ASP . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' A' ' 345' ' ' THR . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 183' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 359' ' ' GLU . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.489 HE21 ' HB3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.479 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.738 0.304 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -127.37 101.25 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.591 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.39 155.87 35.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.518 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -128.26 126.25 40.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.8 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.648 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.994 ' HE3' HD12 ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.838 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.499 HG12 ' HB ' ' A' ' 9' ' ' ILE . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.717 ' CD1' ' HB2' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 53' ' ' THR . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.657 ' HA ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 267' ' ' ASN . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.994 HD12 ' HE3' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.822 ' HB3' HD21 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.878 ' HZ3' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.568 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.717 ' CG ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.065 HD13 ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 1.027 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.906 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.938 ' HD2' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.938 HD11 ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.567 ' H ' ' HA3' ' A' ' 260' ' ' GLY . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB2' HG23 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 139' ' ' LEU . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.765 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.634 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.885 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.885 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HB2' HD21 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.58 HD22 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.411 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.727 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.693 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.773 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.971 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.971 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 161' ' ' ILE . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.573 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.751 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.944 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.581 HG13 ' HA3' ' A' ' 191' ' ' GLY . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.543 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.681 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 188' ' ' ALA . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.761 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 192' ' ' LEU . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.811 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 195' ' ' LEU . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.811 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.78 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.78 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.591 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.837 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.674 ' HB2' ' CG2' ' A' ' 208' ' ' THR . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.837 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.631 ' HA ' HG23 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.738 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.738 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.693 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.631 HG23 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 156' ' ' PHE . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.826 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.564 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.826 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . -98.07 -38.66 9.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.526 ' HB3' ' OD1' ' A' ' 234' ' ' ASN . 75.7 m95 -87.43 -80.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.671 0.272 . . . . 0.0 110.651 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.48 31.01 19.59 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.763 0.316 . . . . 0.0 111.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' A' ' 232' ' ' TRP . 6.4 p-10 -108.37 167.67 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 235' ' ' ILE . 0.0 OUTLIER -152.92 48.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.834 0.826 . . . . 0.0 110.564 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -157.99 157.17 32.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.671 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.23 115.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.12 120.23 21.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.95 156.69 16.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' ' CE1' ' A' ' 242' ' ' TYR . 12.2 p -170.96 -21.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.968 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.28 56.55 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 240' ' ' VAL . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.435 HD23 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.765 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.729 HG22 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.944 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 1.015 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 1.015 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.685 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.877 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.967 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.771 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 266' ' ' ILE . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.619 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.846 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 284' ' ' LEU . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.664 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.825 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.44 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . 1.027 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.932 HD13 ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.825 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 314' ' ' ASP . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.628 ' HE1' ' HG2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.805 HD22 ' HB1' ' A' ' 112' ' ' ALA . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.736 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.718 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.713 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.713 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.639 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 339' ' ' PHE . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 343' ' ' VAL . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.78 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.78 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 7.8 mm-40 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.659 HG23 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 357' ' ' VAL . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 367' ' ' ARG . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.54 ' NE2' HG11 ' A' ' 183' ' ' VAL . 1.3 mp0 -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.675 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.762 0.315 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -116.01 145.14 43.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.574 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -121.72 129.7 52.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -166.83 130.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.016 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.715 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.91 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.783 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.91 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 9' ' ' ILE . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.735 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.617 ' OD2' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.016 HG23 ' HA ' ' A' ' 9' ' ' ILE . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 10' ' ' TRP . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.903 ' HB2' HG23 ' A' ' 261' ' ' VAL . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.927 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.988 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.808 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.77 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.641 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.808 HD13 ' HB3' ' A' ' 71' ' ' ALA . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.685 ' HZ3' HD21 ' A' ' 103' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.685 HD21 ' HZ3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.77 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.72 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.82 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.864 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.978 ' HD2' HD22 ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.978 HD22 ' HD2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.49 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.701 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CZ2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.902 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.902 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.959 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.548 ' CB ' HD12 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.547 ' O ' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.698 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.654 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.821 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' H ' ' HD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.458 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.661 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.673 ' HH2' ' HB2' ' A' ' 168' ' ' ALA . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CZ2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 157' ' ' THR . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.599 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HG2' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.808 ' CG2' ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' A' ' 361' ' ' LEU . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 195' ' ' LEU . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.587 ' HA ' ' NZ ' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.718 ' CG2' HD12 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.864 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.645 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.864 HD13 ' HB2' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.967 ' CD1' HG23 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.905 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 145' ' ' SER . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.967 HG23 ' CD1' ' A' ' 217' ' ' PHE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.944 HG22 HD23 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.451 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.671 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.556 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.19 -67.89 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.853 ' HZ3' HD11 ' A' ' 235' ' ' ILE . 1.2 m95 -102.18 -17.66 15.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.366 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.24 35.67 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.14 -49.11 0.46 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.754 0.311 . . . . 0.0 110.755 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.853 HD11 ' HZ3' ' A' ' 232' ' ' TRP . 10.4 pt -107.02 -5.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.03 163.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.286 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.5 p -77.3 170.47 16.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.053 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.61 -30.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.421 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.91 -177.49 6.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.779 0.323 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.4 t -132.82 -34.52 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.922 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -79.64 84.75 5.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.82 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.655 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HG ' HD13 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.474 HG22 ' HD3' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' ' 162' ' ' ALA . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.785 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 1.085 HG12 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.988 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.84 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.801 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.776 HD23 ' HE1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.743 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.801 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.776 ' HE1' HD23 ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 283' ' ' TYR . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.662 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD1' ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.945 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.611 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.945 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.8 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.8 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.701 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 317' ' ' ILE . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.742 ' N ' HG22 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.716 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.973 ' HA ' HD13 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.701 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 301' ' ' ALA . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.744 ' HB1' HG11 ' A' ' 244' ' ' VAL . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.655 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 321' ' ' MET . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 1.085 ' HA ' HG12 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.656 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.722 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.519 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.629 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.73 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.861 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.861 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.4 m120 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.818 HE21 ' HB2' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 358' ' ' ASP . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.668 ' O ' ' HE2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.818 ' HB2' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.686 ' HB3' ' NZ ' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.808 ' HG2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.8 m -105.0 135.46 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 160.23 25.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.332 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.77 151.65 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.819 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.944 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.772 ' HB3' HG23 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.94 HD13 ' HB3' ' A' ' 15' ' ' LYS . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.94 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.657 HG12 ' HD2' ' A' ' 283' ' ' TYR . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 31' ' ' THR . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 HG13 ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 7' ' ' LEU . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 37' ' ' VAL . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.978 ' HA ' HD12 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 46' ' ' LYS . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.659 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.633 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 58' ' ' ASP . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.694 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.694 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.788 ' HB2' HG23 ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.672 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.895 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 75' ' ' LEU . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.885 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.594 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' N ' ' HG2' ' A' ' 83' ' ' LYS . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CB ' ' HE1' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' THR . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.783 ' O ' HG22 ' A' ' 97' ' ' VAL . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.82 HG11 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.761 ' CG ' HD11 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 72' ' ' GLN . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HD3' HG11 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.899 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.574 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.494 HD22 HG21 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.774 HD12 HD13 ' A' ' 247' ' ' LEU . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 122' ' ' LEU . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.621 ' CG ' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.558 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.551 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.661 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.028 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 1.028 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.621 HD23 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.723 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.723 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.072 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.512 ' CB ' ' HB3' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.604 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.021 ' HB3' HD21 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.633 HG22 ' C ' ' A' ' 191' ' ' GLY . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.636 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.636 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.021 HD21 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.622 HG23 ' CD2' ' A' ' 151' ' ' LEU . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.611 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.773 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.903 ' CD2' HG23 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.426 ' HD2' ' OE1' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 219' ' ' LYS . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.621 ' HB2' ' CG ' ' A' ' 122' ' ' LEU . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 1.072 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.903 HG23 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 217' ' ' PHE . 14.9 p30 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.899 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.98 11.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -97.79 103.23 15.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.49 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.1 m -76.55 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -62.89 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 235' ' ' ILE . 15.9 tt -73.43 116.26 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.069 0.462 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.54 103.57 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 m -66.66 136.45 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 77.5 p -134.88 113.93 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.9 170.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.326 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 240' ' ' VAL . 13.4 m -84.69 92.84 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -170.18 40.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.257 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 114' ' ' SER . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.65 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.774 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.551 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.676 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' HIS . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.672 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.997 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.87 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 36.7 m-80 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.73 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.998 HD23 HD22 ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.625 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.998 HD22 HD23 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 304' ' ' LEU . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.906 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.933 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.933 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.844 ' N ' HG21 ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.853 ' HB ' HD23 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.853 HD23 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.771 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.771 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.717 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.621 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.753 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.605 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.65 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.713 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 45.1 m-80 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.544 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 333' ' ' ILE . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.583 ' O ' HG22 ' A' ' 347' ' ' VAL . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 343' ' ' VAL . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.5 m-80 -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 1.064 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 1.064 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 2.2 pp0? -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -119.23 -178.76 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.074 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -110.41 166.36 11.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.15 122.06 34.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.201 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.77 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.954 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 37' ' ' VAL . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.669 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.859 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.636 ' NZ ' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.777 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.655 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.777 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 HD12 ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.702 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.954 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 62' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB2' HG22 ' A' ' 11' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.967 ' HE1' HD11 ' A' ' 60' ' ' ILE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.833 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.861 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HB1' ' A' ' 71' ' ' ALA . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.602 ' HG3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.724 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.86 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.86 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.759 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.775 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 61' ' ' PHE . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.718 ' OE2' ' HB1' ' A' ' 109' ' ' ALA . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.783 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.771 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HD1' ' CD1' ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 121' ' ' LEU . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.499 ' CD1' ' HD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.692 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.725 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' CD ' HD23 ' A' ' 135' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.73 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.635 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.73 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.792 ' O ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.69 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 155' ' ' TYR . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.631 ' O ' HD12 ' A' ' 160' ' ' LEU . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.648 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.631 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.897 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 331' ' ' PRO . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.897 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 196' ' ' VAL . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.722 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.674 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.434 ' HB3' ' H ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 203' ' ' HIS . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 213' ' ' ALA . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.556 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.833 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.556 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.598 ' HB2' ' OG1' ' A' ' 208' ' ' THR . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.959 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 1.09 ' HB2' HG23 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.959 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 145' ' ' SER . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.69 ' HB3' ' H ' ' A' ' 148' ' ' MET . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . 1.09 HG23 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.918 HD12 ' CD2' ' A' ' 149' ' ' PHE . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.783 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.28 -71.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.21 89.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.091 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.28 162.25 17.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 110.496 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 57.82 171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.087 0.47 . . . . 0.0 111.138 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.7 pp -128.44 159.95 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.003 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.15 -174.53 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 t -137.66 -44.42 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.175 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -51.35 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.882 0.373 . . . . 0.0 110.957 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -154.74 -73.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.167 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 p -176.26 123.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 111.409 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -126.18 51.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.705 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.466 ' CE2' HD23 ' A' ' 160' ' ' LEU . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 1.032 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 1.032 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.777 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.642 ' O ' HD13 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 265' ' ' GLY . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.581 HD21 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.615 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.698 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.619 ' CB ' ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.935 HD21 HD11 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.636 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 290' ' ' LEU . 0.4 OUTLIER -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.893 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.925 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.855 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.925 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.518 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.935 HD11 HD21 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.908 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.704 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.864 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.487 HG21 ' CG1' ' A' ' 110' ' ' VAL . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.542 ' HA ' ' HE3' ' A' ' 326' ' ' LYS . 5.2 m120 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 329' ' ' ILE . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.879 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 335' ' ' GLN . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG12 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.426 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.5 ' HB1' ' CZ ' ' A' ' 341' ' ' TYR . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 158' ' ' TRP . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.533 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.605 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.659 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 348' ' ' ILE . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.751 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.738 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 358' ' ' ASP . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.793 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 356' ' ' THR . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.793 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.428 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 0.8 OUTLIER -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 364' ' ' ALA . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.58 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.666 0.27 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 2' ' ' THR . 7.8 t -106.17 76.06 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.929 0.395 . . . . 0.0 110.929 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.96 125.15 50.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HB3' ' OD1' ' A' ' 272' ' ' ASN . 0.2 OUTLIER -147.29 134.42 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.261 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.912 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.856 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.816 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' OD2' HD13 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.945 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.856 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 46' ' ' LYS . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.912 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 58' ' ' ASP . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.816 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.758 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.758 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.944 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.944 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.95 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD13 ' HB3' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.996 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' HD13 ' A' ' 266' ' ' ILE . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.696 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 97' ' ' VAL . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.766 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.842 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.65 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.677 HG23 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.639 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.581 HD23 ' HA3' ' A' ' 228' ' ' GLY . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB3' HG23 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.856 HG21 ' OG1' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.576 ' CD2' HD22 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.512 ' O ' HD12 ' A' ' 122' ' ' LEU . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 119' ' ' LYS . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.589 ' CD2' HD11 ' A' ' 139' ' ' LEU . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.488 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.835 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.902 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.96 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.96 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.75 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.542 ' O ' HG22 ' A' ' 222' ' ' THR . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.842 HD22 HG23 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.854 HG22 HD12 ' A' ' 195' ' ' LEU . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.769 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.419 HD11 ' NE1' ' A' ' 129' ' ' TRP . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.665 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.57 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.853 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.853 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.643 HG21 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.552 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.854 HD12 HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.842 HG23 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.652 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.606 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.717 HG22 HG23 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.734 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 1.027 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 145' ' ' SER . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 122' ' ' LEU . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.647 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . 1.027 HG22 ' HD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 225' ' ' THR . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.628 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.581 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 233' ' ' SER . . . -122.83 -42.69 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.5 t90 71.57 -18.64 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.597 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 231' ' ' ALA . 2.5 t 60.73 169.34 0.09 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.901 0.381 . . . . 0.0 111.058 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -174.39 165.36 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.222 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 235' ' ' ILE . 0.2 OUTLIER -153.2 179.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.015 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.83 -39.62 83.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -101.02 91.03 4.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 90.3 p -68.22 143.24 55.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.12 177.71 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.508 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.814 HG23 ' CE1' ' A' ' 242' ' ' TYR . 9.3 p -139.69 146.57 25.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.79 44.41 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.814 ' CE1' HG23 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.612 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.49 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 252' ' ' GLY . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.73 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.627 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.577 ' HZ1' ' C ' ' A' ' 327' ' ' GLY . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.944 HG23 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.001 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.944 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 266' ' ' ILE . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.996 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.626 ' ND2' ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.626 ' HB2' ' ND2' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.811 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.834 ' O ' ' HB2' ' A' ' 294' ' ' ASN . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 1.078 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 2.0 m120 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.774 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.737 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.911 ' HB2' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.889 HG11 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.956 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.985 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.797 ' CB ' HD13 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.985 HG21 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.535 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 316' ' ' ARG . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.577 ' C ' ' HZ1' ' A' ' 256' ' ' LYS . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.57 ' HG2' ' OH ' ' A' ' 171' ' ' TYR . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.67 ' CE ' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.895 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.895 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.414 ' OE1' HD11 ' A' ' 333' ' ' ILE . 44.6 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.462 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.61 ' HG3' HH11 ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.804 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.804 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 362' ' ' LYS . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.853 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.632 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.43 ' C ' HD13 ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 367' ' ' ARG . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.701 ' HA ' HD12 ' A' ' 368' ' ' ILE . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 1.101 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 1.101 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.787 0.327 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 p -131.68 148.02 52.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.92 116.95 32.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.56 -68.66 0.57 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.695 ' C ' HG23 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.824 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 6' ' ' LYS . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.962 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.733 ' CD1' HD21 ' A' ' 20' ' ' LEU . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 1.014 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.82 HD12 ' HB2' ' A' ' 14' ' ' ASP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.82 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB2' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.733 HD21 ' CD1' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.764 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.695 HG23 ' C ' ' A' ' 5' ' ' GLY . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG22 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.633 ' HB ' HG13 ' A' ' 8' ' ' VAL . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.829 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' A' ' 50' ' ' VAL . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.962 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' CG1' HD12 ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.014 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 264' ' ' ALA . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.503 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.048 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.655 ' ND1' HG23 ' A' ' 261' ' ' VAL . 2.4 p-80 -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.016 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.741 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' O ' HD22 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.838 HD13 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.054 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD12 ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 90' ' ' TYR . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.66 ' NE1' HD12 ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 97' ' ' VAL . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.741 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 1.016 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.736 ' HB3' HG23 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 247' ' ' LEU . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.788 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.788 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.768 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.058 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.574 HD23 HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.541 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.644 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.755 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 1.004 HG23 HD22 ' A' ' 195' ' ' LEU . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.663 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.816 ' HA2' HD21 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.904 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.431 HG12 HE22 ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.627 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.816 HD21 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.531 ' HA ' ' NZ ' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.531 ' NZ ' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.004 HD22 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.435 ' O ' ' HG2' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.725 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.979 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 1.045 ' HB2' HG23 ' A' ' 225' ' ' THR . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.76 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 1.045 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 113' ' ' LEU . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.705 ' C ' HD23 ' A' ' 113' ' ' LEU . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -161.52 85.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.55 -37.76 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.836 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.1 t 61.47 160.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -136.91 165.68 25.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.503 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 235' ' ' ILE . 0.9 OUTLIER -168.23 117.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.36 67.49 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -140.93 -57.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.45 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.05 51.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.36 116.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.975 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.57 126.1 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -171.33 120.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' ' 115' ' ' LEU . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.768 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.876 HG22 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.646 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.56 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.663 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.655 HG23 ' ND1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.048 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.954 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 266' ' ' ILE . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 1.054 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.991 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.789 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.789 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.807 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 1.078 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.832 ' CB ' HD23 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.789 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.634 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.634 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.856 ' HB3' HG21 ' A' ' 110' ' ' VAL . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.807 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 290' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.941 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.712 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.941 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.659 HG21 ' CD2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.628 ' H ' HD13 ' A' ' 317' ' ' ILE . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.496 HG21 ' CG1' ' A' ' 110' ' ' VAL . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.642 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.795 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.712 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 344' ' ' ARG . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.646 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.979 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.646 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.979 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.856 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.627 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.523 ' HA ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 365' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.555 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.059 0.457 . . . . 0.0 111.421 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -85.79 169.24 13.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.27 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.66 151.91 37.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.39 76.37 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.771 ' C ' HG23 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.129 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.972 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.716 ' HB3' HG23 ' A' ' 60' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.753 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.771 HG23 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.753 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.676 ' OG1' HG22 ' A' ' 8' ' ' VAL . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.972 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 11' ' ' ILE . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.45 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 46' ' ' LYS . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 1.129 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 59' ' ' ILE . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 10' ' ' TRP . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.785 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.062 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 23.7 t60 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.73 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 104' ' ' ILE . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.974 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.974 HD23 ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.79 ' HG3' HG22 ' A' ' 104' ' ' ILE . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.691 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.497 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.874 ' HD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.874 ' HB2' ' HD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HD2' HD21 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.79 HG22 ' HG3' ' A' ' 78' ' ' GLU . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.612 ' CD1' ' HD2' ' A' ' 107' ' ' PRO . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.011 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.741 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.517 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 226' ' ' ILE . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.78 HD23 HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.915 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.406 ' OH ' HD12 ' A' ' 122' ' ' LEU . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.64 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.639 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.874 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.765 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.559 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.002 HD23 ' HG3' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 1.002 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.771 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.928 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.915 HD23 ' HG3' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.766 ' HZ ' HD11 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.493 HG22 ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.742 ' HD2' ' C ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 1.103 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.894 ' HB2' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.607 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.644 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.786 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 1.103 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.534 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.657 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.706 ' HA ' ' CD ' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.737 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.737 ' H ' HG13 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.559 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.737 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.521 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.635 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.836 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.836 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.976 ' CD1' HG23 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.534 ' HB ' ' CA ' ' A' ' 146' ' ' ALA . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.915 ' HG3' HD23 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.976 HG23 ' CD1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 225' ' ' THR . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 299' ' ' LEU . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.517 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.03 32.97 2.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -122.93 110.97 16.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 110.49 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.3 p -126.41 165.37 19.19 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.013 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.24 147.87 45.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.76 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 235' ' ' ILE . 0.8 OUTLIER -156.12 78.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 111.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.09 28.03 15.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.39 -179.58 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 91.0 p -168.6 -32.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.313 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -148.79 132.09 16.52 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.764 0.316 . . . . 0.0 111.235 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 t -143.26 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -91.29 90.78 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 HD23 ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 160' ' ' LEU . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.445 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.894 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.923 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.805 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.441 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.735 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.924 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.924 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.882 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.695 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.497 ' H ' HD12 ' A' ' 317' ' ' ILE . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.452 ' HA ' ' OE2' ' A' ' 308' ' ' GLU . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 306' ' ' SER . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.807 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 1.114 HD21 HG21 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 1.114 HG21 HD21 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 110' ' ' VAL . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.515 HD21 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.721 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 359' ' ' GLU . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 355' ' ' GLN . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 361' ' ' LEU . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.699 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.786 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 365' ' ' GLN . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.461 ' OXT' ' HG3' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.805 0.336 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.5 p -130.94 -176.75 4.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.683 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.13 166.85 10.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -134.95 -75.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.449 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.848 HD22 HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.877 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.678 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.664 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.676 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' CG2' HG23 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 8' ' ' VAL . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.877 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.678 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.842 HD12 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.842 ' HE3' HD12 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.807 ' HB3' HG11 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.814 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.1 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.914 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.83 ' HB1' ' CD2' ' A' ' 76' ' ' LEU . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.62 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.606 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.83 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.861 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.58 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.557 ' HE1' ' HH ' ' A' ' 106' ' ' TYR . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.812 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.533 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 93' ' ' THR . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.62 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.685 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.601 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HD2' ' HD1' ' A' ' 106' ' ' TYR . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.787 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.987 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 1.093 ' HB3' HG23 ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.1 t-20 -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.659 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.732 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.735 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.732 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.899 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.899 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.465 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.885 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.945 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.652 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.652 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.56 ' O ' HG23 ' A' ' 178' ' ' ILE . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.584 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.658 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 204' ' ' MET . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.7 OUTLIER -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.593 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.817 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 1.011 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 219' ' ' LYS . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 145' ' ' SER . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 122' ' ' LEU . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.945 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.665 ' H ' HG22 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.655 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.04 11.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.42 155.58 48.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.6 t -99.42 -38.35 8.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.025 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.3 m120 61.15 118.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.87 -38.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.613 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.12 115.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.156 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m 59.92 167.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.67 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 21.1 m 70.8 -56.55 0.61 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.664 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -141.8 113.47 7.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.866 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.1 m -152.87 29.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.37 100.66 11.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 1.093 HG23 ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.735 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.932 HG22 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.448 ' C ' ' HG2' ' A' ' 253' ' ' GLN . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.932 ' HD3' HG22 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.895 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 108' ' ' ILE . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 67' ' ' PHE . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.446 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.814 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 23.8 m-80 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.7 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 26.8 m-80 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.404 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.742 ' HD1' HD23 ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.786 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.707 ' H ' HG23 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.562 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.786 ' HG2' ' O ' ' A' ' 287' ' ' ASP . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.681 ' OD1' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.753 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.54 ' CG2' HG21 ' A' ' 317' ' ' ILE . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 304' ' ' LEU . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.783 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.783 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 315' ' ' PRO . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.67 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 318' ' ' ALA . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.753 HG13 ' HA2' ' A' ' 300' ' ' GLY . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.745 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.58 ' HG3' ' HG2' ' A' ' 325' ' ' GLN . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.58 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.441 ' HB3' ' HE3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.55 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . 0.477 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 3.5 mm-40 -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.849 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.792 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.849 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.792 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.658 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.5 mm-40 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.755 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.842 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CB ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 18.0 t-20 -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' A' ' 292' ' ' ALA . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.696 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.763 HG11 ' HA2' ' A' ' 289' ' ' GLY . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.743 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 279' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 9' ' ' ILE . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.842 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' HD21 ' A' ' 12' ' ' ASN . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' O ' HG22 ' A' ' 53' ' ' THR . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 1.006 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.9 ' HB2' HG23 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HB3' HD23 ' A' ' 262' ' ' LEU . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.707 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.657 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.584 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.899 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.658 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.95 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.95 HG23 ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 1.024 ' HA ' HG12 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.024 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 78' ' ' GLU . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.83 ' HD2' ' HG1' ' A' ' 245' ' ' THR . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.494 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.757 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 1.096 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.649 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.096 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.779 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' OE2' HD23 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.509 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' HD2' ' HD2' ' A' ' 156' ' ' PHE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.544 ' H ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.711 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.624 ' CD1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.624 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.85 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 255' ' ' SER . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.926 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.738 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.738 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.926 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.782 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.833 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.85 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.431 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB2' ' CG2' ' A' ' 199' ' ' ILE . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.015 ' HB ' HD11 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.744 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.696 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.744 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.737 ' CD2' ' HB ' ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.714 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.737 ' HB ' ' CD2' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.723 ' HB3' ' HZ ' ' A' ' 217' ' ' PHE . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.74 0.305 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.83 ' HG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.649 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.657 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.9 HG23 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 50.4 m-80 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.814 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.853 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.447 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.682 HD11 HG11 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.483 ' CA ' HD13 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.541 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA2' HG11 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.715 HD23 HD21 ' A' ' 294' ' ' ASN . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.919 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.839 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.715 HD21 HD23 ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.919 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.608 ' O ' HD23 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.968 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.753 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.968 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.555 HG21 ' HE1' ' A' ' 64' ' ' HIS . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.405 ' HB3' ' HD2' ' A' ' 331' ' ' PRO . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 330' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 335' ' ' GLN . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.534 ' H ' HG22 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.614 ' HD2' HG23 ' A' ' 345' ' ' THR . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.912 HD22 ' HG3' ' A' ' 355' ' ' GLN . 0.6 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.613 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.912 ' HG3' HD22 ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 359' ' ' GLU . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.72 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.543 HD11 HG22 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.782 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.77 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 363' ' ' ASP . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.77 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.864 0.364 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.739 ' CG1' ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.513 HD12 HG21 ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 40' ' ' PRO . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.598 HD11 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' CG ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.941 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.733 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.784 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.818 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 20' ' ' LEU . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE1' HD13 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.822 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' OE1' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.808 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' C ' HG13 ' A' ' 59' ' ' ILE . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.987 ' HB3' HD21 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.884 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.884 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.83 ' CB ' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' OE1' HG21 ' A' ' 104' ' ' ILE . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.657 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.657 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.83 HD12 ' CB ' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.705 HG23 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.687 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 107' ' ' PRO . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.747 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.824 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 97' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.452 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.857 HD12 ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.612 HG23 ' HB2' ' A' ' 131' ' ' GLU . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.873 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.612 ' HB2' HG23 ' A' ' 128' ' ' THR . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 132' ' ' ILE . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 146' ' ' ALA . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.802 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.681 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.009 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.722 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 1.051 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.692 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.692 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.419 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 195' ' ' LEU . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.716 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.965 HD13 ' HG ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.542 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.43 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.593 ' CG1' HG23 ' A' ' 183' ' ' VAL . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.452 HD22 ' H ' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.452 ' H ' HD22 ' A' ' 185' ' ' ASN . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.965 ' HG ' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.493 HD21 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.668 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.674 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.917 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.917 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 1.107 ' HB3' HG23 ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 145' ' ' SER . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 1.051 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 1.107 HG23 ' HB3' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.759 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.541 ' H ' HH22 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.953 0.406 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 244' ' ' VAL . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.51 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 1.056 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 1.056 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.987 HD21 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.509 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.678 ' HA ' HD23 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.705 ' HE3' HG23 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.83 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.83 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.647 ' HA ' HD23 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.691 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.714 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 294' ' ' ASN . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 1.125 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.941 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.73 ' HB2' HD13 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 1.125 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.715 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.715 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.464 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.586 HG11 ' OD1' ' A' ' 294' ' ' ASN . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.738 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.833 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 305' ' ' LYS . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.833 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 1.086 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 1.086 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 317' ' ' ILE . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.51 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.71 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.747 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 335' ' ' GLN . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.467 ' H ' HG13 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 343' ' ' VAL . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.636 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 363' ' ' ASP . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' A' ' 345' ' ' THR . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 183' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 359' ' ' GLU . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 181' ' ' VAL . 1.2 tm0? -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.479 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.903 0.382 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.803 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.648 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.994 ' HE3' HD12 ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.838 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.499 HG12 ' HB ' ' A' ' 9' ' ' ILE . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.717 ' CD1' ' HB2' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 53' ' ' THR . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.657 ' HA ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 267' ' ' ASN . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.994 HD12 ' HE3' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.822 ' HB3' HD21 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.878 ' HZ3' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.568 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.717 ' CG ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.065 HD13 ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 1.027 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.906 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' NE2' ' A' ' 72' ' ' GLN . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.938 ' HD2' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.938 HD11 ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.567 ' H ' ' HA3' ' A' ' 260' ' ' GLY . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB2' HG23 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 139' ' ' LEU . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.765 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.634 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.885 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.885 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HB2' HD21 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.58 HD22 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.411 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.727 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.693 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.773 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.971 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.971 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 161' ' ' ILE . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.573 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.751 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.944 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.581 HG13 ' HA3' ' A' ' 191' ' ' GLY . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.543 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.681 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 188' ' ' ALA . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.761 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 192' ' ' LEU . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.811 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 195' ' ' LEU . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.811 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.78 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.78 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.591 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.837 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.674 ' HB2' ' CG2' ' A' ' 208' ' ' THR . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.837 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.631 ' HA ' HG23 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.738 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.738 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.693 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.631 HG23 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 156' ' ' PHE . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.826 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.564 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.826 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.435 HD23 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.765 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.729 HG22 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.944 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 1.015 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 1.015 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.685 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.877 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.967 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.771 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 266' ' ' ILE . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.619 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.846 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 284' ' ' LEU . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.664 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.825 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.44 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 1.027 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.932 HD13 ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.825 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 314' ' ' ASP . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.628 ' HE1' ' HG2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.805 HD22 ' HB1' ' A' ' 112' ' ' ALA . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.736 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.718 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.713 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.713 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.639 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 339' ' ' PHE . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 343' ' ' VAL . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.78 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.78 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 11.5 mm100 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.659 HG23 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.617 ' HG ' HE22 ' A' ' 365' ' ' GLN . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 367' ' ' ARG . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.617 HE22 ' HG ' ' A' ' 361' ' ' LEU . 0.4 OUTLIER -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.675 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.016 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.715 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.91 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.783 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.91 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 9' ' ' ILE . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.735 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.617 ' OD2' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.016 HG23 ' HA ' ' A' ' 9' ' ' ILE . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 10' ' ' TRP . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.903 ' HB2' HG23 ' A' ' 261' ' ' VAL . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.927 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.988 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.808 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.77 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.641 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.808 HD13 ' HB3' ' A' ' 71' ' ' ALA . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.685 ' HZ3' HD21 ' A' ' 103' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.685 HD21 ' HZ3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.77 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.72 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.82 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.864 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.978 ' HD2' HD22 ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.978 HD22 ' HD2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.49 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.701 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CZ2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.902 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.902 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.959 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.548 ' CB ' HD12 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.547 ' O ' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.698 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.654 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.821 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' H ' ' HD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.458 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.661 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.673 ' HH2' ' HB2' ' A' ' 168' ' ' ALA . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CZ2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 157' ' ' THR . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.599 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HG2' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.808 ' CG2' ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' A' ' 361' ' ' LEU . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 195' ' ' LEU . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.587 ' HA ' ' NZ ' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.718 ' CG2' HD12 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.864 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.645 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.864 HD13 ' HB2' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.967 ' CD1' HG23 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.905 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 145' ' ' SER . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.967 HG23 ' CD1' ' A' ' 217' ' ' PHE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.944 HG22 HD23 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.451 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.671 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.556 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.82 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.655 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HG ' HD13 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.474 HG22 ' HD3' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' ' 162' ' ' ALA . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.785 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 1.085 HG12 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.988 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.84 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.801 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.776 HD23 ' HE1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.743 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.801 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.776 ' HE1' HD23 ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 283' ' ' TYR . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.662 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD1' ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.945 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.611 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.945 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.8 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.8 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.701 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 317' ' ' ILE . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.742 ' N ' HG22 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.716 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.973 ' HA ' HD13 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.701 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 301' ' ' ALA . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.744 ' HB1' HG11 ' A' ' 244' ' ' VAL . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.655 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 321' ' ' MET . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 1.085 ' HA ' HG12 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.656 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.722 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.519 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.629 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.73 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.861 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.861 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.818 HE21 ' HB2' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 358' ' ' ASP . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.668 ' O ' ' HE2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.818 ' HB2' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.686 ' HB3' ' NZ ' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.808 ' HG2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.623 0.249 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.944 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.772 ' HB3' HG23 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.94 HD13 ' HB3' ' A' ' 15' ' ' LYS . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.94 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.657 HG12 ' HD2' ' A' ' 283' ' ' TYR . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 31' ' ' THR . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 HG13 ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 7' ' ' LEU . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' VAL . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.978 ' HA ' HD12 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 46' ' ' LYS . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.659 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.633 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 58' ' ' ASP . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.694 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.694 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.788 ' HB2' HG23 ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.672 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.895 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 75' ' ' LEU . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.885 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.594 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' N ' ' HG2' ' A' ' 83' ' ' LYS . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CB ' ' HE1' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' THR . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.783 ' O ' HG22 ' A' ' 97' ' ' VAL . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.82 HG11 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.761 ' CG ' HD11 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 72' ' ' GLN . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HD3' HG11 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 108' ' ' ILE . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.899 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.574 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.494 HD22 HG21 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.774 HD12 HD13 ' A' ' 247' ' ' LEU . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 122' ' ' LEU . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.621 ' CG ' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.558 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.551 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.661 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.028 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 1.028 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.621 HD23 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.723 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.723 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.072 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.512 ' CB ' ' HB3' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.604 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.021 ' HB3' HD21 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.633 HG22 ' C ' ' A' ' 191' ' ' GLY . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.636 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.636 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.021 HD21 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.622 HG23 ' CD2' ' A' ' 151' ' ' LEU . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.611 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.773 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.903 ' CD2' HG23 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.426 ' HD2' ' OE1' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 219' ' ' LYS . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.621 ' HB2' ' CG ' ' A' ' 122' ' ' LEU . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 1.072 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.903 HG23 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 217' ' ' PHE . 1.3 p-10 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.899 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.973 0.416 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 114' ' ' SER . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.65 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.774 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.551 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.676 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' HIS . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.672 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.997 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.87 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 21.5 m120 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.73 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.998 HD23 HD22 ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.625 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.998 HD22 HD23 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 304' ' ' LEU . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.906 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.933 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.933 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.844 ' N ' HG21 ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.853 ' HB ' HD23 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.853 HD23 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.771 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.771 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.717 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.621 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.753 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.605 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.65 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.713 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 14.4 m120 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.544 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 333' ' ' ILE . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.583 ' O ' HG22 ' A' ' 347' ' ' VAL . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 343' ' ' VAL . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 345' ' ' THR . 0.3 OUTLIER -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 1.064 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 1.064 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.849 0.356 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.77 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.954 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 37' ' ' VAL . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.669 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.859 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.636 ' NZ ' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.777 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.655 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.777 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 HD12 ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.702 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.954 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 62' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB2' HG22 ' A' ' 11' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.967 ' HE1' HD11 ' A' ' 60' ' ' ILE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.833 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.861 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HB1' ' A' ' 71' ' ' ALA . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.602 ' HG3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.724 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.86 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.86 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.759 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.775 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 61' ' ' PHE . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.718 ' OE2' ' HB1' ' A' ' 109' ' ' ALA . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.783 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.771 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HD1' ' CD1' ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 121' ' ' LEU . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.499 ' CD1' ' HD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.692 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.725 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' CD ' HD23 ' A' ' 135' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.73 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.635 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.73 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.792 ' O ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.69 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 155' ' ' TYR . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.631 ' O ' HD12 ' A' ' 160' ' ' LEU . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.648 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.631 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.897 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 331' ' ' PRO . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' NE2' ' A' ' 365' ' ' GLN . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.897 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 196' ' ' VAL . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.722 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.674 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.434 ' HB3' ' H ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 203' ' ' HIS . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 213' ' ' ALA . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.556 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.833 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.556 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.598 ' HB2' ' OG1' ' A' ' 208' ' ' THR . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.959 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 1.09 ' HB2' HG23 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.959 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 145' ' ' SER . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.69 ' HB3' ' H ' ' A' ' 148' ' ' MET . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 1.09 HG23 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.918 HD12 ' CD2' ' A' ' 149' ' ' PHE . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.783 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.676 HG23 HD21 ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.705 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.466 ' CE2' HD23 ' A' ' 160' ' ' LEU . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 1.032 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 1.032 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.777 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.642 ' O ' HD13 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 265' ' ' GLY . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.581 HD21 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.615 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.698 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.619 ' CB ' ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.935 HD21 HD11 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.636 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 290' ' ' LEU . 16.8 t-20 -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.893 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.925 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.855 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.925 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.518 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.935 HD11 HD21 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.908 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.704 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.864 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.487 HG21 ' CG1' ' A' ' 110' ' ' VAL . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.676 HD21 HG23 ' A' ' 246' ' ' VAL . 2.1 m-80 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 329' ' ' ILE . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.879 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 335' ' ' GLN . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG12 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.426 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.5 ' HB1' ' CZ ' ' A' ' 341' ' ' TYR . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 158' ' ' TRP . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.533 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.605 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.659 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 348' ' ' ILE . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.751 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.738 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 358' ' ' ASP . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.793 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 356' ' ' THR . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.793 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.483 ' NE2' HG21 ' A' ' 181' ' ' VAL . 5.0 tm0? -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 364' ' ' ALA . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.58 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HB3' ' OD1' ' A' ' 272' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.912 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.856 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.816 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' OD2' HD13 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.945 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.856 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 46' ' ' LYS . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.912 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 58' ' ' ASP . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.816 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.758 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.758 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.944 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.944 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.95 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.95 HD13 ' HB3' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.996 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' HD13 ' A' ' 266' ' ' ILE . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.696 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 97' ' ' VAL . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.766 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.842 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.65 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.677 HG23 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.639 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.581 HD23 ' HA3' ' A' ' 228' ' ' GLY . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB3' HG23 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.856 HG21 ' OG1' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.576 ' CD2' HD22 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.512 ' O ' HD12 ' A' ' 122' ' ' LEU . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 119' ' ' LYS . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.589 ' CD2' HD11 ' A' ' 139' ' ' LEU . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.466 HD22 ' HD2' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' HD22 ' A' ' 124' ' ' ASN . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.488 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.835 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.902 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.96 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.96 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.75 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.542 ' O ' HG22 ' A' ' 222' ' ' THR . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.842 HD22 HG23 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.854 HG22 HD12 ' A' ' 195' ' ' LEU . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.769 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.419 HD11 ' NE1' ' A' ' 129' ' ' TRP . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.665 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.57 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.853 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.853 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.643 HG21 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.552 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.854 HD12 HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.842 HG23 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.652 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.606 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.717 HG22 HG23 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.734 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 1.027 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 145' ' ' SER . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 122' ' ' LEU . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.647 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 1.027 HG22 ' HD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 225' ' ' THR . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.628 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.581 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.612 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.49 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 252' ' ' GLY . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.73 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.627 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.577 ' HZ1' ' C ' ' A' ' 327' ' ' GLY . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.944 HG23 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.001 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.944 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 266' ' ' ILE . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.996 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.626 ' ND2' ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.626 ' HB2' ' ND2' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.811 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.834 ' O ' ' HB2' ' A' ' 294' ' ' ASN . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 1.078 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.474 HG13 HD22 ' A' ' 294' ' ' ASN . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 1.4 m-80 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.774 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.737 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.911 ' HB2' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.889 HG11 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.956 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.985 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.797 ' CB ' HD13 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.985 HG21 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.535 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.625 ' HA ' HD21 ' A' ' 323' ' ' ASN . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 320' ' ' THR . 6.2 p30 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.577 ' C ' ' HZ1' ' A' ' 256' ' ' LYS . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.57 ' HG2' ' OH ' ' A' ' 171' ' ' TYR . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.67 ' CE ' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.895 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.895 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.553 ' NE2' HD11 ' A' ' 333' ' ' ILE . 38.5 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.462 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.61 HH11 ' HG3' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.804 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.804 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 362' ' ' LYS . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.853 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.632 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 367' ' ' ARG . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.701 ' HA ' HD12 ' A' ' 368' ' ' ILE . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 1.101 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 1.101 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.695 ' C ' HG23 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.824 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 6' ' ' LYS . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.962 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.733 ' CD1' HD21 ' A' ' 20' ' ' LEU . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 1.014 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.82 HD12 ' HB2' ' A' ' 14' ' ' ASP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.82 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB2' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.733 HD21 ' CD1' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.764 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.695 HG23 ' C ' ' A' ' 5' ' ' GLY . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG22 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.633 ' HB ' HG13 ' A' ' 8' ' ' VAL . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.829 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' A' ' 50' ' ' VAL . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.962 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' CG1' HD12 ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.014 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 264' ' ' ALA . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.503 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.048 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.862 ' CD2' HG23 ' A' ' 261' ' ' VAL . 0.4 OUTLIER -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.016 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.741 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' O ' HD22 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.838 HD13 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.054 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.66 HD12 ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 90' ' ' TYR . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.66 ' NE1' HD12 ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 97' ' ' VAL . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.741 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 1.016 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.736 ' HB3' HG23 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 247' ' ' LEU . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.788 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.788 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.768 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.058 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.574 HD23 HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.541 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.644 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.755 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 1.004 HG23 HD22 ' A' ' 195' ' ' LEU . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.663 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.816 ' HA2' HD21 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.904 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.431 HG12 HE22 ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.627 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.816 HD21 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.531 ' HA ' ' NZ ' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.531 ' NZ ' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.004 HD22 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.725 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.979 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 1.045 ' HB2' HG23 ' A' ' 225' ' ' THR . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.76 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 1.045 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 113' ' ' LEU . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.705 ' C ' HD23 ' A' ' 113' ' ' LEU . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' ' 115' ' ' LEU . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.768 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.876 HG22 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.646 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.56 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.663 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.862 HG23 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.048 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.954 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 266' ' ' ILE . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 1.054 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.991 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.789 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.789 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.807 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 1.078 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.832 ' CB ' HD23 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.789 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.634 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.634 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.856 ' HB3' HG21 ' A' ' 110' ' ' VAL . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.807 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 290' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.941 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.712 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.941 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.659 HG21 ' CD2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.628 ' H ' HD13 ' A' ' 317' ' ' ILE . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.496 HG21 ' CG1' ' A' ' 110' ' ' VAL . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.642 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.795 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.563 HE22 HG13 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.712 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 344' ' ' ARG . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.646 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.979 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.646 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.979 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.856 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 4.7 mm100 -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.627 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.523 ' HA ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.563 HG13 HE22 ' A' ' 335' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.555 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.771 ' C ' HG23 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.129 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.972 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.716 ' HB3' HG23 ' A' ' 60' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.67 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.753 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.771 HG23 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.753 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.676 ' OG1' HG22 ' A' ' 8' ' ' VAL . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.972 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 11' ' ' ILE . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.45 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 46' ' ' LYS . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 1.129 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 59' ' ' ILE . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 10' ' ' TRP . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.785 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.062 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 16.3 t-80 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.73 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 104' ' ' ILE . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.974 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.854 HE21 HG21 ' A' ' 104' ' ' ILE . 1.2 tt0 -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.974 HD23 ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.79 ' HG3' HG22 ' A' ' 104' ' ' ILE . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.691 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.497 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.874 ' HD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.874 ' HB2' ' HD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HD2' HD21 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.854 HG21 HE21 ' A' ' 72' ' ' GLN . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.612 ' CD1' ' HD2' ' A' ' 107' ' ' PRO . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.011 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.741 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.517 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 226' ' ' ILE . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.78 HD23 HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.915 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.406 ' OH ' HD12 ' A' ' 122' ' ' LEU . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.64 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.639 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.874 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.765 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.559 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.002 HD23 ' HG3' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 1.002 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.771 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.928 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.915 HD23 ' HG3' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.766 ' HZ ' HD11 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.493 HG22 ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.742 ' HD2' ' C ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 1.103 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.894 ' HB2' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.607 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.644 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.786 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 1.103 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.534 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.657 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.706 ' HA ' ' CD ' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.737 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.737 ' H ' HG13 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.559 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.485 ' HD2' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.737 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.521 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 203' ' ' HIS . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.635 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.836 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.836 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.976 ' CD1' HG23 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.534 ' HB ' ' CA ' ' A' ' 146' ' ' ALA . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.915 ' HG3' HD23 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.976 HG23 ' CD1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 225' ' ' THR . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.6 HD22 HG22 ' A' ' 225' ' ' THR . 3.9 m-80 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 299' ' ' LEU . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.517 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.638 0.256 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 HD23 ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 160' ' ' LEU . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.445 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.894 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.923 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.805 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.441 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.735 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.924 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.924 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.882 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.695 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.497 ' H ' HD12 ' A' ' 317' ' ' ILE . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.452 ' HA ' ' OE2' ' A' ' 308' ' ' GLU . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 306' ' ' SER . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.807 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 1.114 HD21 HG21 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 1.114 HG21 HD21 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 110' ' ' VAL . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.515 HD21 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.721 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 359' ' ' GLU . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 355' ' ' GLN . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 361' ' ' LEU . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.699 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.786 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 365' ' ' GLN . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.461 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.892 0.377 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.848 HD22 HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.877 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.678 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.544 HD21 ' HZ3' ' A' ' 62' ' ' TRP . 1.6 p30 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.664 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.676 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' CG2' HG23 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 8' ' ' VAL . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.877 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.678 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.842 HD12 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.842 ' HE3' HD12 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.807 ' HB3' HG11 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.814 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.914 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.83 ' HB1' ' CD2' ' A' ' 76' ' ' LEU . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.62 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.622 ' CD2' HD22 ' A' ' 267' ' ' ASN . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.83 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.861 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.58 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.557 ' HE1' ' HH ' ' A' ' 106' ' ' TYR . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.812 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.533 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 93' ' ' THR . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.62 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.685 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.601 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HD2' ' HD1' ' A' ' 106' ' ' TYR . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.787 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.987 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 1.093 ' HB3' HG23 ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' N ' HD22 ' A' ' 118' ' ' ASN . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.659 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.732 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.735 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.732 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.899 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.899 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.465 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.885 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.945 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.652 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.652 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.56 ' O ' HG23 ' A' ' 178' ' ' ILE . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.584 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.658 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 204' ' ' MET . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' HIS . 5.6 p30 -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.593 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.817 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 1.011 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 20.5 t-20 -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 219' ' ' LYS . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 145' ' ' SER . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 122' ' ' LEU . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.945 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.665 ' H ' HG22 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.655 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.88 0.371 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 1.093 HG23 ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.526 HG23 ' ND2' ' A' ' 323' ' ' ASN . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.735 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.932 HG22 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.448 ' C ' ' HG2' ' A' ' 253' ' ' GLN . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.932 ' HD3' HG22 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.895 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 108' ' ' ILE . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 67' ' ' PHE . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.446 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.814 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 13.6 m120 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.945 HD22 HD13 ' A' ' 275' ' ' LEU . 15.1 m120 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.945 HD13 HD22 ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.404 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.742 ' HD1' HD23 ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.786 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.707 ' H ' HG23 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.921 ' HA ' HD21 ' A' ' 294' ' ' ASN . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.921 HD21 ' HA ' ' A' ' 291' ' ' GLU . 12.7 p30 -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.753 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.54 ' CG2' HG21 ' A' ' 317' ' ' ILE . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 304' ' ' LEU . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.783 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.783 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 315' ' ' PRO . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.67 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 318' ' ' ALA . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.753 HG13 ' HA2' ' A' ' 300' ' ' GLY . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.745 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.58 ' HG3' ' HG2' ' A' ' 325' ' ' GLN . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.526 ' ND2' HG23 ' A' ' 246' ' ' VAL . 12.4 m120 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.58 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.55 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . 0.477 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.849 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.792 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.506 ' HB2' ' NE2' ' A' ' 355' ' ' GLN . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.849 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.792 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.658 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.9 mm100 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.755 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.24 153.02 49.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.986 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -128.72 157.46 41.35 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.745 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.53 174.18 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.48 42.47 1.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.646 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.1 145.98 22.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.938 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -144.56 136.13 25.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.596 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.006 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 40.0 t -103.01 128.97 55.45 Favored 'Isoleucine or valine' 0 C--O 1.25 1.118 0 CA-C-O 121.285 0.564 . . . . 0.0 111.759 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.842 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 1.4 tt -90.98 153.88 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.197 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CB ' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -139.51 111.0 7.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 3.6 pt -128.51 134.53 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.681 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 18.0 t-20 -132.64 69.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.21 0.528 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.75 3.05 2.7 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.755 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -82.45 -29.84 30.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 117.089 0.444 . . . . 0.0 110.712 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 mttp 72.41 -92.84 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.215 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 30.46 76.76 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 N-CA-C 115.825 1.09 . . . . 0.0 115.825 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.7 -60.07 2.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.699 0.285 . . . . 0.0 111.091 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.47 -31.88 53.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.678 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' A' ' 292' ' ' ALA . . . -55.65 -61.87 6.93 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.728 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -68.34 -25.61 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.22 -46.17 68.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.206 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.696 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 6.4 pt-20 -74.01 -59.23 2.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.763 HG11 ' HA2' ' A' ' 289' ' ' GLY . 18.8 m -46.52 -35.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.4 -43.05 88.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.141 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -78.19 -30.8 49.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -35.41 78.76 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 33' ' ' ILE . 5.0 m-85 -70.34 -57.99 4.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.743 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 9.8 pt-20 -52.62 -27.77 18.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.548 0.69 . . . . 0.0 110.286 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.49 -31.69 62.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.447 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . 0.9 OUTLIER -61.59 -57.62 11.32 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER 158.08 35.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.993 176.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.25 41.13 0.02 OUTLIER Glycine 0 C--N 1.338 0.684 0 C-N-CA 117.632 -2.223 . . . . 0.0 115.774 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 279' ' ' PHE . 2.7 mp -137.8 95.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.179 0.99 . . . . 0.0 111.362 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 123.18 47.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.619 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.76 136.6 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.59 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.739 ' O ' HG22 ' A' ' 9' ' ' ILE . 3.3 m -96.53 118.91 34.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.71 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.842 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 19.2 t -88.57 110.9 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 111.447 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -131.66 151.08 51.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.303 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER -137.1 133.73 18.64 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.313 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 84.7 Cg_endo -87.54 -176.13 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.363 2.042 . . . . 0.0 112.922 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' HD21 ' A' ' 12' ' ' ASN . 12.7 t70 -166.7 -51.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.571 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.81 -0.76 10.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.764 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.18 -11.63 9.81 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.466 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -33.22 56.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 111.535 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -26.22 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.363 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -76.18 -24.91 54.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.017 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 1.4 t80 -42.23 -61.41 1.59 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 20.1 Cg_endo -59.25 -18.55 45.5 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.36 2.04 . . . . 0.0 112.935 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.16 -52.1 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.282 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' O ' HG22 ' A' ' 53' ' ' THR . 15.3 m -75.51 -9.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.14 -38.76 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.722 0.296 . . . . 0.0 111.044 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.04 -13.83 0.35 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 50' ' ' VAL . 13.1 t -85.97 -27.65 24.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.894 0.378 . . . . 0.0 110.607 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.8 2.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.183 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.37 98.82 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.877 0.37 . . . . 0.0 111.752 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.11 -83.64 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.095 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 1.006 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 35.0 Cg_endo -61.06 -172.31 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.469 2.113 . . . . 0.0 111.454 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.9 ' HB2' HG23 ' A' ' 266' ' ' ILE . 12.4 p-10 -155.88 36.37 0.35 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.492 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 8' ' ' VAL . 22.7 mm -148.1 106.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.563 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.615 HD12 ' CB ' ' A' ' 10' ' ' TRP . 3.1 tt -149.16 143.5 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 112.051 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HB3' HD23 ' A' ' 262' ' ' LEU . 27.3 m-85 -117.4 125.83 51.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.153 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.707 ' C ' ' HG ' ' A' ' 262' ' ' LEU . 70.1 t-105 -150.46 161.26 42.86 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -50.0 163.93 0.13 Allowed 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.007 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.791 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.47 -29.16 52.59 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -59.01 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -96.26 15.8 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.657 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.4 t80 -114.2 -60.02 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.584 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -85.09 -9.08 81.01 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.709 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 72' ' ' GLN . . . -102.15 -29.88 5.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.072 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.47 -38.76 10.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -62.98 -26.26 68.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.056 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 4.0 pt20 -58.48 -16.88 17.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 m -111.03 -28.96 8.09 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.287 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -91.76 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.514 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -165.44 81.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.074 0.464 . . . . 0.0 110.974 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.899 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 16.6 tp -131.36 131.43 43.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.639 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.74 147.03 26.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.344 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.658 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.54 161.11 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.726 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 103' ' ' LEU . 1.2 tt -109.15 149.59 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.044 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.3 p -101.66 134.62 20.09 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.74 159.74 10.56 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.438 2.092 . . . . 0.0 112.959 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -116.76 -153.05 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -81.46 -14.79 56.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -62.07 -22.72 66.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 89' ' ' LEU . 24.7 t80 -77.65 -58.05 3.48 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.615 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -29.6 70.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.066 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 4.0 t0 -54.6 -54.68 38.2 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.93 72.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -99.74 141.96 31.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.644 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.95 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -61.64 109.35 2.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.501 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 31.4 Cg_exo -57.51 -28.42 80.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.12 1.88 . . . . 0.0 112.401 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.34 -13.99 62.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.7 0.286 . . . . 0.0 111.347 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.95 HG23 ' HB3' ' A' ' 90' ' ' TYR . 28.4 p -92.12 -50.1 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 1.024 ' HA ' HG12 ' A' ' 97' ' ' VAL . 49.8 p-90 -81.15 -28.35 35.09 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 1.4 t0 -61.99 -24.23 66.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -98.15 -17.98 18.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.547 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.024 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.8 p -95.03 41.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.115 0.483 . . . . 0.0 111.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -116.26 147.15 41.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.783 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -145.96 110.95 5.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.9 t30 63.82 28.48 14.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.58 25.94 74.14 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.92 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.36 146.32 52.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 110.607 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -104.33 78.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 78' ' ' GLU . 1.1 pp -101.47 44.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.471 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.12 142.31 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -134.69 131.06 20.02 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.916 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 4.7 Cg_exo -78.92 133.22 11.08 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.439 2.093 . . . . 0.0 112.954 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' PRO . 9.8 mm -146.73 38.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.62 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.44 123.17 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.8 t -104.34 115.02 45.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.85 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.22 126.82 55.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.33 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -171.89 -177.35 1.92 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.6 mt -117.57 162.48 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.8 p -117.94 162.37 18.26 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.054 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.8 tm? -100.76 114.83 28.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 225' ' ' THR . 37.2 mm -79.09 139.91 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.998 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.83 ' HD2' ' HG1' ' A' ' 245' ' ' THR . 2.0 m-85 -130.16 146.1 51.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.435 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.494 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.4 t-20 -88.59 123.59 33.23 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.2 OUTLIER -8.99 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 113.779 -1.555 . . . . 0.0 114.917 -177.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.757 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -170.13 33.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.607 0.241 . . . . 0.0 110.61 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.58 36.39 3.45 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.683 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 223' ' ' ALA . 1.0 OUTLIER -159.06 74.89 3.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.174 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.08 122.54 4.27 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.69 169.04 1.04 Allowed Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.813 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 1.096 ' HD2' ' HG2' ' A' ' 131' ' ' GLU . 2.2 Cg_endo -79.59 102.98 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.018 2.479 . . . . 0.0 110.872 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 57.0 Cg_endo -70.71 15.91 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.191 1.927 . . . . 0.0 112.948 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.58 ' HE3' ' HB ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -83.47 -25.1 31.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.154 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 131' ' ' GLU . 2.3 t -121.46 142.13 50.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.934 0.397 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.649 ' CD1' ' HD2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -73.77 -39.23 64.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.892 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 12.0 tt0 -54.49 -23.59 16.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.096 ' HG2' ' HD2' ' A' ' 125' ' ' PRO . 1.1 tp10 -66.77 -22.66 66.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.68 0.276 . . . . 0.0 111.074 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 12.0 mm -72.26 -55.42 4.9 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.921 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.779 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 51.1 Cg_exo -52.87 -39.27 78.59 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 113.164 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.41 -27.75 68.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.553 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 20.2 mt -51.95 -23.8 5.53 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.837 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -63.3 -30.94 71.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.348 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 5.9 mmtt -59.22 -50.33 74.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' OE2' HD23 ' A' ' 135' ' ' LEU . 14.3 pt-20 -76.64 -33.45 58.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.59 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 1.8 mm? -70.65 -56.43 6.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.35 . . . . 0.0 110.967 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.96 -27.55 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.74 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -54.04 -17.86 3.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.316 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -61.67 1.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.789 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.67 39.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -154.96 -173.61 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.8 m -139.24 146.58 40.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.054 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -92.23 -7.41 48.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.914 0.388 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -158.86 139.78 12.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -177.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.509 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.1 OUTLIER -156.5 125.76 6.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.786 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' HD2' ' HD2' ' A' ' 156' ' ' PHE . 1.2 t80 -166.48 178.05 6.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -58.19 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.22 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 ' HB ' ' A' ' 208' ' ' THR . 0.0 OUTLIER -147.26 -23.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.544 ' H ' HD22 ' A' ' 151' ' ' LEU . 7.0 pt20 -120.45 37.96 4.12 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 154' ' ' PRO . 1.0 OUTLIER -120.73 151.99 55.23 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 74.3 Cg_endo -79.22 40.89 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.561 2.174 . . . . 0.0 112.572 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.711 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 74.9 m-85 -128.81 -15.1 4.42 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.624 ' CD1' HD13 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -121.61 -56.34 1.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -178.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 195' ' ' LEU . 5.1 t -55.06 -50.87 68.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.029 0.442 . . . . 0.0 111.374 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.55 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -56.35 -53.77 60.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.358 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.711 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 37.5 Cg_endo -65.91 -16.11 51.48 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.452 2.101 . . . . 0.0 112.345 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.624 HD13 ' CD1' ' A' ' 156' ' ' PHE . 2.5 mp -89.47 -39.08 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.85 HG13 ' HA3' ' A' ' 191' ' ' GLY . 17.7 tt -83.08 -7.19 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.065 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.575 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -82.81 -29.11 29.76 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.952 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 255' ' ' SER . . . -75.31 23.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.841 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 162' ' ' ALA . 4.4 m-20 -118.37 -37.25 3.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.09 0.472 . . . . 0.0 110.201 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.3 33.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.57 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.79 106.26 2.88 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.746 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -82.85 162.58 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.736 0.303 . . . . 0.0 110.528 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.87 -63.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.202 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.33 161.47 34.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.074 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.926 ' HG3' ' HB3' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -87.68 105.69 17.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.738 ' CZ ' ' HA2' ' A' ' 174' ' ' GLY . 15.9 t80 -123.28 111.02 15.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.89 125.17 48.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.416 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.5 t30 66.66 -71.09 0.1 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.738 ' HA2' ' CZ ' ' A' ' 171' ' ' TYR . . . -172.05 40.73 0.17 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.413 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 159.9 24.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.079 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -104.94 163.7 12.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.914 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -78.49 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.068 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 179' ' ' LYS . 7.6 tp -178.91 -51.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.764 0.316 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.543 ' HG2' HG23 ' A' ' 178' ' ' ILE . 4.2 pttt -142.72 33.17 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 110.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.926 ' HB3' ' HG3' ' A' ' 170' ' ' LYS . 1.0 OUTLIER -90.72 104.18 16.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.376 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.6 138.86 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.8 44.3 1.53 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.657 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.543 HG22 HD11 ' A' ' 361' ' ' LEU . 12.2 p -108.72 -31.87 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 0.0 110.849 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.782 ' OD1' ' HG2' ' A' ' 362' ' ' LYS . 7.5 t0 -81.35 52.2 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 35.8 p30 -130.86 -174.43 3.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.833 ' HA ' ' HG2' ' A' ' 189' ' ' LYS . . . -79.39 -23.93 42.94 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.956 0.407 . . . . 0.0 111.52 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.88 -41.98 71.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.128 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.401 ' O ' HD11 ' A' ' 161' ' ' ILE . . . -76.02 -34.92 59.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.0 111.151 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.833 ' HG2' ' HA ' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -66.06 -51.17 60.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HG3' ' A' ' 189' ' ' LYS . . . -63.14 -24.27 67.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.85 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -78.85 -39.19 21.39 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.703 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -74.38 -23.44 58.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.81 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 19.8 p -77.83 -36.71 49.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.36 -38.38 74.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.082 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 157' ' ' THR . 1.0 OUTLIER -59.71 -33.02 71.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.627 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 192' ' ' LEU . 22.4 t -68.85 -40.63 81.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.503 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.6 OUTLIER -64.24 -31.95 73.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.175 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.28 -43.47 86.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.5 mt -68.07 -36.33 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.417 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 0.1 OUTLIER -77.27 -33.98 55.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.252 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -81.63 -10.42 59.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.431 ' HD2' ' CE1' ' A' ' 203' ' ' HIS . 0.1 OUTLIER -108.85 -69.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 111.278 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.431 ' CE1' ' HD2' ' A' ' 202' ' ' LYS . 27.4 m80 -87.43 -27.0 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.0 OUTLIER 58.41 20.24 7.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.485 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -170.85 -19.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.488 ' HB2' ' CG2' ' A' ' 199' ' ' ILE . . . 62.61 75.46 0.4 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.095 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 24.87 9.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.145 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.015 ' HB ' HD11 ' A' ' 151' ' ' LEU . 1.7 m -86.63 128.47 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.744 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.4 OUTLIER -109.07 -169.42 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.522 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.696 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 2.5 t80 -78.82 -42.09 28.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.87 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 49.1 m -74.06 -24.11 59.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.367 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.744 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 28.2 mt -79.2 -47.08 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -75.33 -29.9 60.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.504 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 31.4 tt0 -60.73 -28.11 68.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.33 -37.86 75.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 0.0 111.563 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.73 -57.53 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.438 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.737 ' CD2' ' HB ' ' A' ' 225' ' ' THR . 43.3 t80 -54.6 -34.81 62.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.056 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -58.7 -41.17 85.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.135 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.55 1.81 25.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.86 0.362 . . . . 0.0 110.931 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.56 31.89 0.05 OUTLIER Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.952 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -91.73 38.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 224' ' ' MET . 4.0 t -157.37 141.14 15.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -70.38 38.23 0.05 OUTLIER 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -169.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.714 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -157.61 98.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 117.212 -1.795 . . . . 0.0 115.703 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.737 ' HB ' ' CD2' ' A' ' 217' ' ' PHE . 37.7 p -146.79 130.11 16.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.21 -1.814 . . . . 0.0 109.829 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.31 122.38 66.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.86 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.851 HD22 ' HE1' ' A' ' 232' ' ' TRP . 10.2 p-10 -145.99 163.96 33.55 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.019 0.438 . . . . 0.0 112.031 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -131.78 178.77 17.66 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.233 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HA ' ' CH2' ' A' ' 232' ' ' TRP . 21.1 Cg_exo -63.75 -26.66 68.12 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.644 2.23 . . . . 0.0 112.561 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -115.28 54.55 0.79 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.79 24.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.007 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.851 ' HE1' HD22 ' A' ' 227' ' ' ASN . 12.5 m0 -99.05 128.47 45.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.27 115.58 27.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.181 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 60.99 114.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 236' ' ' ASP . 0.9 OUTLIER -62.53 -76.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.753 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.598 ' H ' HD12 ' A' ' 235' ' ' ILE . 3.1 m-20 60.41 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.895 0.378 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 13.5 p -71.78 78.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.468 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 179.46 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.109 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 27.2 2.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.737 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.628 ' HB ' ' HE1' ' A' ' 242' ' ' TYR . 21.8 t -110.37 130.37 63.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.055 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -81.56 137.26 35.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.628 ' HE1' ' HB ' ' A' ' 240' ' ' VAL . 16.3 m-85 -127.33 145.72 50.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.604 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -102.67 128.83 9.68 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.693 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.1 m -114.99 115.89 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.778 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.83 ' HG1' ' HD2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -134.7 164.43 27.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.564 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.19 150.36 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 111.922 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 1.2 mt -59.18 145.34 81.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.649 ' HD2' ' CD1' ' A' ' 129' ' ' TRP . 2.9 Cg_endo -79.89 -153.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.429 2.752 . . . . 0.0 111.45 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 57.3 p -110.78 166.31 11.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 252' ' ' GLY . 4.5 t80 -136.81 120.49 17.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.574 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.8 tttp 67.37 -11.59 0.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 132.21 -6.7 5.37 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.497 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -137.14 137.05 21.73 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.827 0.313 . . . . 0.0 110.903 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 37.1 Cg_endo -67.71 -178.72 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.386 2.057 . . . . 0.0 112.318 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.727 ' HB2' ' HB2' ' A' ' 163' ' ' ALA . 8.5 t -106.35 161.72 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.458 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.551 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -112.36 91.63 17.03 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -93.29 -157.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.651 2.234 . . . . 0.0 111.844 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.25 133.43 41.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.09 140.33 43.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.321 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -142.11 135.88 6.95 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 118.629 -1.748 . . . . 0.0 115.575 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.73 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 21.7 m -130.39 134.74 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.2 mp -91.17 120.86 32.46 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -94.76 130.0 41.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.154 0.502 . . . . 0.0 111.359 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.55 148.37 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.743 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.657 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -174.0 157.57 25.71 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 119.048 -1.549 . . . . 0.0 113.764 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.9 HG23 ' HB2' ' A' ' 58' ' ' ASP . 35.9 mt -122.01 153.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.909 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 269' ' ' ALA . 9.5 p30 -61.19 152.9 27.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -69.64 33.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -145.15 22.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.698 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 137.0 95.08 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.64 133.35 6.05 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.234 1.956 . . . . 0.0 112.73 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 50.4 m-80 60.47 98.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.381 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.44 -42.44 68.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.398 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 277' ' ' LYS . 2.3 tt0 -66.19 -36.58 83.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 110.684 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.814 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 0.0 OUTLIER -72.63 -32.2 65.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.663 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.53 -47.97 36.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.782 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.59 -33.81 74.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.885 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -76.29 -43.41 41.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 111.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.853 ' HE2' HG23 ' A' ' 33' ' ' ILE . 1.5 m-85 -68.14 -43.84 77.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.438 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.447 ' CD1' HD11 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -74.7 -34.36 62.6 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -64.59 -25.42 67.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.679 0.276 . . . . 0.0 111.156 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -110.26 -4.91 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.545 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 44.7 t80 -85.18 -76.52 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.709 0.29 . . . . 0.0 110.826 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.682 HD11 HG11 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -102.73 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.842 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.483 ' CA ' HD13 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -156.54 28.15 0.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.713 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 0.7 OUTLIER -155.27 162.48 40.88 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.025 0.44 . . . . 0.0 111.288 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.541 ' HB2' ' OE2' ' A' ' 291' ' ' GLU . 5.0 p-10 -57.83 -11.75 2.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.318 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -75.07 -55.37 5.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.771 0.319 . . . . 0.0 111.319 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA2' HG11 ' A' ' 23' ' ' VAL . . . -100.92 -32.61 5.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.956 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.715 HD23 HD21 ' A' ' 294' ' ' ASN . 0.2 OUTLIER -57.14 -60.44 3.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 110.832 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.919 ' CA ' ' HB2' ' A' ' 295' ' ' LYS . 77.3 mt-10 -49.22 -26.39 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.87 0.843 . . . . 0.0 111.397 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.839 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -63.84 -56.43 15.48 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 284' ' ' LEU . 13.9 p -86.09 -26.69 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.715 HD21 HD23 ' A' ' 290' ' ' LEU . 37.8 p30 -113.39 -0.34 14.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 122.197 -0.314 . . . . 0.0 111.249 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.919 ' HB2' ' CA ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -118.89 -25.86 6.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.163 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.839 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.7 OUTLIER -50.59 -36.88 36.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 175.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.608 ' O ' HD23 ' A' ' 299' ' ' LEU . 4.8 tttt -172.99 125.02 0.46 Allowed Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.772 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.48 137.75 40.31 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.606 2.204 . . . . 0.0 113.088 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.5 OUTLIER -153.49 -44.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.928 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -125.21 142.68 14.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.968 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -81.91 145.46 30.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.891 0.377 . . . . 0.0 111.878 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 304' ' ' LEU . 11.1 p -99.11 162.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -85.83 55.87 3.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 0.0 110.964 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 HG11 ' A' ' 302' ' ' VAL . 11.2 mt -132.77 120.85 22.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -35.85 81.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.575 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -43.84 84.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.785 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -49.2 60.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.315 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 31.9 mt-10 -61.64 -23.28 65.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.097 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -30.17 71.13 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.5 mt-10 -92.71 -29.69 15.93 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.2 OUTLIER -48.14 -5.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.621 1.569 . . . . 0.0 113.522 177.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.27 -22.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -41.55 61.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.319 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.753 ' HB2' ' CD1' ' A' ' 311' ' ' LEU . 65.1 m-20 -77.02 132.66 70.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 98.3 Cg_endo -94.58 5.73 2.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.929 2.419 . . . . 0.0 112.997 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -72.43 -59.05 2.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.049 0.452 . . . . 0.0 110.28 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.968 ' HB ' ' HB2' ' A' ' 301' ' ' ALA . 17.5 tt -67.89 -31.65 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.224 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -73.35 -53.76 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.06 -51.12 70.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.817 0.341 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 112' ' ' ALA . 5.3 m -64.65 -25.78 68.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.057 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.9 mtt -59.7 -25.28 64.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.46 -52.18 35.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -31.25 66.8 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 111.085 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.5 -44.01 89.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.308 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -64.11 -34.2 77.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.256 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 48.19 1.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.42 . . . . 0.0 111.108 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -129.84 174.49 19.44 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.576 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.89 142.72 45.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.555 HG21 ' HE1' ' A' ' 64' ' ' HIS . 25.8 mt -78.18 138.8 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.35 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.405 ' HB3' ' HD2' ' A' ' 331' ' ' PRO . 3.2 mtp -47.99 157.61 0.62 Allowed Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.411 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 330' ' ' MET . 75.3 Cg_endo -76.57 165.69 28.54 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.552 2.168 . . . . 0.0 112.737 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -144.05 28.47 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.841 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 335' ' ' GLN . 9.7 mt -114.3 140.64 25.33 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' A' ' 333' ' ' ILE . 78.4 Cg_endo -74.41 -26.63 12.0 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.072 1.848 . . . . 0.0 112.185 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.534 ' H ' HG22 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -67.02 -27.03 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.0 tpp -61.79 -26.35 68.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.286 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 5.1 m -62.19 -21.36 65.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.206 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.3 -27.31 67.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.65 -28.08 53.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.85 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -32.69 54.45 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.155 0.502 . . . . 0.0 110.566 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.12 -19.15 60.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.652 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.62 -54.45 5.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.649 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 p -54.77 -35.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.52 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.614 ' HD2' HG23 ' A' ' 345' ' ' THR . 0.0 OUTLIER -70.77 -39.9 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.748 0.308 . . . . 0.0 111.384 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.654 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 34.9 p -80.13 -26.45 39.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.848 0.356 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.81 -60.6 2.21 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.0 t -80.73 -56.25 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 9.8 mm -61.32 -59.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.912 HD22 ' HG3' ' A' ' 355' ' ' GLN . 0.6 OUTLIER -55.94 -48.14 76.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.613 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -66.93 -30.49 70.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.31 -10.55 59.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.483 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -53.5 17.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 0.0 111.101 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.91 -4.59 2.41 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.728 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 354' ' ' ARG . 0.0 OUTLIER -132.22 39.05 3.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.953 0.406 . . . . 0.0 110.72 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.912 ' HG3' HD22 ' A' ' 349' ' ' ASN . 0.1 OUTLIER -148.9 116.44 6.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.562 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 359' ' ' GLU . 5.2 t -94.24 139.74 30.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.87 0.367 . . . . 0.0 110.732 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.5 m -54.55 -27.58 17.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.411 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 4.3 m-20 -64.24 -57.03 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 0.0 111.261 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.72 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -80.94 -24.61 38.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.863 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.6 -51.64 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.543 HD11 HG22 ' A' ' 183' ' ' VAL . 1.1 tm? -82.58 -49.1 10.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.782 ' HG2' ' OD1' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -62.94 -53.77 48.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.4 OUTLIER -64.56 -26.68 68.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.747 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.77 ' O ' HG13 ' A' ' 368' ' ' ILE . . . -62.28 -31.42 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -47.87 72.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.715 0.293 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 363' ' ' ASP . 6.7 t -66.98 -29.37 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.406 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -44.65 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 0.0 110.993 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.77 HG13 ' O ' ' A' ' 364' ' ' ALA . 40.7 mt -58.56 -39.63 76.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.314 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -77.61 -28.05 51.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.65 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.757 0.313 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 p -136.48 87.66 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.013 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -116.17 111.51 20.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -178.87 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.63 -27.47 0.36 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HE3' ' OD1' ' A' ' 55' ' ' ASP . 5.0 pttt -142.24 152.84 43.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 5.1 mt -125.1 155.75 39.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.386 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.739 ' CG1' ' HB3' ' A' ' 57' ' ' PRO . 20.9 t -121.11 117.99 54.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 121.469 0.652 . . . . 0.0 111.876 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.513 HD12 HG21 ' A' ' 59' ' ' ILE . 20.3 mm -91.09 159.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.485 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 40' ' ' PRO . 11.9 t90 -140.5 112.73 7.81 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.598 HD11 ' CG ' ' A' ' 15' ' ' LYS . 17.5 tt -144.09 139.81 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.002 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -134.72 41.74 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.516 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' A' ' 15' ' ' LYS . . . -112.37 -3.98 25.51 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.855 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' CG ' ' O ' ' A' ' 13' ' ' GLY . 1.7 p30 55.08 34.12 21.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.584 0.706 . . . . 0.0 110.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' CG ' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.22 165.37 11.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.846 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.941 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . 25.33 82.2 0.01 OUTLIER Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.088 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -60.28 2.41 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.467 -0.867 . . . . 0.0 112.406 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.57 -30.19 65.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 111.741 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 23' ' ' VAL . . . -56.65 -48.71 75.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.07 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -74.36 -24.6 59.19 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.08 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 5.8 pt-20 -74.64 -57.76 3.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.733 ' H ' ' HG3' ' A' ' 22' ' ' GLU . 12.7 p -46.95 -30.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.795 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.52 -34.99 30.33 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 6.6 tttt -78.84 -26.93 44.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -72.48 -30.23 64.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.222 0.534 . . . . 0.0 110.575 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.784 ' HB3' ' CB ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -70.11 -57.35 5.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.867 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.726 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 2.1 pt-20 -49.7 -28.13 5.65 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.39 0.614 . . . . 0.0 110.067 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 4.2 mttp -51.82 -31.27 26.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.851 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -63.96 -56.83 12.32 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.9 t 157.82 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.074 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.818 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.07 47.92 0.01 OUTLIER Glycine 0 C--N 1.338 0.661 0 C-N-CA 118.168 -1.968 . . . . 0.0 115.408 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.1 mm -138.69 95.08 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 118.017 0.909 . . . . 0.0 112.332 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -111.9 124.89 53.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.386 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 t -110.05 125.76 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.03 121.47 41.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 20' ' ' LEU . 19.8 t -96.78 111.33 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.419 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' OE1' HD13 ' A' ' 43' ' ' LEU . 2.1 mt-10 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.972 0.415 . . . . 0.0 111.054 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.822 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . 18.2 p-80 -129.64 174.68 4.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.075 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' HB2' ' A' ' 39' ' ' HIS . 97.1 Cg_endo -76.75 -127.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.316 2.011 . . . . 0.0 112.669 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 74.67 -76.96 0.06 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.691 0.282 . . . . 0.0 110.89 -179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.93 -25.12 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' OE1' ' A' ' 38' ' ' GLU . 1.2 tt -76.23 -17.03 59.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.659 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 11.4 pt-20 -56.7 -41.09 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 111.193 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 3.3 mm-40 -87.33 -20.04 27.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.36 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.99 -24.27 65.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.075 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.808 ' CE1' ' HG2' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -48.31 -61.05 3.5 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.4 Cg_endo -59.34 -18.64 46.67 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.189 1.926 . . . . 0.0 112.756 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.15 -50.86 5.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.757 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.48 -25.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.022 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . . . -81.34 -30.55 33.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 53' ' ' THR . . . -47.87 -15.75 0.07 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.1 OUTLIER 163.56 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.438 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.43 -92.36 0.33 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.551 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -146.88 78.92 1.51 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.849 0.357 . . . . 0.0 110.748 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 51' ' ' ALA . . . -98.21 153.93 20.08 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.559 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 56.9 Cg_endo -69.18 158.68 56.77 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.946 1.764 . . . . 0.0 112.132 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' C ' HG13 ' A' ' 59' ' ' ILE . 16.1 p-10 -146.75 37.55 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.04 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 52.2 mt -156.34 105.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.363 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 10' ' ' TRP . 13.4 tt -143.64 142.76 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.033 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.987 ' HB3' HD21 ' A' ' 262' ' ' LEU . 1.5 m-85 -112.56 128.15 56.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.018 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.884 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.74 155.16 39.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -49.5 165.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 261' ' ' VAL . 3.7 t60 -76.35 -32.38 58.61 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 27.1 t70 -80.09 -11.24 59.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' HG2' ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -118.35 -9.04 10.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.884 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 6.5 t80 -121.4 -48.13 2.21 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.284 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.58 -13.08 74.33 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.458 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.7 -21.85 8.01 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -30.95 14.46 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.037 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.83 ' CB ' HD12 ' A' ' 76' ' ' LEU . . . -71.39 -25.0 62.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.735 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' OE1' HG21 ' A' ' 104' ' ' ILE . 5.9 tp60 -56.83 -18.61 13.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 m -114.47 -28.41 7.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.657 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -60.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.774 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.657 HD13 ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -171.2 60.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.545 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.83 HD12 ' CB ' ' A' ' 71' ' ' ALA . 11.8 mt -113.92 141.19 47.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.908 0.385 . . . . 0.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 124.71 32.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -71.23 147.63 48.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.83 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.705 HG23 ' HE3' ' A' ' 277' ' ' LYS . 2.4 mt -93.58 139.38 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.48 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 t -104.64 126.0 32.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.75 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 85' ' ' PHE . 87.3 Cg_endo -81.94 178.92 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.283 1.989 . . . . 0.0 112.798 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 5.8 p-10 -172.11 -78.23 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.38 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 1.9 mttt -120.39 -58.9 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 88' ' ' LYS . . . -54.87 -24.04 21.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.636 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 81' ' ' PRO . 4.0 m-85 -79.18 -44.6 21.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.97 0.414 . . . . 0.0 110.297 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -64.52 -26.95 68.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.805 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -54.87 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -58.7 -41.97 87.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -175.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 88' ' ' LYS . 8.5 mp -133.78 131.3 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.7 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -76.16 156.89 83.7 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.083 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 54.1 Cg_exo -53.8 -22.76 24.5 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.486 2.124 . . . . 0.0 112.832 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -53.83 52.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.87 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -70.97 -30.34 66.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.488 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.687 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.6 m0 -63.45 -24.59 67.89 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.14 -25.31 64.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.43 -33.4 11.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 111.087 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HG3' ' A' ' 107' ' ' PRO . 26.1 m -86.54 41.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.465 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 148.49 46.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.793 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.747 ' OH ' ' HB2' ' A' ' 332' ' ' ASN . 0.3 OUTLIER -145.33 113.91 6.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.743 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.21 -77.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.67 25.65 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.277 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -144.99 151.38 38.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.115 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.63 89.3 6.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.706 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.824 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.31 39.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.909 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -174.98 134.43 0.34 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.09 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.641 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.3 OUTLIER -115.38 124.46 30.08 Favored Pre-proline 0 N--CA 1.462 0.141 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.881 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.815 ' HG3' HG11 ' A' ' 97' ' ' VAL . 90.0 Cg_endo -79.8 130.45 8.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.442 2.095 . . . . 0.0 112.258 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -155.05 39.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 110.519 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -175.82 125.43 0.22 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.916 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' A' ' 301' ' ' ALA . 11.4 t -113.42 106.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.917 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.452 ' OE1' ' HG2' ' A' ' 229' ' ' PRO . 18.8 mt-10 -115.7 129.85 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.836 0.35 . . . . 0.0 110.465 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -167.42 176.9 6.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.811 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -112.55 158.26 20.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 112.645 -177.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.792 ' HB2' ' CZ3' ' A' ' 232' ' ' TRP . 0.1 OUTLIER -118.06 172.59 7.31 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 245' ' ' THR . 7.5 tp -111.33 109.82 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 225' ' ' THR . 4.3 mt -73.46 132.01 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -123.29 135.86 54.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.193 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 122' ' ' LEU . 92.4 m-20 -112.79 135.65 53.3 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -124.35 75.94 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 121' ' ' LEU . 9.6 t0 -152.66 -38.44 0.11 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.081 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -152.69 44.11 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.898 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.857 HD12 ' HB2' ' A' ' 118' ' ' ASN . 30.4 mt -144.6 131.56 10.19 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.103 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.19 158.26 52.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.774 2.316 . . . . 0.0 112.106 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -69.53 121.07 81.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.525 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.51 142.16 11.55 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.789 2.326 . . . . 0.0 112.448 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 22.8 Cg_endo -63.17 -157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.435 2.09 . . . . 0.0 112.182 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -108.32 37.55 2.46 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.612 HG23 ' HB2' ' A' ' 131' ' ' GLU . 6.1 t -140.39 142.02 35.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.873 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 0.0 OUTLIER -72.85 -33.56 66.19 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 120.871 0.367 . . . . 0.0 110.385 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -61.74 -22.04 65.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.12 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.612 ' HB2' HG23 ' A' ' 128' ' ' THR . 8.7 mm-40 -78.45 -33.26 48.58 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.3 tt -58.87 -38.11 61.16 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.754 ' HD3' HG22 ' A' ' 132' ' ' ILE . 45.6 Cg_exo -58.14 -42.66 54.93 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.879 1.719 . . . . 0.0 112.282 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.85 -29.84 67.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 111.471 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -33.76 73.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.006 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -63.16 -38.28 90.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.11 -28.4 70.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.777 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.5 -47.2 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.009 HD13 ' HB2' ' A' ' 146' ' ' ALA . 4.1 mp -68.64 -38.34 80.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.832 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.6 85.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.169 0.509 . . . . 0.0 110.629 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.03 -15.41 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -103.52 -57.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.133 0.492 . . . . 0.0 110.161 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.23 39.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.694 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.802 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -159.71 -176.81 5.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.22 0.533 . . . . 0.0 111.151 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.681 ' HB3' HG21 ' A' ' 222' ' ' THR . 0.1 OUTLIER -130.02 166.97 19.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.094 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.009 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -112.59 -6.58 13.92 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.494 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.722 ' CB ' ' HB2' ' A' ' 224' ' ' MET . 4.1 pp -170.39 154.47 4.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.793 0.437 . . . . 0.0 110.352 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 1.051 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -163.63 127.56 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.303 0.641 . . . . 0.0 109.521 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HA ' ' CZ ' ' A' ' 217' ' ' PHE . 38.1 p90 -132.96 173.82 11.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.692 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 5.9 t-20 -58.2 -172.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -131.05 -39.68 1.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.904 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.92 36.12 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.96 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.692 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 5.6 tp10 -108.54 130.42 22.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.83 52.05 4.14 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.325 2.017 . . . . 0.0 112.792 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.419 ' CD1' ' HG3' ' A' ' 153' ' ' GLU . 11.3 m-85 -124.15 -6.97 7.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 8.9 p90 -125.72 -49.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 111.101 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.486 HG23 ' HG ' ' A' ' 195' ' ' LEU . 21.2 m -54.89 -52.26 63.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.693 -1.14 . . . . 0.0 113.332 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.497 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -53.24 -55.06 37.98 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.362 -179.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.716 ' HB2' ' HB2' ' A' ' 255' ' ' SER . 60.0 Cg_endo -71.09 -25.75 22.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.715 2.277 . . . . 0.0 112.483 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 0.3 OUTLIER -73.13 -52.29 14.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.718 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.965 HD13 ' HG ' ' A' ' 192' ' ' LEU . 27.4 mt -77.45 5.07 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.41 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.542 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -92.77 -54.92 3.56 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 54.11 -107.69 0.38 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.33 -31.36 3.82 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 120.708 0.29 . . . . 0.0 110.768 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.44 -31.46 16.24 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.895 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -62.69 86.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.206 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -106.71 146.83 30.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 110.43 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.35 -44.41 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 335' ' ' GLN . 75.8 m-85 -135.37 136.68 41.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.764 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -95.24 117.3 30.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.672 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 139.15 41.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.603 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 174' ' ' GLY . 1.5 tt0 -122.19 115.52 22.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.966 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.1 t30 71.89 -31.93 0.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.262 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.59 37.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.141 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -117.19 132.55 56.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.192 0.52 . . . . 0.0 111.052 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.43 ' HB2' ' CD1' ' A' ' 333' ' ' ILE . 19.5 p90 -78.29 150.12 33.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.076 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 6.1 p-10 -91.59 177.31 6.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.5 mm -113.13 -57.41 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.706 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.49 19.76 3.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 177' ' ' ASP . 1.5 m-20 -79.7 101.27 8.3 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.091 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.593 ' CG1' HG23 ' A' ' 183' ' ' VAL . 22.4 t -125.37 145.8 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.0 44.52 1.18 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.419 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 181' ' ' VAL . 15.0 t -88.21 -38.68 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.33 . . . . 0.0 110.805 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.04 45.23 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.996 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.452 HD22 ' H ' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -101.34 172.95 6.68 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 110.478 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.452 ' H ' HD22 ' A' ' 185' ' ' ASN . . . -70.57 -32.94 70.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.924 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.36 -35.98 69.61 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.29 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 192' ' ' LEU . . . -75.17 -37.08 61.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -72.68 -43.84 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.286 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.6 55.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.077 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.13 -45.61 95.03 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.965 ' HG ' HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.78 -36.41 83.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.912 0.387 . . . . 0.0 110.788 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -32.73 74.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.512 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -37.53 65.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.493 HD21 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -57.14 -45.05 83.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.564 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 12.4 t -65.62 -41.03 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 22.3 m-20 -65.05 -28.39 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.668 ' O ' ' HG2' ' A' ' 202' ' ' LYS . 0.1 OUTLIER -71.21 -56.88 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.901 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.653 ' HA ' ' CG ' ' A' ' 202' ' ' LYS . 1.6 pt -69.87 -31.69 49.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.752 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -70.83 -24.68 62.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.556 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 1.1 m120 -99.22 6.9 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.537 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HG3' ' H ' ' A' ' 203' ' ' HIS . 1.1 ptmt -118.87 -56.49 2.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.674 ' H ' ' HG3' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -98.64 -50.58 4.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.813 0.34 . . . . 0.0 111.094 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.7 tmm? 64.01 24.07 13.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.812 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 2.0 m-80 -149.61 -59.61 0.21 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.615 0.721 . . . . 0.0 109.931 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 151' ' ' LEU . . . 68.12 47.71 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.583 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.18 -8.54 55.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.523 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.6 p -68.23 139.74 56.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -111.81 -168.32 1.3 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.422 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.917 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.1 OUTLIER -78.3 -42.83 29.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.479 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 59.5 p -72.26 -25.52 61.65 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.057 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 209' ' ' ASP . 17.7 mt -84.33 -58.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.362 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.74 -29.84 71.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.917 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 3.7 tt0 -56.06 -34.86 66.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.82 -25.01 64.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 220' ' ' GLY . . . -67.57 -36.23 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 1.107 ' HB3' HG23 ' A' ' 225' ' ' THR . 37.5 m-85 -72.42 -62.33 1.48 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.86 -30.5 28.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.86 -4.09 18.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 216' ' ' ALA . . . -76.43 -109.1 0.13 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 118.838 -1.649 . . . . 0.0 111.899 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 6.0 pt-20 158.62 63.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 145' ' ' SER . 18.8 p -157.74 155.63 30.21 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.822 178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.96 40.34 0.07 Allowed 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 119.158 -1.017 . . . . 0.0 113.696 -170.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 1.051 ' HB3' ' H ' ' A' ' 148' ' ' MET . 2.5 tpt -147.92 95.87 2.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 116.947 -1.901 . . . . 0.0 115.768 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 1.107 HG23 ' HB3' ' A' ' 217' ' ' PHE . 98.6 m -145.69 133.71 21.44 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.377 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.41 119.57 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.47 164.64 29.57 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.8 -143.32 7.86 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.33 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.759 ' HA ' HH12 ' A' ' 316' ' ' ARG . 53.2 Cg_exo -55.6 144.67 73.77 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.325 2.017 . . . . 0.0 112.6 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.541 ' H ' HH22 ' A' ' 316' ' ' ARG . 34.2 m95 57.21 80.07 0.17 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.45 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -160.96 -60.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.166 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.792 ' CZ3' ' HB2' ' A' ' 114' ' ' SER . 1.4 p90 -91.31 -2.49 57.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.264 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.31 68.84 10.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.441 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 64.35 154.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.753 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 235' ' ' ILE . 0.2 OUTLIER -135.61 -24.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.913 -179.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.414 ' OD2' HG12 ' A' ' 235' ' ' ILE . 1.8 p30 -172.16 -34.98 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.2 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 m -151.52 150.41 30.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.63 0.252 . . . . 0.0 110.858 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.9 m -66.72 105.53 1.59 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -107.39 -24.01 12.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.212 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 240' ' ' VAL . 14.7 p 42.44 59.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.34 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.97 65.26 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -142.6 136.39 29.14 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.48 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.77 124.42 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.075 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 244' ' ' VAL . 18.2 m -111.26 128.25 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.617 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 69.1 p -142.29 164.16 30.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.574 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.51 HG23 ' ND2' ' A' ' 323' ' ' ASN . 8.9 p -90.48 149.24 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.457 0.17 . . . . 0.0 110.823 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.31 145.93 73.07 Favored Pre-proline 0 N--CA 1.456 -0.17 0 CA-C-O 121.187 0.517 . . . . 0.0 111.512 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 73.2 Cg_endo -87.54 -153.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.983 2.456 . . . . 0.0 112.105 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 6.1 t -81.74 171.09 14.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.032 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 251' ' ' LYS . 59.0 m-85 -141.79 114.34 8.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.606 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.438 ' CG ' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 50.48 17.66 0.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.039 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 138.7 -38.89 1.63 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 1.056 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -138.36 152.13 70.75 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.86 0.33 . . . . 0.0 111.127 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 1.056 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 42.9 Cg_endo -65.26 159.1 48.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.838 2.359 . . . . 0.0 111.854 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.716 ' HB2' ' HB2' ' A' ' 159' ' ' PRO . 87.4 p -80.92 159.22 25.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 256' ' ' LYS . 8.7 ptpt -114.15 87.23 12.85 Favored Pre-proline 0 CA--C 1.528 0.103 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -91.74 -151.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.76 2.307 . . . . 0.0 110.799 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -145.2 172.23 13.41 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.511 0.672 . . . . 0.0 112.463 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.1 p -110.06 157.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -121.34 117.35 3.42 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.818 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.746 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 9.8 p -125.64 142.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.665 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.987 HD21 ' HB3' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -90.39 134.38 34.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.037 -0.414 . . . . 0.0 111.144 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 64' ' ' HIS . 1.7 p -106.27 125.11 50.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.549 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -94.63 145.34 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.475 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.509 ' N ' ' HE2' ' A' ' 67' ' ' PHE . . . -135.35 153.25 21.16 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.702 -1.237 . . . . 0.0 114.18 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.9 OUTLIER -126.59 116.64 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.101 -0.549 . . . . 0.0 110.084 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.678 ' HA ' HD23 ' A' ' 76' ' ' LEU . 10.3 m120 -50.67 145.01 7.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.955 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.01 10.6 1.14 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.598 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -109.57 28.5 8.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.274 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 110.37 24.25 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.72 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.09 11.7 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.017 1.812 . . . . 0.0 112.442 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.02 87.65 1.35 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.749 0.309 . . . . 0.0 110.697 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.42 -32.24 68.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.892 0.377 . . . . 0.0 110.441 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -47.89 68.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -29.67 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.25 -53.58 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.861 0.362 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.705 ' HE3' HG23 ' A' ' 79' ' ' ILE . 2.2 mttp -75.79 -28.1 58.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 111.064 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.86 -26.19 68.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.19 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.83 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 m-85 -73.62 -61.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -21.16 66.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 5.8 tt0 -86.14 -13.98 45.5 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.47 10.67 2.73 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.83 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 0.0 OUTLIER -113.2 -54.31 2.63 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.9 tp -101.46 39.63 1.41 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.874 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.647 ' HA ' HD23 ' A' ' 290' ' ' LEU . 0.0 OUTLIER -169.82 37.98 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.494 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.691 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 2.4 m -145.42 171.9 13.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 1.0 OUTLIER -63.79 -26.95 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -78.16 -38.5 43.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 112.007 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.714 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -96.61 -50.81 1.77 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.32 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.73 HD13 ' HB2' ' A' ' 294' ' ' ASN . 0.4 OUTLIER -52.59 -31.14 34.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.358 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 1.125 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.1 OUTLIER -78.7 -24.95 44.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.555 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.9 -61.49 1.98 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.455 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.941 HG23 ' HA3' ' A' ' 16' ' ' GLY . 14.9 p -87.59 -27.65 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.73 ' HB2' HD13 ' A' ' 290' ' ' LEU . 9.5 m-20 -105.36 -4.43 21.51 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 122.426 -0.171 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 1.125 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 1.2 tptt -116.07 -24.44 8.06 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -52.31 -35.93 51.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.715 ' CG ' ' HD2' ' A' ' 298' ' ' PRO . 1.6 ttmt 176.8 155.3 0.42 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.845 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.715 ' HD2' ' CG ' ' A' ' 297' ' ' LYS . 92.1 Cg_endo -78.47 150.51 25.07 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.535 2.157 . . . . 0.0 112.778 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.464 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -137.74 -48.89 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.07 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 316' ' ' ARG . . . -144.17 -179.79 20.91 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.49 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -79.08 80.21 5.44 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.586 HG11 ' OD1' ' A' ' 294' ' ' ASN . 9.4 p -117.65 109.58 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.204 0.526 . . . . 0.0 110.319 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.738 ' HB2' ' HG ' ' A' ' 311' ' ' LEU . . . -172.83 101.69 0.14 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.319 0.581 . . . . 0.0 111.483 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.833 ' HG ' ' HB2' ' A' ' 307' ' ' TYR . 0.3 OUTLIER -58.98 -172.88 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 305' ' ' LYS . 0.1 OUTLIER -61.79 -43.18 99.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.799 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 28.1 t -79.89 -40.27 28.67 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 111.832 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.833 ' HB2' ' HG ' ' A' ' 304' ' ' LEU . 1.3 m-85 -72.27 -47.23 51.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.678 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 1.086 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 5.8 tm-20 -60.93 -17.7 52.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -39.01 86.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -91.57 -29.88 16.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 1.086 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 1.3 mm? -49.04 -4.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.458 1.503 . . . . 0.0 113.668 177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -43.31 -23.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.23 -32.5 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 317' ' ' ILE . 0.3 OUTLIER -78.76 122.94 85.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.72 0.295 . . . . 0.0 110.81 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.64 -3.03 5.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.809 2.339 . . . . 0.0 113.617 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 4.7 mtt-85 -72.28 -60.18 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.028 0.442 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.7 HG13 ' CB ' ' A' ' 301' ' ' ALA . 1.2 mp -60.34 -39.43 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.581 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 321' ' ' MET . . . -65.38 -47.98 74.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 111.928 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.58 56.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -63.9 -27.79 69.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 0.0 OUTLIER -58.11 -28.89 65.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.503 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -46.79 68.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.227 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.51 ' ND2' HG23 ' A' ' 246' ' ' VAL . 20.2 m-80 -72.06 -28.92 63.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.075 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.07 -41.22 74.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -69.95 -22.58 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.706 0.288 . . . . 0.0 111.271 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.71 ' HE3' ' HG3' ' A' ' 254' ' ' PRO . 0.0 OUTLIER -133.38 61.92 1.67 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.391 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.82 -176.32 24.43 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.902 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -123.78 151.22 43.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mm -89.95 124.54 42.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -54.33 131.87 61.78 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.655 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.34 -158.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.926 2.417 . . . . 0.0 112.553 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.747 ' HB2' ' OH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -152.23 85.58 1.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.896 0.379 . . . . 0.0 110.977 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 335' ' ' GLN . 1.4 tp -128.33 127.26 23.71 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.829 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.95 -26.95 83.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.211 1.941 . . . . 0.0 112.597 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.467 ' H ' HG13 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.82 -22.39 36.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.517 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -35.32 75.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.189 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 43.6 t -59.43 -34.92 73.1 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.21 -26.9 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.351 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -25.91 35.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.704 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.39 -25.45 49.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.988 0.423 . . . . 0.0 110.777 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.15 -19.97 61.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.13 -57.67 3.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.386 0.612 . . . . 0.0 111.496 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.708 ' O ' HG22 ' A' ' 347' ' ' VAL . 12.6 m -50.45 -37.22 14.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.372 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 348' ' ' ILE . 2.9 mtt180 -65.7 -59.91 3.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.042 0.449 . . . . 0.0 111.106 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 2.0 m -55.84 -27.24 50.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.905 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.93 -55.12 5.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 343' ' ' VAL . 15.7 m -73.75 -59.43 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 349' ' ' ASN . 2.5 pt -78.42 -55.07 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.699 ' HB2' ' O ' ' A' ' 345' ' ' THR . 4.7 m-80 -53.87 -49.65 68.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -65.07 -28.3 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.558 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.26 -8.13 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.72 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 1.1 t -65.72 -53.38 41.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 111.125 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.15 -2.78 4.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.681 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.62 ' O ' ' HG3' ' A' ' 355' ' ' GLN . 1.2 mpp_? -138.62 37.52 2.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.771 0.319 . . . . 0.0 110.678 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.636 ' O ' ' HA ' ' A' ' 350' ' ' ALA . 53.0 mt-30 -157.12 108.42 2.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.556 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.4 p -89.35 159.31 17.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.431 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 11.1 p -63.41 -27.98 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.287 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -74.94 -32.36 61.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.298 0.571 . . . . 0.0 110.504 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 363' ' ' ASP . 10.3 tt0 -80.29 -51.12 9.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.619 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' A' ' 345' ' ' THR . . . -78.76 -43.11 26.32 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 183' ' ' VAL . 0.9 OUTLIER -79.09 -57.15 3.88 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.679 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.69 -53.99 51.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.51 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 359' ' ' GLU . 12.4 t70 -58.17 -30.16 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -65.14 -32.38 74.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 181' ' ' VAL . 1.2 tm0? -64.94 -30.89 71.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.738 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.4 m -78.61 -30.39 46.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -40.7 63.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 111.075 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.3 tt -68.92 -17.73 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.252 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.5 m -74.69 -28.34 60.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.891 0.377 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.479 ' O ' ' HE3' ' A' ' 370' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.909 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.2 mttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.738 0.304 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -127.37 101.25 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.591 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.39 155.87 35.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.518 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -128.26 126.25 40.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.8 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.92 47.26 1.37 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.201 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -134.64 154.26 51.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 2.1 mt -139.17 137.17 35.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.214 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 57' ' ' PRO . 7.6 p -115.43 115.62 49.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 CA-C-O 121.866 0.841 . . . . 0.0 112.515 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.648 ' O ' ' HD1' ' A' ' 10' ' ' TRP . 31.8 mt -91.36 156.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.307 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.994 ' HE3' HD12 ' A' ' 60' ' ' ILE . 17.1 m0 -134.41 111.4 10.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 11' ' ' ILE . 29.3 pt -132.39 132.29 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.335 0.588 . . . . 0.0 111.698 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.7 OUTLIER -87.84 39.09 0.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.786 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.78 64.78 1.47 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.734 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 11' ' ' ILE . 3.5 p30 -84.75 32.7 0.52 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 110.995 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 62.97 -129.08 0.54 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.526 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 29.29 77.82 0.02 OUTLIER Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.463 0.945 . . . . 0.0 115.463 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -60.17 2.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 0.0 111.286 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -76.85 -23.09 52.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.83 -61.49 7.04 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.589 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.53 -22.79 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.5 -54.8 41.57 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 23' ' ' VAL . 10.2 pt-20 -68.27 -57.8 5.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.284 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.4 t -45.57 -30.59 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.5 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.16 -38.38 47.09 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.858 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.98 -36.76 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -34.84 76.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.751 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -68.59 -56.08 9.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.66 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 5.6 tm-20 -52.2 -29.81 24.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.607 0.717 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -36.25 62.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.242 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.689 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -57.63 -57.31 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.281 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 8.8 t 157.68 36.19 0.0 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.932 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.838 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 155.99 42.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 118.157 -1.973 . . . . 0.0 115.493 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.7 mm -134.91 98.54 2.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 118.088 0.944 . . . . 0.0 111.63 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -122.94 134.23 54.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.0 146.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 8' ' ' VAL . 5.8 t -118.42 136.13 53.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.092 0.472 . . . . 0.0 111.411 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.499 HG12 ' HB ' ' A' ' 9' ' ' ILE . 5.2 m -118.12 132.72 67.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.532 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -134.77 158.92 42.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.913 0.387 . . . . 0.0 111.157 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 109.21 42.2 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.911 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 7.3 Cg_exo -72.78 117.21 5.02 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.567 2.178 . . . . 0.0 112.48 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -133.14 -67.57 0.62 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.073 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -116.47 0.82 12.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.163 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 8.3 mp -54.15 -20.76 7.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.592 0.234 . . . . 0.0 111.591 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.97 -20.13 35.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.392 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -96.44 -21.36 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.614 0.245 . . . . 0.0 110.919 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -80.64 -33.04 36.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.025 0.44 . . . . 0.0 110.885 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.717 ' CD1' ' HB2' ' A' ' 51' ' ' ALA . 1.2 t80 -46.9 -53.44 26.46 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.499 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 9.2 Cg_endo -52.84 -24.29 23.47 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.355 2.037 . . . . 0.0 112.873 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -90.24 -53.18 4.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.944 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.67 -21.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . . . -80.6 -36.25 33.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.618 ' O ' HG23 ' A' ' 53' ' ' THR . . . -46.64 -21.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER 162.7 140.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.752 0.31 . . . . 0.0 110.42 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -96.48 0.5 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.701 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -151.45 89.45 1.5 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.399 . . . . 0.0 110.915 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.59 148.77 19.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.657 ' HA ' HG11 ' A' ' 8' ' ' VAL . 63.3 Cg_endo -73.47 164.68 34.4 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 267' ' ' ASN . 19.4 p30 -156.03 36.21 0.34 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 22.5 mt -146.9 106.22 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 122.019 -0.426 . . . . 0.0 110.744 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.994 HD12 ' HE3' ' A' ' 10' ' ' TRP . 18.5 tt -152.61 144.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.822 ' HB3' HD21 ' A' ' 262' ' ' LEU . 7.1 m-85 -125.99 138.65 53.76 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.878 ' HZ3' HD13 ' A' ' 60' ' ' ILE . 2.1 p90 -165.74 173.93 10.22 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -47.34 156.96 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.967 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 1.0 OUTLIER -79.1 -28.83 43.01 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -68.58 -13.66 62.49 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.568 ' C ' ' HE1' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -122.01 4.76 9.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -110.0 -32.5 7.0 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.021 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -84.93 -12.15 74.97 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.269 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.99 -29.99 5.29 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.159 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -89.39 -46.16 8.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.891 0.377 . . . . 0.0 110.591 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -66.89 -45.31 78.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.717 ' CG ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -56.35 -19.28 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.682 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -97.8 -28.44 13.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.16 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.03 -84.54 0.41 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.411 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -176.73 72.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.966 0.413 . . . . 0.0 110.818 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.065 HD13 ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -103.37 146.71 28.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -96.29 117.39 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 102' ' ' LYS . 7.8 pt-20 -61.38 146.89 46.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 80' ' ' THR . 18.0 mt -90.13 164.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.509 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -132.64 141.47 41.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.57 ' HB3' ' CD2' ' A' ' 85' ' ' PHE . 95.8 Cg_endo -85.18 176.65 5.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.7 -82.38 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -119.88 -50.26 2.29 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.377 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.89 22.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 12.0 m-85 -78.61 -52.1 8.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.862 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.25 -34.85 78.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.727 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 t0 -50.21 -55.78 13.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.283 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 1.027 ' HD3' ' HB2' ' A' ' 306' ' ' SER . 4.0 tttp 165.29 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.771 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.751 HD12 HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -84.94 -77.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.784 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.906 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 4.8 t80 -173.96 128.49 0.47 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.7 Cg_exo -69.21 -37.08 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.457 2.105 . . . . 0.0 112.015 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 6.7 m-85 -88.0 -15.17 37.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.444 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' TYR . 6.5 t -64.27 -48.05 77.24 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.391 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 91' ' ' PRO . 1.8 p-90 -89.74 -30.15 18.22 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 123.301 0.375 . . . . 0.0 111.016 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.446 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 19.1 t70 -63.24 -39.84 95.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.73 -39.05 37.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.434 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 94' ' ' TRP . 14.1 p -80.0 51.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 110.741 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 123.67 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.651 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' HB3' ' NE2' ' A' ' 72' ' ' GLN . 83.3 m-85 -131.0 105.17 7.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 59.55 22.79 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.419 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.66 -22.83 38.09 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.855 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.938 ' HD2' HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -111.62 173.89 6.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.13 118.68 27.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.106 0.479 . . . . 0.0 111.06 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.938 HD11 ' HD2' ' A' ' 102' ' ' LYS . 2.0 mp -116.08 42.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.883 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . -166.15 169.06 14.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . 1.9 t80 -151.06 113.63 3.11 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 84.4 Cg_endo -79.31 148.07 20.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.187 1.924 . . . . 0.0 112.23 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 108' ' ' ILE . 9.6 tp -173.28 40.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.271 0.558 . . . . 0.0 111.118 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . . . -172.19 125.39 0.53 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.118 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 16.9 t -110.5 114.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.069 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.567 ' H ' ' HA3' ' A' ' 260' ' ' GLY . 5.3 mt-10 -121.42 128.85 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 0.0 110.726 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -168.64 179.57 4.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.075 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 227' ' ' ASN . 0.1 OUTLIER -107.92 159.61 16.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB2' HG23 ' A' ' 244' ' ' VAL . 3.3 p -119.35 160.75 21.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.047 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 tp -102.69 111.33 23.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.63 138.35 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -139.76 148.49 42.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.317 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -118.24 143.96 46.15 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.41 78.32 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 0.0 111.783 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -149.12 -39.93 0.15 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.482 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.2 pp -155.82 38.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 139' ' ' LEU . 1.9 mt -158.49 73.49 3.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -93.6 124.8 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.819 2.346 . . . . 0.0 112.479 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 0.4 OUTLIER -175.09 117.48 0.31 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.87 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.05 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.224 1.949 . . . . 0.0 111.54 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 87.7 Cg_endo -85.94 85.98 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.379 2.052 . . . . 0.0 112.885 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.43 -30.66 11.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.485 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 141.27 48.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.063 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.765 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.2 m95 -64.86 -37.94 89.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.634 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 12.2 tt0 -58.63 -34.8 71.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.775 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -23.14 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.885 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 27.0 mm -66.54 -59.99 7.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.885 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 78.1 Cg_exo -50.92 -40.22 58.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.392 2.062 . . . . 0.0 112.671 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.91 -27.87 68.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -68.86 -36.87 78.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.572 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HB2' HD21 ' A' ' 147' ' ' LEU . 9.9 t0 -62.41 -37.94 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.404 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -35.96 76.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.582 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.95 -33.32 65.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.58 HD22 ' C ' ' A' ' 145' ' ' SER . 8.5 mp -74.37 -36.0 63.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.201 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -40.58 91.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.298 0.57 . . . . 0.0 109.914 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.08 -10.36 6.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.064 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -115.24 -59.03 2.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.917 0.389 . . . . 0.0 110.504 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.67 40.03 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.566 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.411 ' C ' ' HB3' ' A' ' 139' ' ' LEU . 0.3 OUTLIER -162.18 -174.46 4.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 139' ' ' LEU . 1.4 m -141.45 165.35 27.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.318 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.727 ' HA ' ' HB ' ' A' ' 222' ' ' THR . . . -116.46 -7.26 11.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.693 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.7 OUTLIER -148.72 151.71 35.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.027 0.442 . . . . 0.0 112.175 -178.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -167.87 111.1 0.63 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.267 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.773 ' CE2' ' HA ' ' A' ' 151' ' ' LEU . 4.2 p90 -111.84 169.4 8.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.272 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.971 ' HB2' ' HB2' ' A' ' 153' ' ' GLU . 47.1 m-80 -57.34 -17.73 13.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.914 0.388 . . . . 0.0 110.515 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 0.5 OUTLIER 78.64 -50.2 0.46 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.383 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.24 36.88 4.05 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.811 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.971 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -119.82 155.85 54.59 Favored Pre-proline 0 CA--C 1.522 -0.126 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.723 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.12 -156.59 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.515 2.143 . . . . 0.0 112.206 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 21.8 m-85 68.61 -4.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.717 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.585 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 19.9 t80 -123.3 -57.27 1.68 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.64 0.733 . . . . 0.0 111.686 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 161' ' ' ILE . 60.9 p -50.09 -52.83 31.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.651 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.573 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 14.1 t-105 -60.93 -54.27 55.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.315 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.751 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 12.3 Cg_endo -57.13 -10.9 6.72 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.514 2.142 . . . . 0.0 112.664 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.944 ' HG ' ' HE2' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -104.56 -43.7 5.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.997 0.427 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.581 HG13 ' HA3' ' A' ' 191' ' ' GLY . 16.3 tt -80.69 -9.19 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.253 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.73 -57.52 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.543 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 49.01 -151.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.941 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 4.9 t70 -112.46 21.49 15.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 0.0 110.635 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.94 -52.08 0.43 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.31 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.67 114.74 5.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.549 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.01 142.51 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.834 0.35 . . . . 0.0 111.165 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -92.63 -65.68 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -143.51 149.88 38.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 0.7 OUTLIER -95.94 130.96 42.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.632 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -138.7 124.65 19.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.05 119.08 37.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.079 0.466 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 67.78 -67.25 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.83 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.22 34.13 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.367 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.51 127.53 15.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.261 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -93.22 168.84 10.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.681 ' HB2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -92.37 -82.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.863 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 179' ' ' LYS . 8.6 tp 174.83 -48.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.315 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.675 ' HG3' HG21 ' A' ' 369' ' ' THR . 0.0 OUTLIER -110.01 30.56 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.224 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.681 ' OD2' ' HB2' ' A' ' 177' ' ' ASP . 72.4 m-20 -79.16 105.82 10.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.984 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' ALA . 8.6 p -147.47 141.96 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.39 55.69 0.73 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.532 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.665 ' O ' ' HB3' ' A' ' 188' ' ' ALA . 15.3 t -112.73 -31.15 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.888 0.375 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.569 ' OD2' ' HG2' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -84.25 31.13 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -114.53 -178.67 3.43 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.195 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.1 -22.77 65.8 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.04 -51.58 54.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.256 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 183' ' ' VAL . . . -76.6 -25.32 53.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -49.12 76.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.863 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.1 93.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 161' ' ' ILE . . . -61.87 -38.7 96.43 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.004 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.761 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -67.74 -34.27 76.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.789 0.328 . . . . 0.0 111.211 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -31.98 63.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.639 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -60.25 2.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.477 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -50.12 -35.96 27.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.097 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 192' ' ' LEU . 26.8 t -73.43 -48.25 42.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.811 ' HA ' ' HE2' ' A' ' 200' ' ' LYS . 10.0 t70 -72.02 -27.35 62.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -39.22 32.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 111.299 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 195' ' ' LEU . 1.1 tt -68.76 -40.72 81.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.811 ' HE2' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -74.94 -9.67 58.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.7 2.71 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.78 ' O ' ' HG2' ' A' ' 204' ' ' MET . 0.0 OUTLIER -120.39 -18.91 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.462 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.78 ' HG2' ' O ' ' A' ' 203' ' ' HIS . 0.1 OUTLIER 44.41 26.94 0.19 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -152.75 101.3 2.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -85.72 82.06 8.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.27 12.56 7.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.378 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' A' ' 151' ' ' LEU . 29.5 m -67.87 130.43 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.591 ' HB2' HG12 ' A' ' 212' ' ' ILE . 0.3 OUTLIER -99.39 -164.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.963 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.837 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.2 OUTLIER -78.84 -43.74 24.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 m -79.34 -24.61 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 209' ' ' ASP . 34.1 mm -70.13 -57.73 7.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.869 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.674 ' HB2' ' CG2' ' A' ' 208' ' ' THR . . . -67.52 -29.65 69.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.269 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.837 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 20.5 tt0 -56.33 -22.83 33.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.15 -56.16 23.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.714 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.16 -29.69 31.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.081 0.467 . . . . 0.0 111.282 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.631 ' HA ' HG23 ' A' ' 225' ' ' THR . 1.8 t80 -66.61 -60.25 2.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.1 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -45.11 95.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.228 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.738 ' HG2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -81.0 -10.26 59.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.027 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.69 34.52 0.48 Allowed Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.024 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.738 ' HG3' ' HG2' ' A' ' 219' ' ' LYS . 2.3 mm-40 -89.45 36.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.077 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 146' ' ' ALA . 7.3 p -158.82 148.23 19.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.18 38.7 0.07 Allowed 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.317 -0.953 . . . . 0.0 113.471 -170.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.693 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -160.15 98.31 1.3 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 117.264 -1.775 . . . . 0.0 115.403 176.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.631 HG23 ' HA ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -147.49 136.07 21.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.855 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.57 HD13 ' HD1' ' A' ' 156' ' ' PHE . 17.0 pt -132.99 125.93 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.458 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.826 ' HB2' ' CB ' ' A' ' 231' ' ' ALA . 6.8 p-10 -132.17 144.34 50.6 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.131 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.54 -142.96 6.88 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.564 ' HB3' ' OE2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -60.91 132.86 44.34 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.219 1.946 . . . . 0.0 112.218 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 17.4 m0 63.71 46.96 3.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.085 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.826 ' CB ' ' HB2' ' A' ' 227' ' ' ASN . . . -98.07 -38.66 9.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.526 ' HB3' ' OD1' ' A' ' 234' ' ' ASN . 75.7 m95 -87.43 -80.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.671 0.272 . . . . 0.0 110.651 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.48 31.01 19.59 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.763 0.316 . . . . 0.0 111.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' A' ' 232' ' ' TRP . 6.4 p-10 -108.37 167.67 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 235' ' ' ILE . 0.0 OUTLIER -152.92 48.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.834 0.826 . . . . 0.0 110.564 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -157.99 157.17 32.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.671 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.23 115.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.12 120.23 21.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.95 156.69 16.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' ' CE1' ' A' ' 242' ' ' TYR . 12.2 p -170.96 -21.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.968 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.28 56.55 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.839 0.352 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 240' ' ' VAL . 13.7 p90 -131.96 138.5 48.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.344 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.67 123.16 5.48 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.475 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 114' ' ' SER . 7.5 p -95.55 123.22 47.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.526 0.203 . . . . 0.0 110.678 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.4 m -135.12 162.64 31.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.828 ' HB ' ' HG3' ' A' ' 322' ' ' GLU . 9.9 p -97.46 151.96 4.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.661 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.435 HD23 ' HZ2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -56.91 145.25 64.68 Favored Pre-proline 0 N--CA 1.462 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.879 -176.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.765 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 79.6 Cg_endo -78.75 -166.01 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.703 2.268 . . . . 0.0 112.396 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.729 HG22 ' HD3' ' A' ' 254' ' ' PRO . 70.3 p -93.07 167.3 11.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.671 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.944 ' HE2' ' HG ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.47 113.89 14.25 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.701 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.89 -11.78 0.33 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.309 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 156.54 -25.34 0.52 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.92 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 1.015 ' HG3' ' HD2' ' A' ' 254' ' ' PRO . 0.8 OUTLIER -141.09 151.75 62.96 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.761 0.281 . . . . 0.0 110.8 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 1.015 ' HD2' ' HG3' ' A' ' 253' ' ' GLN . 29.5 Cg_endo -62.43 -174.2 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.285 1.99 . . . . 0.0 112.114 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.685 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 24.9 p -105.62 -178.69 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.275 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -102.56 90.77 2.35 Favored Pre-proline 0 N--CA 1.461 0.094 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.685 ' HD3' ' O ' ' A' ' 255' ' ' SER . 55.8 Cg_endo -95.43 -149.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.209 2.606 . . . . 0.0 110.768 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 323' ' ' ASN . 0.1 OUTLIER -170.81 158.96 6.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.988 0.813 . . . . 0.0 112.382 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 329' ' ' ILE . 9.5 p -86.25 157.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.598 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -94.09 120.01 6.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.167 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 41.8 t -132.06 116.2 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.877 ' HG ' ' O ' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -88.44 137.95 31.86 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.967 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 2.4 t -103.52 125.87 50.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.598 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' TYR . . . -88.51 155.29 19.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.761 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.771 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -121.48 148.83 17.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.74 -1.219 . . . . 0.0 114.239 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 266' ' ' ILE . 7.9 tp -138.12 102.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.125 -0.537 . . . . 0.0 109.747 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HB2' ' CB ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -58.08 145.46 36.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.331 -178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -80.49 4.51 18.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -108.65 39.4 2.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.457 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 95.6 p -108.3 101.72 43.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.56 -48.94 4.94 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.599 2.2 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -76.78 53.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.408 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -29.57 66.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -65.68 -43.13 90.21 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.451 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 20.4 mt -76.56 -31.52 57.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.918 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -49.18 71.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.9 OUTLIER -64.71 -43.85 92.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.619 ' CG ' ' HA ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -71.34 -32.11 68.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.965 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 1.2 t80 -69.12 -58.7 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.65 0.262 . . . . 0.0 111.332 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -41.53 96.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.4 tt0 -61.3 -24.23 66.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.44 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -115.17 -0.81 13.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.705 0.288 . . . . 0.0 110.765 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.734 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 4.7 t80 -84.41 -70.4 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -113.15 41.34 2.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.208 0.527 . . . . 0.0 110.168 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.687 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.4 OUTLIER -144.42 20.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.557 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 287' ' ' ASP . 21.1 m -149.74 167.69 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.114 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.846 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.8 OUTLIER -69.15 -8.53 46.38 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.693 0.283 . . . . 0.0 111.64 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -48.06 24.67 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.35 -0.219 . . . . 0.0 111.369 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -108.44 -58.17 0.55 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.315 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 284' ' ' LEU . 5.3 tt -54.99 -31.33 60.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 35.1 tt0 -72.93 -31.24 64.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -77.73 -29.27 51.12 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 110.57 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 290' ' ' LEU . 10.1 p -77.54 -24.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.548 0.689 . . . . 0.0 110.584 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.9 -16.37 18.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.907 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.664 ' HG3' ' HG2' ' A' ' 291' ' ' GLU . 11.1 mmtm -90.07 -40.73 12.1 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 0.8 OUTLIER -52.54 -45.55 66.4 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 175.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 2.2 mtmp? 174.17 131.92 0.12 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.634 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.42 141.85 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.775 2.317 . . . . 0.0 112.781 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.825 ' O ' ' HB3' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -123.72 -86.09 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.204 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 317' ' ' ILE . . . -159.96 94.58 0.13 Allowed Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.136 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . -172.11 140.92 1.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.467 0.307 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 302' ' ' VAL . 7.2 p -177.86 105.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 111.138 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -117.03 48.6 1.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 303' ' ' ALA . 3.8 mp -153.7 122.88 6.52 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.727 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.44 ' N ' ' HD1' ' A' ' 90' ' ' TYR . 1.9 tttm -60.63 -33.01 72.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.339 . . . . 0.0 110.75 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 1.027 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 47.2 t -66.85 -43.97 82.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.276 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -68.72 -47.4 66.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.965 0.412 . . . . 0.0 110.028 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 311' ' ' LEU . 2.3 tm-20 -59.09 -17.83 29.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.635 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.24 -28.52 57.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.61 . . . . 0.0 111.571 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 312' ' ' ALA . 3.8 tt0 -83.71 -28.12 28.5 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.932 HD13 ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -43.67 -8.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.527 1.531 . . . . 0.0 113.499 177.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -59.44 -17.12 28.27 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.164 -0.335 . . . . 0.0 111.81 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -133.73 54.86 1.93 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 317' ' ' ILE . 2.2 m-20 -113.36 156.21 43.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 316' ' ' ARG . 69.5 Cg_endo -94.65 -66.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.583 2.189 . . . . 0.0 114.448 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.825 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -81.39 -58.74 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 314' ' ' ASP . 1.9 pp -62.26 -25.73 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 314' ' ' ASP . . . -74.96 -40.79 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.883 0.373 . . . . 0.0 111.274 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -49.09 -41.55 35.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.664 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 110' ' ' VAL . 62.1 p -58.96 -25.47 63.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.628 ' HE1' ' HG2' ' A' ' 308' ' ' GLU . 4.1 ttm -60.12 -22.91 63.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.611 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 246' ' ' VAL . 0.2 OUTLIER -49.33 -54.33 17.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.449 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.805 HD22 ' HB1' ' A' ' 112' ' ' ALA . 39.7 m-80 -61.39 -42.21 98.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.281 0.562 . . . . 0.0 109.934 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.08 64.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.736 ' HB2' ' O ' ' A' ' 322' ' ' GLU . 5.2 mm-40 -39.66 -35.15 0.29 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.563 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -65.44 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 150.46 34.25 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.881 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -118.1 137.04 53.2 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.245 1.023 . . . . 0.0 109.052 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.718 ' HA ' ' CG1' ' A' ' 259' ' ' VAL . 4.2 mp -108.15 99.34 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.524 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.713 ' SD ' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 53.03 146.01 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.644 178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.713 ' HD2' ' SD ' ' A' ' 330' ' ' MET . 70.4 Cg_endo -72.91 -174.67 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.321 2.681 . . . . 0.0 111.565 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -129.03 9.52 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.639 HG13 ' HD2' ' A' ' 334' ' ' PRO . 1.5 tt -122.22 131.51 24.39 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 120.648 0.261 . . . . 0.0 110.804 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 333' ' ' ILE . 88.7 Cg_endo -82.57 -8.93 11.35 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.459 2.106 . . . . 0.0 112.967 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -69.1 -21.16 64.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.413 ' O ' ' CD1' ' A' ' 339' ' ' PHE . 3.4 ttp -48.34 -23.12 0.82 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 2.8 p -60.94 -20.27 61.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 111.532 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 368' ' ' ILE . . . -58.15 -27.02 63.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG12 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -48.65 -26.07 2.09 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -65.17 -50.03 67.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.797 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -75.67 -22.34 56.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.839 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.78 -53.65 6.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 339' ' ' PHE . 15.0 p -56.84 -35.87 47.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.3 OUTLIER -62.75 -58.56 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 1.7 m -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.21 -48.73 19.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 343' ' ' VAL . 22.0 t -77.34 -59.02 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -69.06 -51.57 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.78 ' ND2' ' HG3' ' A' ' 355' ' ' GLN . 0.0 OUTLIER -57.17 -56.26 24.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 355' ' ' GLN . . . -61.75 -26.89 68.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -85.97 -9.64 56.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.254 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 25.0 p -67.04 -52.83 37.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.831 0.348 . . . . 0.0 111.77 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 138.79 -11.12 3.41 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.447 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -131.07 39.53 3.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.012 0.406 . . . . 0.0 110.783 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.78 ' HG3' ' ND2' ' A' ' 349' ' ' ASN . 11.5 mm100 -154.97 118.76 4.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.659 HG23 ' HB2' ' A' ' 359' ' ' GLU . 1.3 t -88.57 150.41 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 361' ' ' LEU . 30.0 m -59.34 -27.61 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.437 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.754 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 11.1 m-20 -75.12 -37.07 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 356' ' ' THR . 0.7 OUTLIER -81.46 -40.07 23.88 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.195 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.51 -47.97 16.25 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.617 ' HG ' HE22 ' A' ' 365' ' ' GLN . 10.3 tp -77.84 -57.35 3.85 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 5.5 mtmt -56.76 -52.66 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.408 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 366' ' ' THR . 9.1 t0 -61.72 -26.14 67.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 367' ' ' ARG . . . -75.69 -25.21 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.836 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.617 HE22 ' HG ' ' A' ' 361' ' ' LEU . 0.4 OUTLIER -72.44 -29.99 64.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.466 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 363' ' ' ASP . 8.6 t -80.33 -41.15 25.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.01 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -70.22 -31.26 68.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.323 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 338' ' ' ALA . 16.2 tt -70.27 -39.98 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.747 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.675 HG21 ' HG3' ' A' ' 179' ' ' LYS . 0.2 OUTLIER -65.5 -38.48 89.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.971 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.7 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.762 0.315 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.0 p -116.01 145.14 43.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.574 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -121.72 129.7 52.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -166.83 130.07 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -168.46 25.22 0.12 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.489 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 170.3 22.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.91 0.386 . . . . 0.0 110.821 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' HG ' ' OD2' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -149.09 117.42 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.279 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 19.0 t -81.94 119.22 31.09 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.659 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.016 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -90.56 156.71 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.354 -178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.715 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.96 112.92 7.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.656 177.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' O ' ' HD2' ' A' ' 40' ' ' PRO . 20.5 pt -152.98 155.04 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.861 0.362 . . . . 0.0 111.672 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.33 66.79 1.35 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 230' ' ' TRP . . . 117.74 61.78 0.3 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.639 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.75 6.94 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.74 -140.43 0.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.87 80.89 0.01 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 115.823 1.089 . . . . 0.0 115.823 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -60.05 2.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.228 -0.486 . . . . 0.0 111.727 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.31 -35.8 78.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.805 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.27 -60.93 7.93 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.086 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -23.64 67.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.754 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.66 -44.74 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.65 -57.88 5.06 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.899 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' ' HD1' ' A' ' 27' ' ' PHE . 22.0 t -45.14 -42.45 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.52 95.81 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.541 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -29.32 39.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 111.554 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -30.81 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.019 0.438 . . . . 0.0 111.681 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.91 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 12.4 m-85 -75.38 -57.73 3.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.837 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.783 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.64 -27.59 7.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.429 0.633 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.32 -30.74 52.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' THR . 1.2 m-20 -63.89 -57.2 10.55 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.9 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.925 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' HG13 ' A' ' 33' ' ' ILE . . . 156.46 43.95 0.02 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 118.103 -1.998 . . . . 0.0 115.913 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.91 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.9 mt -141.53 95.29 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 118.405 1.103 . . . . 0.0 111.573 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 28' ' ' GLU . 0.6 OUTLIER -129.95 126.65 38.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.921 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 9' ' ' ILE . 16.0 m -122.5 128.61 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 9' ' ' ILE . 7.2 p -103.53 120.79 41.55 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.442 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 15.6 m -86.44 122.44 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.953 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.16 154.03 22.31 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.959 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.77 94.47 37.53 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.727 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.735 ' HA ' ' CD1' ' A' ' 43' ' ' LEU . 83.3 Cg_endo -82.29 145.96 13.78 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.084 1.856 . . . . 0.0 113.026 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 43' ' ' LEU . 3.9 t70 -149.46 -52.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.131 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 0.64 13.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.099 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.735 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 2.6 mp -61.02 -10.35 5.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.983 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.24 -28.35 18.29 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 111.592 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -91.11 -34.34 15.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.832 0.349 . . . . 0.0 111.014 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -70.84 -26.24 63.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.474 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t80 -54.57 -56.28 28.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.137 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.1 Cg_endo -59.18 -22.29 63.9 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.64 2.226 . . . . 0.0 113.129 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -89.31 -51.33 5.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -73.72 -25.22 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.06 95.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.58 -15.0 0.37 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.926 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -77.21 -58.97 2.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 111.277 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.43 31.09 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.932 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.617 ' OD2' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER 56.98 96.22 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.33 -78.6 0.21 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.908 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 30.9 Cg_endo -62.96 158.92 40.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.381 2.054 . . . . 0.0 112.113 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HG ' ' A' ' 7' ' ' LEU . 23.6 p-10 -134.1 36.42 3.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.016 HG23 ' HA ' ' A' ' 9' ' ' ILE . 7.5 tp -172.94 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.412 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.715 ' CG1' ' HB3' ' A' ' 10' ' ' TRP . 11.0 tt -147.43 143.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.794 -177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -118.9 137.98 53.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.699 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -157.94 170.95 21.16 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.194 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . . . -55.99 162.32 1.94 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.586 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.903 ' HB2' HG23 ' A' ' 261' ' ' VAL . 1.8 t60 -78.53 -30.79 47.2 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.927 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 1.6 p-10 -80.82 -13.44 58.95 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 ptp180 -115.34 -16.32 11.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.988 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 2.1 t80 -120.74 -28.24 4.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.782 0.325 . . . . 0.0 110.5 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.76 -30.63 65.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.499 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.85 -13.02 11.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.299 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -81.64 -47.67 12.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.945 0.372 . . . . 0.0 110.72 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.808 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -64.88 -38.52 91.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.77 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.83 -8.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 t -79.32 -30.08 42.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.584 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.641 ' C ' HD22 ' A' ' 75' ' ' LEU . . . -161.82 -15.63 0.03 OUTLIER Glycine 0 CA--C 1.52 0.377 0 C-N-CA 119.348 -1.405 . . . . 0.0 115.247 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD22 ' C ' ' A' ' 74' ' ' GLY . 4.3 mm? -126.98 38.47 4.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.362 1.081 . . . . 0.0 112.682 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.808 HD13 ' HB3' ' A' ' 71' ' ' ALA . 5.4 tp -144.12 121.37 11.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.321 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -98.69 157.31 16.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.94 139.9 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.968 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.84 154.84 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -105.27 157.57 34.07 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.87 172.84 8.58 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.579 2.186 . . . . 0.0 112.267 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 83' ' ' LYS . 4.8 p-10 -151.98 -92.24 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.251 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.9 OUTLIER -120.23 -34.62 3.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.715 0.293 . . . . 0.0 110.781 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -50.02 -22.85 1.74 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.235 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.95 -57.8 3.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.45 -33.13 70.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.922 0.391 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -51.26 -55.29 18.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.726 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.657 ' HD2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 175.06 64.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.313 0.578 . . . . 0.0 110.825 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -108.42 126.21 52.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.483 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' CE1' ' HD3' ' A' ' 305' ' ' LYS . 1.1 t80 -57.57 126.11 74.39 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.572 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.04 -24.41 52.52 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.239 1.959 . . . . 0.0 112.138 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -42.4 71.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.6 p -64.87 -32.11 73.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.971 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.685 ' HZ3' HD21 ' A' ' 103' ' ' LEU . 3.1 m95 -77.14 -37.83 53.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.8 OUTLIER -71.59 -22.9 61.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.844 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.51 -45.55 8.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.502 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 97' ' ' VAL . 21.1 t -81.04 42.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.419 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -111.43 151.48 28.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.205 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -171.76 121.19 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.743 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.43 21.64 11.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.33 23.77 71.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.674 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.03 149.36 51.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.635 0.255 . . . . 0.0 110.367 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.685 HD21 ' HZ3' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -88.14 63.61 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.214 0.53 . . . . 0.0 111.19 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.77 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 1.6 pp -89.8 40.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.204 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 64' ' ' HIS . . . -174.87 130.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.576 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.7 t80 -137.71 114.5 9.44 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.51 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.771 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 73.2 Cg_endo -91.19 149.48 3.72 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.624 2.216 . . . . 0.0 112.463 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.72 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.2 OUTLIER -151.91 39.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.64 133.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 301' ' ' ALA . 41.2 t -104.41 118.01 50.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.514 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.97 127.95 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.799 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -169.54 178.52 4.16 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 226' ' ' ILE . 7.6 mp -129.3 172.62 11.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.82 ' HB2' HG13 ' A' ' 244' ' ' VAL . 93.6 p -123.72 174.54 7.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.299 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HB3' ' O ' ' A' ' 245' ' ' THR . 1.1 tp -105.65 113.36 26.88 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.864 HG12 ' HB ' ' A' ' 225' ' ' THR . 1.0 OUTLIER -73.74 135.48 27.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -153.38 121.93 6.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.523 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.51 -152.53 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.978 ' HD2' HD22 ' A' ' 121' ' ' LEU . 6.4 mmtt 65.25 112.35 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.747 0.784 . . . . 0.0 111.181 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.84 30.73 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.913 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.978 HD22 ' HD2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -136.34 36.6 2.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 177.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.59 116.86 17.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.662 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 21.2 Cg_exo -64.25 160.51 38.31 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.627 2.218 . . . . 0.0 112.0 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.68 123.75 84.2 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.49 ' HG3' ' HE2' ' A' ' 117' ' ' TYR . 75.7 Cg_endo -82.73 149.58 14.28 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.189 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.6 ' HG2' ' HB3' ' A' ' 131' ' ' GLU . 53.6 Cg_endo -69.31 -161.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.17 1.913 . . . . 0.0 112.246 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -108.33 28.89 7.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.582 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.701 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 3.6 t -133.15 153.27 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.957 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CZ2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -64.27 -30.55 71.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.897 0.38 . . . . 0.0 110.75 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.629 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -49.76 -24.02 2.13 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.196 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.9 pt-20 -56.47 -35.55 68.06 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.151 -0.343 . . . . 0.0 110.939 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.902 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 43.8 mm -60.08 -59.05 15.1 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.547 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.902 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 32.3 Cg_exo -53.14 -41.36 72.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.889 1.726 . . . . 0.0 111.955 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.959 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . . . -71.37 -29.8 65.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.13 0.491 . . . . 0.0 110.885 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . 0.3 OUTLIER -72.52 -29.66 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.044 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 2.1 t0 -63.26 -45.75 90.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.717 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.959 ' HD3' ' HA ' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.95 -38.27 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.788 0.328 . . . . 0.0 110.351 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.98 -42.34 89.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -75.96 -42.8 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.583 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -67.75 -30.34 69.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.837 0.351 . . . . 0.0 110.866 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -57.97 -12.92 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.94 -57.26 2.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.178 0.513 . . . . 0.0 110.649 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.86 41.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.029 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.548 ' CB ' HD12 ' A' ' 139' ' ' LEU . 19.7 mttp -161.51 178.57 8.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.864 0.364 . . . . 0.0 110.927 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.547 ' O ' HG22 ' A' ' 222' ' ' THR . 68.4 m -124.17 161.01 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.638 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 223' ' ' ALA . . . -106.96 -13.18 15.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.413 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.698 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -155.65 147.11 22.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.654 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.5 OUTLIER -175.17 124.32 0.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 O-C-N 121.988 -0.445 . . . . 0.0 111.373 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.821 ' HE2' ' H ' ' A' ' 226' ' ' ILE . 2.1 t80 -152.27 175.6 12.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' H ' ' HD1' ' A' ' 149' ' ' PHE . 1.8 m120 -53.28 -179.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.476 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 208' ' ' THR . 20.6 mt -136.41 -33.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.458 ' CD ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -112.11 34.28 4.35 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.134 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.3 159.99 52.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' HH2' ' A' ' 340' ' ' TRP . 4.9 Cg_exo -80.5 -163.48 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.591 2.194 . . . . 0.0 112.002 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.661 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 23.7 m-85 70.53 -7.2 1.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.051 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.625 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -122.63 -64.52 1.18 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.437 0.636 . . . . 0.0 112.323 -178.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -47.3 -51.15 20.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.324 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.673 ' HH2' ' HB2' ' A' ' 168' ' ' ALA . 61.8 t-105 -58.27 -56.33 36.27 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 22.1 Cg_endo -60.32 -9.57 11.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.917 2.411 . . . . 0.0 113.099 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.493 HD11 ' CZ2' ' A' ' 129' ' ' TRP . 0.5 OUTLIER -102.22 -37.18 8.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.066 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 157' ' ' THR . 13.2 tt -95.77 14.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.599 ' HB3' ' OG ' ' A' ' 255' ' ' SER . . . -98.45 -49.7 4.56 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 110.358 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 50.86 -161.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.792 ' HB2' ' HB3' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -115.13 39.2 2.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 110.355 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -150.3 -38.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.585 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.85 112.16 3.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.733 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -102.72 142.21 34.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.673 ' HB2' ' HH2' ' A' ' 158' ' ' TRP . . . -92.59 -65.9 0.97 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.629 ' HE1' ' HE2' ' A' ' 339' ' ' PHE . 71.7 m-85 -120.16 145.77 46.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -96.47 118.89 33.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.418 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -136.9 121.12 17.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.83 136.92 54.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.182 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.92 -64.95 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.661 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.5 51.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.815 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -141.79 165.76 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.773 0.32 . . . . 0.0 110.612 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -116.96 167.22 11.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 179' ' ' LYS . 3.5 t70 -144.26 -160.29 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.465 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 179' ' ' LYS . 0.7 OUTLIER -163.55 -44.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.507 ' HG2' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -60.71 -32.23 71.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.753 0.311 . . . . 0.0 111.627 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.54 110.42 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.084 0.469 . . . . 0.0 111.01 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.6 m -148.3 146.58 17.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.101 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.63 41.23 1.53 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.624 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.808 ' CG2' ' HG2' ' A' ' 365' ' ' GLN . 16.8 m -78.96 -39.1 21.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -85.02 36.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.18 179.39 5.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.874 0.369 . . . . 0.0 111.018 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.59 -29.62 52.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.72 58.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.108 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.31 83.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 0.0 111.49 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.781 ' HD2' HD12 ' A' ' 361' ' ' LEU . 0.2 OUTLIER -62.52 -33.61 75.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.197 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.63 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.315 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -59.7 -45.64 95.36 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.819 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.61 -36.53 83.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.626 0.251 . . . . 0.0 111.354 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 24.6 m -69.26 -28.7 66.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -58.58 3.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.065 0.459 . . . . 0.0 111.568 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -53.15 -51.33 62.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.024 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 192' ' ' LEU . 7.7 p -58.45 -36.45 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 111.57 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.63 -32.31 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 111.501 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 195' ' ' LEU . 51.5 mt -65.47 -40.93 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.637 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 mt -63.34 -36.86 77.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.284 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -66.95 -46.65 74.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -83.44 19.09 1.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.997 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.587 ' HA ' ' NZ ' ' A' ' 202' ' ' LYS . 0.0 OUTLIER -120.06 -67.22 0.99 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.45 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ASN . 0.3 OUTLIER -118.71 -10.48 9.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 72.87 -39.69 0.45 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.719 0.295 . . . . 0.0 110.888 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -123.46 131.44 53.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.2 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.95 80.44 2.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.06 21.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.073 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.718 ' CG2' HD12 ' A' ' 151' ' ' LEU . 9.1 t -87.12 137.43 32.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 110.16 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.864 ' HB2' HD13 ' A' ' 212' ' ' ILE . 0.2 OUTLIER -120.52 -156.67 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.642 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.645 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 13.1 m-85 -78.65 -50.3 11.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.217 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.7 m -62.29 -24.18 67.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.864 HD13 ' HB2' ' A' ' 209' ' ' ASP . 3.6 mp -81.66 -58.54 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.455 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.57 70.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.3 tt0 -55.16 -22.53 17.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.385 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -56.25 -57.4 12.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -83.39 -33.43 25.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.607 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.967 ' CD1' HG23 ' A' ' 225' ' ' THR . 71.6 t80 -66.87 -58.95 4.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.716 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.905 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 3.2 t30 -64.05 -44.25 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.935 0.398 . . . . 0.0 111.237 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 8.2 mttt -83.69 -4.1 58.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.566 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 33.65 39.28 0.1 Allowed Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.295 -0.411 . . . . 0.0 114.084 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.48 35.82 0.88 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.487 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 145' ' ' SER . 68.0 p -159.0 154.29 25.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -73.16 38.46 0.09 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.547 -171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.698 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.49 97.47 1.34 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 117.159 -1.816 . . . . 0.0 115.797 176.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.967 HG23 ' CD1' ' A' ' 217' ' ' PHE . 39.1 m -149.18 143.86 26.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.975 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.944 HG22 HD23 ' A' ' 113' ' ' LEU . 11.4 mm -124.96 114.82 42.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.451 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 7.8 p30 -118.38 128.15 54.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.626 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.671 ' CA ' ' HG ' ' A' ' 113' ' ' LEU . . . -141.14 -138.54 3.57 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.11 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.47 133.67 43.85 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.893 1.729 . . . . 0.0 111.247 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.556 ' HE3' ' HA ' ' A' ' 230' ' ' TRP . 2.2 m95 65.38 46.95 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.239 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.19 -67.89 0.82 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.986 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.853 ' HZ3' HD11 ' A' ' 235' ' ' ILE . 1.2 m95 -102.18 -17.66 15.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.366 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.24 35.67 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.14 -49.11 0.46 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.754 0.311 . . . . 0.0 110.755 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.853 HD11 ' HZ3' ' A' ' 232' ' ' TRP . 10.4 pt -107.02 -5.99 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.03 163.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.286 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.5 p -77.3 170.47 16.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.053 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.61 -30.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.421 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -81.91 -177.49 6.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.779 0.323 . . . . 0.0 110.787 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.4 t -132.82 -34.52 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.922 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -79.64 84.75 5.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.63 126.84 29.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.383 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.34 116.84 3.71 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.845 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.82 HG13 ' HB2' ' A' ' 114' ' ' SER . 40.9 t -103.24 125.96 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.129 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -141.96 161.69 37.34 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.655 ' CG1' ' HB3' ' A' ' 322' ' ' GLU . 10.3 m -95.49 151.95 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.47 ' HG ' HD13 ' A' ' 115' ' ' LEU . 1.1 mt -56.86 148.73 47.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.922 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.38 -158.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.98 2.453 . . . . 0.0 112.437 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.474 HG22 ' HD3' ' A' ' 254' ' ' PRO . 32.4 p -102.96 166.74 10.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 251' ' ' LYS . 6.3 t80 -130.52 112.33 13.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.28 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER 66.98 -4.1 0.85 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.433 -179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.18 -33.73 0.78 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.277 -0.964 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 164' ' ' ASP . 0.6 OUTLIER -137.12 156.66 75.45 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.997 0.399 . . . . 0.0 111.243 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 249' ' ' THR . 36.6 Cg_endo -65.3 -165.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.599 ' OG ' ' HB3' ' A' ' 162' ' ' ALA . 10.5 t -111.52 170.13 8.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 91.62 5.94 Favored Pre-proline 0 CA--C 1.528 0.113 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.785 ' O ' ' HB2' ' A' ' 328' ' ' GLU . 43.9 Cg_endo -96.4 -153.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.131 2.554 . . . . 0.0 110.483 177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 33.8 p90 -151.26 179.29 8.44 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.474 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 1.085 HG12 ' HA ' ' A' ' 329' ' ' ILE . 10.2 p -117.38 156.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 259' ' ' VAL . . . -113.86 128.76 8.43 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.469 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 64' ' ' HIS . 4.2 m -130.89 132.2 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.428 0.156 . . . . 0.0 110.73 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -84.08 123.63 30.24 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.657 -0.652 . . . . 0.0 110.426 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.707 ' HB3' ' HA ' ' A' ' 64' ' ' HIS . 57.1 p -93.93 122.97 36.98 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.296 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -74.34 126.34 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.917 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.988 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -85.54 122.88 6.13 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.541 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 266' ' ' ILE . 0.5 OUTLIER -129.47 104.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.009 0.433 . . . . 0.0 110.681 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.72 147.62 32.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.84 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.59 1.1 23.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.839 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.55 29.21 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.248 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.4 m -107.16 89.2 4.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.88 33.9 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.255 1.97 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.01 65.35 0.71 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 110.44 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -65.51 -24.68 67.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 278' ' ' GLU . 20.3 mt-10 -56.25 -54.67 42.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -37.06 71.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.738 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.51 89.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 0.1 OUTLIER -72.83 -38.23 67.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.092 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.801 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 19.7 tt0 -66.68 -39.58 88.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.466 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.9 OUTLIER -67.56 -47.87 68.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.086 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.776 HD23 ' HE1' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -58.95 -51.48 69.87 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.743 ' HG2' ' O ' ' A' ' 277' ' ' LYS . 15.0 pt-20 -74.02 -13.38 60.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.801 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.1 m120 -107.16 -7.23 16.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.619 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.776 ' HE1' HD23 ' A' ' 280' ' ' LEU . 1.5 p90 -100.0 -51.1 3.78 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.399 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 283' ' ' TYR . 5.8 tp -119.78 44.13 2.48 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.483 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.662 ' HB3' ' O ' ' A' ' 281' ' ' GLU . 0.5 OUTLIER -151.74 27.66 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 110.654 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.28 163.39 37.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.704 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 0.2 OUTLIER -69.03 -9.67 53.68 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.55 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -46.65 36.64 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -115.2 -46.86 0.57 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.394 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' CD1' ' HG ' ' A' ' 284' ' ' LEU . 12.5 tp -61.76 -23.39 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 3.6 tp10 -80.5 -32.49 36.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.945 ' HA ' ' HG2' ' A' ' 295' ' ' LYS . . . -77.52 -29.57 52.46 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.086 0.47 . . . . 0.0 110.931 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 290' ' ' LEU . 16.2 m -75.63 -24.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.078 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.611 ' ND2' ' HG3' ' A' ' 298' ' ' PRO . 1.5 t30 -103.32 -12.81 16.99 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.169 176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.945 ' HG2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -86.84 -40.92 14.46 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.8 ' OD2' ' HE2' ' A' ' 297' ' ' LYS . 0.6 OUTLIER -56.15 -46.16 79.37 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 175.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.8 ' HE2' ' OD2' ' A' ' 296' ' ' ASP . 0.0 OUTLIER 160.54 126.79 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.622 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.701 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . 8.6 Cg_exo -72.09 144.29 42.02 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.333 2.022 . . . . 0.0 112.749 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 300' ' ' GLY . 0.8 OUTLIER -99.6 -45.25 5.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 317' ' ' ILE . . . -154.92 -178.04 28.82 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.742 ' N ' HG22 ' A' ' 317' ' ' ILE . . . -79.11 108.2 12.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 111.477 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.4 p -174.81 104.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.774 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 307' ' ' TYR . . . 177.07 46.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.891 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 308' ' ' GLU . 3.0 mp 53.76 -171.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.196 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 90' ' ' TYR . 9.0 mtmt -83.84 -30.01 26.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.465 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.1 t -75.22 -51.45 13.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.749 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.716 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 13.0 m-85 -71.3 -50.33 33.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.315 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.973 ' HA ' HD13 ' A' ' 311' ' ' LEU . 3.3 mt-10 -54.4 -17.88 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.82 -28.58 64.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -82.87 -29.98 28.92 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 308' ' ' GLU . 4.2 mp -48.74 -5.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.317 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -58.16 -21.34 46.72 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.081 -0.387 . . . . 0.0 111.705 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -72.28 -12.23 61.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.644 0.259 . . . . 0.0 111.421 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.701 ' OD2' ' HB2' ' A' ' 298' ' ' PRO . 0.4 OUTLIER -96.42 123.7 53.64 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.581 179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.81 -32.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.446 2.098 . . . . 0.0 112.312 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.659 ' O ' HG22 ' A' ' 320' ' ' THR . 0.2 OUTLIER -61.06 -57.68 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.023 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 301' ' ' ALA . 1.4 pp -57.19 -30.94 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.645 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.41 -44.75 42.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.673 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.744 ' HB1' HG11 ' A' ' 244' ' ' VAL . . . -65.37 -43.63 90.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 316' ' ' ARG . 5.1 t -64.32 -28.31 69.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 325' ' ' GLN . 6.5 mtp -68.53 -23.27 64.51 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.243 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.655 ' HB3' ' CG1' ' A' ' 246' ' ' VAL . 3.8 mm-40 -65.63 -49.6 68.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.735 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.75 -46.19 59.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.09 81.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.687 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 321' ' ' MET . 8.4 tt0 -70.66 -48.21 56.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.232 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -98.53 38.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.42 -172.05 17.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.583 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 257' ' ' PRO . 8.0 mt-10 -90.33 153.45 20.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 110.934 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 1.085 ' HA ' HG12 ' A' ' 259' ' ' VAL . 37.9 pt -118.26 139.08 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.656 ' HG2' ' HD2' ' A' ' 331' ' ' PRO . 0.0 OUTLIER 70.7 146.63 0.11 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 30.7 Cg_endo -62.59 158.32 42.19 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.67 2.246 . . . . 0.0 112.241 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 -81.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 334' ' ' PRO . 3.1 tt -135.02 140.52 35.18 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.722 ' HD2' HG13 ' A' ' 333' ' ' ILE . 31.2 Cg_exo -64.32 -14.43 43.96 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.446 2.098 . . . . 0.0 112.471 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.519 ' HB2' HG12 ' A' ' 333' ' ' ILE . 13.4 mt-30 -58.59 -21.56 53.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.742 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 339' ' ' PHE . 0.0 OUTLIER -52.63 -22.92 5.61 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.691 0.281 . . . . 0.0 111.719 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.0 t -61.38 -49.22 77.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.37 -26.62 67.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.629 ' HE2' ' HE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -52.36 -24.06 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.348 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.73 ' HH2' ' HB3' ' A' ' 154' ' ' PRO . 4.0 m95 -50.65 -31.64 16.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.124 0.488 . . . . 0.0 111.097 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -19.85 65.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.138 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.47 -56.1 4.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.164 0.506 . . . . 0.0 111.518 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.59 -35.4 44.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.782 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.632 ' HA ' HD12 ' A' ' 348' ' ' ILE . 39.1 mtp180 -64.2 -49.48 71.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.934 0.397 . . . . 0.0 111.383 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.861 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 m -72.35 -27.25 62.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.182 0.515 . . . . 0.0 111.98 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.6 -61.16 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.32 -59.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 344' ' ' ARG . 15.0 mt -57.15 -54.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.861 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -59.28 -47.24 86.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.533 0.206 . . . . 0.0 111.525 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -66.11 -28.06 68.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.349 . . . . 0.0 111.908 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.51 -12.42 58.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.668 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -47.31 22.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.022 0.439 . . . . 0.0 111.692 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 135.95 -7.28 4.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.828 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.2 mtt180 -124.94 38.75 4.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 111.344 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.818 HE21 ' HB2' ' A' ' 360' ' ' ALA . 9.6 tp60 -158.07 126.61 5.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.109 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 358' ' ' ASP . 6.6 m -104.75 136.66 43.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 0.0 110.91 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.4 p -58.08 -26.81 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.668 ' O ' ' HE2' ' A' ' 362' ' ' LYS . 1.1 m-20 -66.74 -55.8 13.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.638 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 2.1 mt-10 -79.67 -30.15 41.06 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.818 ' HB2' HE21 ' A' ' 355' ' ' GLN . . . -72.99 -34.37 66.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -75.04 -55.45 5.73 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.448 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.686 ' HB3' ' NZ ' ' A' ' 189' ' ' LYS . 1.5 pttt -71.09 -55.24 8.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.638 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -58.47 -56.59 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 360' ' ' ALA . . . -57.6 -37.58 73.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.066 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.808 ' HG2' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -68.63 -34.25 75.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.424 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 362' ' ' LYS . 61.2 p -78.83 -28.98 44.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.32 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.85 73.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.626 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 pt -79.58 -33.22 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.602 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 m -69.0 -41.93 77.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.8 m -105.0 135.46 46.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.43 160.23 25.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.332 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.77 151.65 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.819 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.534 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -102.4 61.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.727 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 22.3 mtpt -153.89 173.46 15.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.944 ' HB2' HG12 ' A' ' 35' ' ' VAL . 3.9 mp -136.43 114.41 11.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.171 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 57' ' ' PRO . 36.6 t -94.77 116.49 36.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 121.073 0.463 . . . . 0.0 111.81 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 HG21 ' A' ' 59' ' ' ILE . 6.6 mm -89.73 153.32 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.838 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.772 ' HB3' HG23 ' A' ' 60' ' ' ILE . 3.9 m0 -139.87 110.15 6.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.935 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.94 HD13 ' HB3' ' A' ' 15' ' ' LYS . 1.5 pp -156.92 145.56 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 41' ' ' ASP . 5.3 m-80 -124.04 117.29 24.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 132.99 31.95 0.42 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.699 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER 73.15 -57.83 0.62 Allowed 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.445 0.298 . . . . 0.0 110.252 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.94 ' HB3' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 30.04 105.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.941 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 29.61 88.69 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.928 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -81.56 -59.24 2.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.907 -1.146 . . . . 0.0 112.189 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -76.22 -27.08 56.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.807 0.337 . . . . 0.0 111.667 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -72.68 -56.44 6.0 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.801 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -64.56 -23.96 67.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.892 0.377 . . . . 0.0 111.533 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.31 -43.18 67.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.72 -57.65 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.351 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.657 HG12 ' HD2' ' A' ' 283' ' ' TYR . 21.9 t -51.58 -43.04 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.673 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.12 -52.61 35.38 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.763 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.07 -26.18 67.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -59.37 -31.01 68.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -60.8 2.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -52.44 -37.71 57.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.68 -24.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.352 -1.294 . . . . 0.0 113.538 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 31' ' ' THR . 0.2 OUTLIER -93.98 -56.69 2.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 118.165 -1.414 . . . . 0.0 110.628 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER 169.22 43.36 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.14 -129.25 6.14 Favored Glycine 0 N--CA 1.41 -3.058 0 CA-C-N 112.407 -2.179 . . . . 0.0 112.401 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 HG13 ' CD1' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -138.71 152.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 112.963 -1.619 . . . . 0.0 112.901 -177.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -94.32 139.2 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 7' ' ' LEU . 15.8 m -103.44 137.88 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.002 0.429 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -109.09 111.11 22.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 37' ' ' VAL . 10.5 p -73.6 116.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -138.1 158.24 44.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.911 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 11' ' ' ILE . 11.3 p80 -130.61 117.01 17.4 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.672 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.978 ' HA ' HD12 ' A' ' 43' ' ' LEU . 41.7 Cg_endo -67.81 -73.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.209 1.939 . . . . 0.0 113.252 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 21.2 t0 67.06 -74.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -96.37 -0.04 49.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.516 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -73.17 -6.56 46.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.628 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.55 -39.55 91.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.816 0.341 . . . . 0.0 111.113 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.76 -35.79 57.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.663 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -73.28 -24.31 60.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.348 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 13.4 t80 -47.97 -57.48 10.15 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.9 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 25.7 Cg_endo -60.75 -15.39 37.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.611 2.207 . . . . 0.0 113.399 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -90.42 -55.09 3.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.098 0.475 . . . . 0.0 110.269 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 46' ' ' LYS . 27.0 m -75.39 -15.48 15.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.324 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -61.01 -44.99 96.6 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.99 -19.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.881 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -69.55 -60.77 2.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.7 32.06 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.742 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.61 94.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.952 0.406 . . . . 0.0 111.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.29 -89.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.891 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.659 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_endo -65.56 178.1 2.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.602 2.201 . . . . 0.0 111.405 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.633 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.0 p30 -155.74 37.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.872 -0.731 . . . . 0.0 112.875 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 58' ' ' ASP . 15.4 mm -146.92 106.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.772 HG23 ' HB3' ' A' ' 10' ' ' TRP . 2.7 mt -145.7 142.84 21.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.538 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' HG22 ' A' ' 11' ' ' ILE . 2.6 m-85 -120.89 123.38 42.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.764 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.694 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -150.95 169.43 21.78 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.694 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.14 165.31 0.34 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 110.902 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.788 ' HB2' HG23 ' A' ' 261' ' ' VAL . 7.9 t-80 -78.07 -27.72 48.65 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.59 -10.77 59.85 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -119.24 -7.59 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.672 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 0.2 OUTLIER -118.47 -40.85 2.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.521 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.8 -5.91 70.63 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.642 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.2 -31.71 5.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.661 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.75 -39.31 12.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.023 0.439 . . . . 0.0 111.231 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -59.91 -45.34 92.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.683 0.754 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.895 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.6 pp0? -46.97 -15.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.79 -31.12 61.65 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.982 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.81 -35.78 0.11 Allowed Glycine 0 CA--C 1.518 0.258 0 C-N-CA 118.864 -1.636 . . . . 0.0 115.157 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 75' ' ' LEU . 3.0 tp -80.81 35.22 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.059 0.929 . . . . 0.0 112.615 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.885 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -137.41 108.5 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.102 0.477 . . . . 0.0 110.898 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.997 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.83 125.05 28.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.339 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 1.9 mp0 -79.55 154.05 29.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.545 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.594 HG12 ' OH ' ' A' ' 106' ' ' TYR . 1.2 pt -130.78 165.49 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.787 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.3 p -109.83 126.98 27.92 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.017 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.78 178.36 6.11 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.62 2.214 . . . . 0.0 112.092 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -155.06 -70.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HE2' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -66.37 -46.15 77.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.273 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' N ' ' HG2' ' A' ' 83' ' ' LYS . . . -52.11 -22.36 4.12 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.329 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.95 -60.75 2.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.445 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -78.68 -29.77 45.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.841 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 21.6 t70 -51.93 -10.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 0.0 OUTLIER 75.07 71.31 0.09 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.357 0.598 . . . . 0.0 110.157 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CB ' ' HE1' ' A' ' 94' ' ' TRP . 0.3 OUTLIER -80.97 163.35 23.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.244 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.622 ' O ' HG22 ' A' ' 93' ' ' THR . 1.2 t80 -77.29 125.07 86.92 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.6 -27.08 39.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.589 2.192 . . . . 0.0 112.814 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -64.24 -35.59 81.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.143 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.783 ' O ' HG22 ' A' ' 97' ' ' VAL . 9.1 t -80.77 -39.48 26.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 89' ' ' LEU . 53.8 m95 -66.17 -30.44 70.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.79 -26.85 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.183 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -78.49 -40.09 36.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 111.025 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.82 HG11 ' HD3' ' A' ' 107' ' ' PRO . 4.5 m -87.16 41.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.673 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.64 110.38 21.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.761 ' CG ' HD11 ' A' ' 104' ' ' ILE . 79.8 m-85 -125.36 91.09 3.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 t30 69.28 -47.18 0.58 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.66 33.38 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.248 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.37 137.71 35.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.867 0.365 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -80.05 86.2 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 72' ' ' GLN . 1.9 pp -114.94 38.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.4 153.65 9.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 264' ' ' ALA . 37.6 m-85 -140.95 100.97 6.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HD3' HG11 ' A' ' 97' ' ' VAL . 66.9 Cg_endo -87.89 128.7 2.41 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.09 2.527 . . . . 0.0 112.206 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 108' ' ' ILE . 2.8 pp -147.56 39.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.92 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.825 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -166.11 162.72 17.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 9.0 m -133.33 107.62 11.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.677 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.899 ' HA ' ' HG2' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -111.7 129.24 56.17 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.383 0.611 . . . . 0.0 111.579 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.574 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -167.14 178.69 5.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.475 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.494 HD22 HG21 ' A' ' 226' ' ' ILE . 4.6 pp -108.87 160.06 16.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.62 ' HB3' HG13 ' A' ' 244' ' ' VAL . 15.6 m -118.38 162.51 18.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.286 -1.325 . . . . 0.0 107.835 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.774 HD12 HD13 ' A' ' 247' ' ' LEU . 8.2 tt -102.5 113.63 27.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 225' ' ' THR . 1.2 tp -72.83 135.71 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 122' ' ' LEU . 29.2 t80 -141.59 145.09 34.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.806 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 122' ' ' LEU . 4.1 t-20 -121.67 146.86 46.59 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.05 -40.29 7.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.52 -7.56 44.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.86 39.46 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.621 ' CG ' ' HB2' ' A' ' 223' ' ' ALA . 0.3 OUTLIER -158.0 72.01 4.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -101.15 122.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.242 2.628 . . . . 0.0 111.902 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.558 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 26.4 p30 -178.19 169.5 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.532 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.596 ' HG2' ' OE2' ' A' ' 131' ' ' GLU . 89.9 Cg_endo -90.63 103.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.971 2.447 . . . . 0.0 111.025 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' ASN . 64.8 Cg_endo -87.44 39.79 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.383 2.055 . . . . 0.0 112.82 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -74.66 -65.27 0.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.629 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.92 17.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.594 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.551 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.7 OUTLIER -67.74 -29.51 68.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.661 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 2.7 tp10 -60.28 -21.68 62.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.991 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' OE2' ' HG2' ' A' ' 125' ' ' PRO . 4.4 mm-40 -65.03 -51.59 60.71 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.028 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.8 pt -52.67 -40.68 78.75 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 1.028 ' HD3' HG13 ' A' ' 132' ' ' ILE . 80.7 Cg_exo -47.88 -52.4 8.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.191 1.928 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.59 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.749 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 3.6 mm? -63.31 -29.35 70.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.756 0.312 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -73.5 -29.98 62.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.06 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -70.69 -31.15 67.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.453 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.41 -43.11 24.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.717 0.294 . . . . 0.0 111.092 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.621 HD23 ' HB3' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -68.93 -36.92 78.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.875 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -65.88 -37.44 86.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.06 -13.01 44.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.763 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -107.98 -59.8 1.8 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.298 0.571 . . . . 0.0 110.159 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.87 40.07 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.082 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.723 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -158.8 -174.77 4.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.727 0.299 . . . . 0.0 110.62 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.723 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 4.8 m -135.23 173.49 11.67 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -119.11 -10.8 9.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.689 0.28 . . . . 0.0 110.984 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.072 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 2.6 tt -149.19 151.25 33.98 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.512 ' CB ' ' HB3' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -173.29 122.77 0.38 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.92 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' A' ' 217' ' ' PHE . 4.7 t80 -162.45 176.48 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.772 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -54.07 169.45 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.547 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 199' ' ' ILE . 0.1 OUTLIER -140.54 -34.79 0.51 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.661 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -107.79 36.26 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.488 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 13.5 mp0 -142.33 173.33 4.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.481 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 69.7 Cg_endo -83.8 -155.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.145 1.897 . . . . 0.0 111.812 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.604 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 0.2 OUTLIER 71.76 -17.16 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.348 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 5.8 t80 -121.83 -58.79 1.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.911 0.386 . . . . 0.0 111.476 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.2 t -54.45 -49.35 70.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.43 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -62.58 -55.66 37.0 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.844 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 35.7 Cg_endo -64.77 -11.33 28.67 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.091 1.861 . . . . 0.0 113.146 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.021 ' HB3' HD21 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -91.24 -41.67 10.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.178 179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.633 HG22 ' C ' ' A' ' 191' ' ' GLY . 1.8 pt -75.76 -0.46 2.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.714 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -90.54 -41.3 11.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.98 0.419 . . . . 0.0 110.88 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -52.73 -21.52 4.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.142 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -74.02 -56.88 4.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.488 ' C ' ' HA3' ' A' ' 187' ' ' GLY . . . 159.8 32.34 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.683 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.7 112.25 3.83 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.389 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.49 158.33 15.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.872 0.367 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.63 -66.84 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.754 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -149.14 -175.84 5.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.282 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.636 ' HB2' ' CG ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -108.33 119.69 40.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 18.0 t80 -124.17 117.53 24.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.754 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.07 132.6 49.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 34.8 t30 67.84 -70.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.568 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 178.06 38.19 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.698 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -165.53 165.35 19.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -99.1 165.38 11.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.955 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -71.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -155.18 56.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.035 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.67 57.74 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.025 0.44 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.636 ' CG ' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -62.5 138.26 58.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.077 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.22 130.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.24 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -126.56 39.97 1.89 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.019 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -80.2 -36.21 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.309 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 365' ' ' GLN . 0.1 OUTLIER -79.64 41.56 0.49 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.972 0.415 . . . . 0.0 111.106 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.29 163.27 13.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.98 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.843 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ASP . . . -67.36 -54.8 18.14 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.726 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.01 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.557 -0.378 . . . . 0.0 111.19 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -50.13 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 194' ' ' PHE . . . -61.08 -26.04 67.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 195' ' ' LEU . . . -69.88 -54.2 12.78 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.216 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -63.56 -29.56 70.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.676 0.275 . . . . 0.0 111.552 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.8 m -77.65 -39.04 46.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.733 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 0.1 OUTLIER -86.39 -30.76 21.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.267 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.021 HD21 ' HB3' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -63.2 -55.57 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.398 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 192' ' ' LEU . 12.1 p -60.25 -38.19 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.347 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 0.5 OUTLIER -59.42 -34.51 72.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.281 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -65.98 -35.05 79.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.091 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.622 HG23 ' CD2' ' A' ' 151' ' ' LEU . 37.1 mt -70.64 -49.49 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 204' ' ' MET . 26.5 tttp -65.18 -21.61 66.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.465 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.6 OUTLIER -97.96 -2.88 39.5 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -109.42 -66.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.386 . . . . 0.0 111.345 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.87 -17.42 11.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.375 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 200' ' ' LYS . 0.6 OUTLIER 69.17 -67.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 110.605 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.04 117.0 29.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 0.0 110.194 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.91 77.28 2.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.844 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.3 -8.33 20.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.256 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.611 ' CG2' ' HB2' ' A' ' 151' ' ' LEU . 4.6 t -61.69 143.49 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 212' ' ' ILE . 0.6 OUTLIER -114.0 -170.26 1.68 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.272 0.558 . . . . 0.0 110.793 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.773 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 9.0 p90 -78.83 -41.36 30.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.067 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 32.5 t -76.25 -24.11 54.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.498 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 209' ' ' ASP . 43.3 mt -77.94 -50.66 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.555 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.31 -29.72 66.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.385 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.773 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.8 tt0 -57.74 -22.71 48.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.84 -56.07 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 148' ' ' MET . . . -77.96 -28.5 49.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.903 ' CD2' HG23 ' A' ' 225' ' ' THR . 17.7 t80 -67.07 -57.11 7.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.049 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -56.58 -41.49 77.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.4 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.426 ' HD2' ' OE1' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.3 -8.8 52.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.543 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 39.57 36.09 0.64 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.913 -0.585 . . . . 0.0 114.299 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 219' ' ' LYS . 2.5 tt0 -92.14 36.54 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.829 0.814 . . . . 0.0 110.332 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 145' ' ' SER . 80.7 p -159.72 150.81 19.52 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.621 ' HB2' ' CG ' ' A' ' 122' ' ' LEU . . . -71.89 38.64 0.07 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -170.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 1.072 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -159.86 97.72 1.31 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 116.893 -1.923 . . . . 0.0 115.228 176.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.903 HG23 ' CD2' ' A' ' 217' ' ' PHE . 80.4 m -149.42 134.66 18.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.84 -1.982 . . . . 0.0 108.761 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 113' ' ' LEU . 4.5 mt -126.2 114.06 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.69 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 217' ' ' PHE . 1.3 p-10 -133.73 160.71 36.77 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.66 23.72 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.31 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.899 ' HG2' ' HA ' ' A' ' 111' ' ' GLU . 16.4 Cg_exo -67.01 159.3 52.64 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.076 2.517 . . . . 0.0 111.874 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.45 6.05 1.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.403 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.98 11.54 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.152 0.501 . . . . 0.0 110.805 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -97.79 103.23 15.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.49 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.1 m -76.55 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -62.89 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 235' ' ' ILE . 15.9 tt -73.43 116.26 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.069 0.462 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.54 103.57 7.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.0 m -66.66 136.45 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 77.5 p -134.88 113.93 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.9 170.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.326 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 240' ' ' VAL . 13.4 m -84.69 92.84 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.291 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -170.18 40.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.257 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -127.94 149.07 50.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.51 131.38 10.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 114' ' ' SER . 12.4 t -114.6 117.64 56.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.3 p -135.53 164.14 28.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.128 0.489 . . . . 0.0 111.339 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.65 HG23 ' OD1' ' A' ' 323' ' ' ASN . 10.8 p -94.95 152.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.774 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mm? -56.58 143.16 68.69 Favored Pre-proline 0 N--CA 1.454 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 111.747 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.551 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.8 Cg_exo -78.19 -163.4 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.248 2.632 . . . . 0.0 112.014 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -108.78 177.2 4.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.498 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.61 122.36 3.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.53 3.24 2.3 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.295 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.6 31.37 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.153 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.483 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 6.8 tt0 -145.17 134.52 11.34 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.884 0.342 . . . . 0.0 110.913 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.527 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 72.0 Cg_endo -74.48 177.17 8.73 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.263 1.976 . . . . 0.0 111.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 1.3 p -92.53 162.57 14.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.18 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 328' ' ' GLU . 3.1 tttt -121.71 95.88 47.64 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -97.84 -141.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.634 2.89 . . . . 0.0 109.948 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 32.7 p90 -152.5 167.26 29.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.944 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 t -95.48 155.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.892 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.676 ' HA3' ' HG3' ' A' ' 111' ' ' GLU . . . -128.33 130.52 6.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.198 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' HIS . 12.4 m -129.29 144.15 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -81.2 123.42 28.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.606 ' HB2' ' HD2' ' A' ' 64' ' ' HIS . 30.3 t -95.96 123.16 39.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 106' ' ' TYR . . . -74.0 155.05 38.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.672 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -111.24 123.87 6.67 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.466 -0.874 . . . . 0.0 114.347 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.5 93.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -62.17 167.85 3.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.09 0.472 . . . . 0.0 112.118 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.997 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -81.27 -0.1 39.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.151 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -107.35 18.58 21.41 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.08 103.06 0.81 Allowed Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 14.7 Cg_endo -59.3 -40.53 67.43 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.985 1.79 . . . . 0.0 112.183 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.87 ' HB3' ' HB2' ' A' ' 275' ' ' LEU . 21.5 m120 -87.46 48.29 1.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.574 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -41.79 31.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.3 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -27.97 65.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.916 0.389 . . . . 0.0 110.866 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 272' ' ' ASN . 1.2 mm? -76.7 -42.72 40.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.305 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' HD12 ' A' ' 280' ' ' LEU . . . -58.28 -42.89 87.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 281' ' ' GLU . 3.4 tmtp? -61.73 -59.62 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 2.6 mt-10 -61.95 -31.9 72.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.414 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.73 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -62.92 -43.4 98.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.72 0.295 . . . . 0.0 111.599 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.998 HD23 HD22 ' A' ' 284' ' ' LEU . 1.5 mt -81.25 -36.9 29.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.625 ' OE1' ' HE2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -82.07 -42.41 19.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 10.0 m-20 -83.33 -18.01 40.43 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.304 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 6.7 m-85 -122.46 -56.92 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.998 HD22 HD23 ' A' ' 280' ' ' LEU . 0.2 OUTLIER -74.29 30.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.439 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 304' ' ' LEU . 0.7 OUTLIER -171.93 38.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.055 0.455 . . . . 0.0 111.327 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 290' ' ' LEU . 6.8 m -138.47 154.49 48.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.648 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.1 m-20 -63.95 -11.25 26.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.687 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -56.58 8.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.801 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -113.48 -36.52 1.43 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.347 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.906 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -59.69 -36.55 76.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.912 0.386 . . . . 0.0 110.691 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 62.0 tt0 -77.13 -26.18 52.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.933 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -77.79 -25.48 49.04 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.657 0.783 . . . . 0.0 110.728 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 290' ' ' LEU . 7.3 p -73.78 -25.95 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.749 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 1.3 p-10 -105.12 -6.15 20.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.933 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 1.8 mmtp -88.26 -50.07 6.58 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -51.48 -46.04 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 15.8 mttt -169.57 149.73 3.77 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.082 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.99 115.66 1.2 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.131 2.554 . . . . 0.0 112.086 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 -71.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.914 0.387 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -123.87 160.89 18.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.743 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.844 ' N ' HG21 ' A' ' 317' ' ' ILE . . . -79.54 155.23 28.29 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.412 0.625 . . . . 0.0 111.185 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.853 ' HB ' HD23 ' A' ' 304' ' ' LEU . 19.3 m -109.77 149.0 13.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.22 41.98 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.852 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.853 HD23 ' HB ' ' A' ' 302' ' ' VAL . 3.8 mm? -100.88 111.79 24.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.848 0.356 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -29.65 61.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.983 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 49.4 m -80.15 -44.68 19.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.684 0.278 . . . . 0.0 111.729 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -80.98 -38.93 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.72 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.771 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.2 mt-10 -56.36 -34.86 67.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.202 0.525 . . . . 0.0 111.079 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.045 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.5 tt0 -88.93 -30.07 19.1 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.771 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.4 OUTLIER -46.71 -6.31 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.598 1.559 . . . . 0.0 113.175 177.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.21 -21.15 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.97 49.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 111.865 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.717 ' CG ' HG13 ' A' ' 317' ' ' ILE . 0.6 OUTLIER -115.77 -179.3 0.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.621 ' HG2' ' CD ' ' A' ' 316' ' ' ARG . 83.5 Cg_endo -92.29 -83.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.567 2.178 . . . . 0.0 115.584 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.753 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.0 OUTLIER -80.72 -55.66 4.68 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 301' ' ' ALA . 8.0 pt -51.17 -25.18 3.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.605 ' HB2' ' OD2' ' A' ' 314' ' ' ASP . . . -68.83 -48.52 63.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.875 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.31 85.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.512 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 38.0 p -63.61 -28.58 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.804 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 mtp -68.45 -34.16 75.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.52 71.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.65 ' OD1' HG23 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -75.6 -37.45 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.499 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.39 97.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.333 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.55 -14.18 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.368 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.32 40.37 3.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.71 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -127.37 -172.0 13.16 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.289 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 256' ' ' LYS . 5.4 tt0 -102.02 141.64 34.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 0.0 110.769 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.681 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.2 tp -83.23 133.36 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.153 0.501 . . . . 0.0 111.136 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.713 ' CE ' HG22 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -51.1 113.28 3.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.349 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 332' ' ' ASN . 97.4 Cg_endo -82.4 -48.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.369 2.046 . . . . 0.0 112.428 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 331' ' ' PRO . 14.4 m120 66.71 102.15 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.708 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 334' ' ' PRO . 11.9 tt -140.82 130.6 13.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.544 ' HD2' HG13 ' A' ' 333' ' ' ILE . 10.0 Cg_endo -52.62 -36.46 71.74 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.709 2.273 . . . . 0.0 112.359 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -62.25 -21.73 65.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 333' ' ' ILE . 0.0 OUTLIER -52.32 -24.99 8.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.386 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.9 p -71.45 -24.89 62.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.352 . . . . 0.0 111.375 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.28 -27.16 60.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.553 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -25.33 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 68.3 m95 -61.62 -26.9 68.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.344 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -21.61 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.37 -55.7 4.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.018 0.437 . . . . 0.0 111.722 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.583 ' O ' HG22 ' A' ' 347' ' ' VAL . 21.0 m -62.52 -34.26 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.36 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 348' ' ' ILE . 0.1 OUTLIER -56.04 -61.5 2.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.446 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 58.4 p -62.37 -27.28 68.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.405 . . . . 0.0 111.52 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -64.96 -60.65 2.82 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 343' ' ' VAL . 2.7 m -77.31 -42.35 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 344' ' ' ARG . 4.7 mm -78.66 -59.52 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 345' ' ' THR . 0.3 OUTLIER -57.88 -53.78 54.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -178.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 1.064 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -56.85 -34.45 67.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.87 -8.77 59.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.5 OUTLIER -67.26 -51.11 57.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.833 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 139.87 16.25 0.51 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.394 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 39.25 0.17 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.38 0.59 . . . . 0.0 111.391 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 1.064 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 5.4 tp-100 -143.56 112.02 6.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 359' ' ' GLU . 9.2 p -94.38 147.36 23.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.016 0.436 . . . . 0.0 111.169 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.69 -27.36 40.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.419 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 362' ' ' LYS . 0.4 OUTLIER -61.76 -57.21 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.498 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 8.5 pt-20 -78.22 -24.28 47.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -78.26 -53.64 7.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.25 -57.0 3.45 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 3.5 tttp -55.61 -51.76 66.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.644 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -66.59 -26.07 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -76.68 -41.41 45.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 111.65 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.787 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -65.98 -33.42 75.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.637 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.8 m -67.65 -36.47 80.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.723 0.297 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -50.35 37.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.217 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 369' ' ' THR . 3.6 pt -56.86 -45.59 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.942 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 365' ' ' GLN . 8.8 t -69.78 -39.5 76.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.326 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.718 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -119.23 -178.76 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.074 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -110.41 166.36 11.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -126.15 122.06 34.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.201 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 37.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.585 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 5.0 pttt -129.09 165.31 21.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.77 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 80.5 mt -147.93 127.06 12.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.33 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.954 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 18.0 t -109.94 123.1 65.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.244 0.545 . . . . 0.0 111.689 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 37' ' ' VAL . 32.6 mt -91.11 156.44 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.814 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.669 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.18 111.6 6.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.115 177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 ' HB2' ' A' ' 61' ' ' PHE . 26.1 pt -159.1 137.14 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.859 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 3.5 t30 -127.91 131.92 49.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.181 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . 151.76 -12.05 0.73 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.746 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 66.2 m-20 73.86 44.05 0.29 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.705 0.288 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -95.65 153.86 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.396 0.617 . . . . 0.0 111.826 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 28.83 80.83 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.14 -57.78 3.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.457 -0.372 . . . . 0.0 111.381 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -26.44 59.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.28 -49.12 34.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.896 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -71.91 -45.04 62.61 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.932 0.396 . . . . 0.0 111.098 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.93 77.17 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -73.42 -57.64 3.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 111.081 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 20' ' ' LEU . 14.0 p -45.12 -32.85 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.97 91.34 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.207 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -76.58 -31.65 57.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.636 ' NZ ' ' HG2' ' A' ' 288' ' ' GLU . 3.7 mtpm? -54.15 -41.1 68.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.777 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.3 m-85 -72.78 -60.66 2.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.677 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.655 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -50.97 -28.7 10.42 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.497 0.665 . . . . 0.0 110.122 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -59.97 -32.57 70.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.972 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -59.74 -57.56 12.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 11.0 t 157.44 35.62 0.0 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.679 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.51 47.65 0.01 OUTLIER Glycine 0 C--N 1.338 0.666 0 C-N-CA 118.203 -1.951 . . . . 0.0 115.588 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.777 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.7 mt -141.64 96.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.104 0.952 . . . . 0.0 111.289 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 48.3 mttt -100.27 129.97 46.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.256 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.53 148.34 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.825 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.98 119.78 18.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.609 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 HD12 ' A' ' 9' ' ' ILE . 14.5 t -82.19 134.44 27.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.467 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -122.4 158.56 29.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 111.006 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -122.86 113.09 30.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 12' ' ' ASN . 41.9 Cg_endo -67.83 155.13 71.07 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.375 2.05 . . . . 0.0 112.541 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.702 ' H ' HD12 ' A' ' 43' ' ' LEU . 13.0 p30 -175.04 -56.43 0.01 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.953 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.51 -8.52 9.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.208 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD12 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -59.87 -10.07 3.59 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.411 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -38.55 72.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.594 0.235 . . . . 0.0 111.304 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -99.06 -16.68 18.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.971 179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HG12 ' A' ' 50' ' ' VAL . 5.8 tttt -79.48 -24.77 42.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.138 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.7 t80 -51.85 -52.87 57.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 15.6 Cg_endo -54.68 -27.91 53.92 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.341 2.027 . . . . 0.0 112.639 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 -46.99 7.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.6 p -71.66 -19.3 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.61 31.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.569 0.223 . . . . 0.0 111.478 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.86 -15.05 0.25 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -78.26 -71.7 0.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.73 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.01 28.75 1.32 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.62 71.56 0.63 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.897 0.379 . . . . 0.0 111.005 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.52 173.86 20.96 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.738 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.954 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 76.9 Cg_exo -48.73 162.4 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.633 2.222 . . . . 0.0 112.256 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 266' ' ' ILE . 2.5 p30 -145.03 37.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.645 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 7' ' ' LEU . 41.7 mt -149.38 118.12 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.621 0.248 . . . . 0.0 110.815 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 62' ' ' TRP . 17.7 tt -157.12 143.52 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB2' HG22 ' A' ' 11' ' ' ILE . 14.3 m-85 -120.92 137.4 54.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.967 ' HE1' HD11 ' A' ' 60' ' ' ILE . 94.6 m95 -159.51 173.01 16.82 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.77 163.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.551 0.215 . . . . 0.0 110.763 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.833 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.9 OUTLIER -65.01 -34.93 79.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' CG ' ' A' ' 332' ' ' ASN . 13.2 p-10 -79.01 -58.45 3.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 2.3 mtm-85 -70.89 -3.94 21.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.861 ' HD2' ' HB2' ' A' ' 62' ' ' TRP . 20.2 t80 -99.94 -47.66 4.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.066 0.46 . . . . 0.0 109.763 177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.743 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -81.36 -14.76 78.02 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.851 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.98 -44.83 1.84 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.616 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -69.98 -52.26 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.05 0.453 . . . . 0.0 109.964 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -64.2 -24.47 67.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.609 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.743 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 2.2 tp60 -61.79 -25.78 67.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.216 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.49 -30.8 11.21 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.284 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.67 -84.87 0.04 OUTLIER Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -176.25 60.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.375 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HB1' ' A' ' 71' ' ' ALA . 3.1 tp -101.18 144.28 30.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.015 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.01 137.02 38.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.602 ' HG3' ' CG2' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -62.85 149.14 45.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -102.33 154.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.986 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 5.0 t -136.27 122.71 13.95 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.694 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 2.7 Cg_endo -79.92 -167.7 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.664 2.243 . . . . 0.0 112.464 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.46 -39.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.568 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -111.99 -37.77 4.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.17 0.51 . . . . 0.0 110.032 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' HD23 ' A' ' 89' ' ' LEU . . . -54.6 -22.05 12.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.591 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -57.72 4.25 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -70.47 -33.2 71.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.771 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 28.4 t70 -52.2 -9.9 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 3.1 mptt 79.68 71.06 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.116 0.484 . . . . 0.0 110.94 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 84' ' ' ALA . 0.4 OUTLIER -86.12 146.35 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.382 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.724 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -66.02 138.01 96.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.648 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.86 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 26.7 Cg_exo -61.39 -44.16 24.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.086 1.857 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -59.33 -14.46 11.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.722 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 90' ' ' TYR . 6.0 p -85.06 -49.72 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.86 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 15.6 p-90 -91.02 -24.53 20.04 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.685 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -69.23 -32.29 71.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.736 0.303 . . . . 0.0 110.957 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.39 -38.64 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.8 m -80.02 44.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.467 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.73 105.52 11.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.862 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -122.27 111.51 17.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.87 32.34 19.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.469 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.32 27.85 63.0 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.202 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 127.16 32.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.024 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.72 101.73 14.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.944 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.759 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -135.8 58.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.067 0.46 . . . . 0.0 111.374 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.775 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 177.67 156.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 263' ' ' SER . 2.3 t80 -156.34 114.24 2.09 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.096 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 74.4 Cg_endo -78.63 134.1 12.04 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.37 2.047 . . . . 0.0 112.825 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 61' ' ' PHE . 2.3 pp -155.34 38.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 121.334 0.588 . . . . 0.0 111.469 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.908 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -158.43 124.93 4.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.209 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 301' ' ' ALA . 14.0 t -98.13 105.07 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.51 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.718 ' OE2' ' HB1' ' A' ' 109' ' ' ALA . 20.2 mp0 -113.2 127.99 56.34 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.211 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.783 ' O ' ' HD3' ' A' ' 229' ' ' PRO . . . -170.09 179.47 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -126.07 167.86 14.78 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 m -118.31 168.31 10.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.781 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.3 tt -102.01 113.75 27.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.771 HG13 ' HB ' ' A' ' 225' ' ' THR . 38.5 mm -72.13 137.39 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HD1' ' CD1' ' A' ' 122' ' ' LEU . 5.9 m-85 -143.68 150.01 38.06 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.942 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -122.25 152.08 40.4 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.03 68.83 0.71 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.071 0.463 . . . . 0.0 111.408 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 121' ' ' LEU . 7.0 t0 -144.95 -37.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -156.14 40.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.261 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.499 ' CD1' ' HD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -103.16 106.16 49.7 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.346 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.6 Cg_endo -71.47 161.53 45.2 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.936 2.424 . . . . 0.0 111.657 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -65.56 103.41 0.44 Allowed Pre-proline 0 CA--C 1.534 0.331 0 O-C-N 123.048 0.218 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 86.2 Cg_endo -86.36 162.7 9.75 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.725 ' HG3' ' HG2' ' A' ' 131' ' ' GLU . 86.8 Cg_endo -81.8 -164.81 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.566 2.178 . . . . 0.0 112.095 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -108.7 15.64 23.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 131' ' ' GLU . 3.1 m -106.83 139.56 41.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.626 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -73.1 -36.45 66.78 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.55 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.692 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -67.88 -22.61 65.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.812 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.725 ' HG2' ' HG3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -66.43 -38.35 87.21 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.495 0.188 . . . . 0.0 111.42 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.829 ' HA ' HD12 ' A' ' 135' ' ' LEU . 16.7 mt -53.6 -49.63 87.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' O ' ' A' ' 130' ' ' GLU . 77.3 Cg_exo -47.97 -28.88 10.93 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.833 2.356 . . . . 0.0 112.755 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.696 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -74.48 -27.05 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.404 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 132' ' ' ILE . 2.0 mt -69.09 -23.14 63.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.59 -28.94 66.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.622 0.248 . . . . 0.0 111.117 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 17.6 pttp -70.6 -37.26 73.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' CD ' HD23 ' A' ' 135' ' ' LEU . 5.9 pt-20 -78.22 -29.78 48.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.73 ' HG ' ' N ' ' A' ' 146' ' ' ALA . 4.1 mm? -69.69 -53.92 16.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.652 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -28.03 67.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -59.37 -14.68 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.609 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -116.1 -58.95 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' LYS . . . 159.29 39.64 0.02 OUTLIER Glycine 0 CA--C 1.517 0.158 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.48 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.635 ' O ' ' HB3' ' A' ' 139' ' ' LEU . 35.5 mttt -157.82 -175.48 5.39 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -143.84 146.78 33.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.988 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.73 ' N ' ' HG ' ' A' ' 139' ' ' LEU . . . -91.74 -8.32 47.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.792 ' O ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp -155.46 143.77 20.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.69 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.21 125.88 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.898 0.38 . . . . 0.0 111.429 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD2' HD12 ' A' ' 226' ' ' ILE . 5.6 t80 -160.9 178.09 9.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.396 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 153' ' ' GLU . 7.5 t-20 -43.1 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 199' ' ' ILE . 11.4 tp -130.95 -42.13 1.12 Allowed 'General case' 0 C--O 1.23 0.068 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -105.37 35.64 2.77 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.722 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 150' ' ' ASN . 0.0 OUTLIER -135.49 173.35 5.81 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 155' ' ' TYR . 5.3 Cg_exo -79.19 -161.09 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.83 2.353 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 154' ' ' PRO . 6.2 m-85 69.45 -15.27 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.631 ' O ' HD12 ' A' ' 160' ' ' LEU . 4.4 t80 -123.52 -58.25 1.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.442 0.639 . . . . 0.0 111.981 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.648 ' O ' HG12 ' A' ' 161' ' ' ILE . 9.9 t -52.44 -51.44 59.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.631 ' HA ' ' CG1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -53.69 -55.45 35.32 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.252 0.345 . . . . 0.0 111.279 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.601 ' HG2' ' O ' ' A' ' 156' ' ' PHE . 23.2 Cg_endo -62.9 -10.36 19.95 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.507 2.138 . . . . 0.0 112.439 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.7 OUTLIER -103.1 -28.46 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.292 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.897 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 18.3 pt -82.75 -16.67 11.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.26 -53.51 8.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 53.28 -89.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.247 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.82 -55.47 2.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.789 0.328 . . . . 0.0 111.334 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.74 66.58 0.34 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.136 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.99 98.65 0.91 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -114.63 174.07 6.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.0 111.196 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.51 -38.72 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 331' ' ' PRO . 12.7 p90 -155.38 166.62 32.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.217 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.537 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 0.5 OUTLIER -88.08 123.86 33.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.273 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 169' ' ' PHE . 52.1 p90 -131.35 129.98 42.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -132.71 116.1 16.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.042 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.41 -70.35 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.65 27.33 0.13 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.257 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.77 158.48 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -115.88 152.01 34.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -78.68 -162.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.2 mt -117.13 -51.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.999 0.428 . . . . 0.0 110.862 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.18 31.68 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 170' ' ' LYS . 14.2 t70 -95.19 100.73 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG21 ' NE2' ' A' ' 365' ' ' GLN . 24.9 t -124.45 151.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.08 48.98 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.434 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 27.7 m -95.24 -34.93 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.45 . . . . 0.0 110.883 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.753 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 50.7 m-20 -100.23 34.42 2.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.045 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 60.4 t30 -95.35 168.12 10.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.822 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.31 -27.62 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.314 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -74.89 -49.71 9.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.731 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 161' ' ' ILE . . . -68.79 -28.89 67.17 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 185' ' ' ASN . 6.4 tptt -66.89 -42.44 85.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.031 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.38 91.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.897 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -62.94 -50.63 62.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.967 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 196' ' ' VAL . 4.6 tt -60.72 -33.37 72.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.536 . . . . 0.0 111.121 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 50.3 m -64.83 -32.73 74.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.998 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.64 69.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.15 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -58.83 -45.02 90.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.077 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.722 ' HA ' HD12 ' A' ' 199' ' ' ILE . 21.4 t -63.02 -56.27 18.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.73 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.02 -31.18 50.45 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.588 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.674 ' O ' ' HB2' ' A' ' 202' ' ' LYS . 4.7 mt -71.28 -49.05 46.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.317 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 196' ' ' VAL . 4.6 mt -55.91 -45.6 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.564 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.8 -29.4 67.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.379 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -101.39 10.44 40.52 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -120.12 -57.76 1.92 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.934 0.397 . . . . 0.0 110.689 179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.434 ' HB3' ' H ' ' A' ' 206' ' ' ALA . 0.7 OUTLIER -103.21 -40.11 6.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.075 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.9 ttt 62.59 30.62 17.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -169.95 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 203' ' ' HIS . . . 59.7 72.48 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.733 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.96 22.07 4.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.088 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 213' ' ' ALA . 2.3 t -73.04 131.1 41.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.733 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.556 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.2 t70 -109.58 -162.33 0.8 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 111.293 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.833 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 18.6 m-85 -78.41 -44.59 24.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.582 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 64.0 m -74.68 -23.48 58.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.424 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.556 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 32.5 mm -81.82 -59.05 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.598 ' HB2' ' OG1' ' A' ' 208' ' ' THR . . . -62.98 -29.2 70.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.255 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.959 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 1.1 tt0 -59.5 -33.71 71.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.79 48.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.72 -58.14 3.13 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 1.09 ' HB2' HG23 ' A' ' 225' ' ' THR . 26.8 p90 -76.89 -49.4 15.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.959 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 28.6 t-20 -55.12 -29.68 58.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.037 0.446 . . . . 0.0 110.654 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.56 -11.61 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.352 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 41.75 56.46 3.67 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.488 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.27 33.99 4.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 145' ' ' SER . 50.2 p -158.82 147.26 18.33 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -71.43 38.15 0.06 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.486 -170.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.69 ' HB3' ' H ' ' A' ' 148' ' ' MET . 1.9 ttt -154.48 97.39 2.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 117.69 -1.604 . . . . 0.0 115.315 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 1.09 HG23 ' HB2' ' A' ' 217' ' ' PHE . 5.2 m -145.83 144.95 30.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.394 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.918 HD12 ' CD2' ' A' ' 149' ' ' PHE . 8.3 mt -118.9 115.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.944 0.402 . . . . 0.0 111.105 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 152.96 42.22 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.829 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -91.1 173.87 38.19 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.861 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.783 ' HD3' ' O ' ' A' ' 112' ' ' ALA . 31.6 Cg_endo -89.65 34.91 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.413 2.075 . . . . 0.0 112.86 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -130.81 -39.89 1.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.395 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.28 -71.51 0.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.59 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.21 89.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.091 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.28 162.25 17.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 0.0 110.496 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.82 171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.087 0.47 . . . . 0.0 111.138 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 235' ' ' ILE . 2.7 pp -128.44 159.95 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.003 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.15 -174.53 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 t -137.66 -44.42 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.175 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -51.35 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.882 0.373 . . . . 0.0 110.957 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -154.74 -73.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.167 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 p -176.26 123.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 111.409 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -126.18 51.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.24 125.88 44.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.677 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -105.68 115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.951 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.2 m -99.1 132.51 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.671 0.236 . . . . 0.0 110.626 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -141.34 163.14 33.75 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.676 HG23 HD21 ' A' ' 323' ' ' ASN . 13.8 p -101.25 146.55 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.708 0.289 . . . . 0.0 111.533 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -58.6 138.06 86.1 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.648 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.705 ' O ' ' HB3' ' A' ' 254' ' ' PRO . 65.6 Cg_endo -87.16 -146.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.152 2.568 . . . . 0.0 112.481 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.742 HG22 ' HD3' ' A' ' 254' ' ' PRO . 49.5 p -92.33 163.35 13.92 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.712 0.291 . . . . 0.0 111.166 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.466 ' CE2' HD23 ' A' ' 160' ' ' LEU . 10.2 t80 -136.88 111.92 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.5 10.22 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.255 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.59 -44.68 0.71 Allowed Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.124 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 1.032 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 0.9 OUTLIER -145.05 157.32 54.16 Favored Pre-proline 0 CA--C 1.535 0.388 0 O-C-N 122.923 -0.163 . . . . 0.0 110.882 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 1.032 ' HD2' ' HG2' ' A' ' 253' ' ' GLN . 30.0 Cg_endo -62.95 -177.47 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.584 2.189 . . . . 0.0 112.035 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.3 p -103.88 171.79 7.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.335 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.51 19.25 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.421 ' HB2' ' H ' ' A' ' 258' ' ' PHE . 94.2 Cg_endo -97.32 -137.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 110.174 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.879 ' HB3' ' HB3' ' A' ' 330' ' ' MET . 0.1 OUTLIER -130.52 148.0 52.28 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.495 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.9 154.4 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.269 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -97.9 100.23 2.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.834 -1.175 . . . . 0.0 113.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 64' ' ' HIS . 1.6 m -130.15 113.87 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.908 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -86.19 130.39 34.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.601 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.777 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -96.65 130.81 43.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.233 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.96 144.72 29.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.671 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.642 ' O ' HD13 ' A' ' 266' ' ' ILE . . . -157.67 172.82 35.0 Favored Glycine 0 C--O 1.229 -0.165 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.402 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 265' ' ' GLY . 27.9 mm -131.02 154.07 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.746 0.308 . . . . 0.0 110.957 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.581 HD21 ' HZ ' ' A' ' 47' ' ' PHE . 2.3 m120 -84.61 150.24 25.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.337 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . . . -65.07 -8.1 14.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.865 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.615 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -65.6 -41.03 93.23 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.344 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.1 t -65.38 104.71 0.6 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.159 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 75.3 Cg_endo -83.88 33.91 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.382 2.055 . . . . 0.0 112.762 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -146.33 77.85 1.49 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.87 0.367 . . . . 0.0 110.284 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.3 OUTLIER -61.56 -27.52 68.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.19 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -37.89 89.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.97 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 279' ' ' PHE . 10.9 tp -72.73 -43.13 63.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.607 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -45.26 77.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.832 0.349 . . . . 0.0 111.263 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -59.72 -49.48 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.041 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 0.5 OUTLIER -71.92 -25.91 62.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.562 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 275' ' ' LEU . 58.6 t80 -59.65 -58.35 8.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.805 0.336 . . . . 0.0 111.776 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.619 ' HG ' ' CB ' ' A' ' 284' ' ' LEU . 0.2 OUTLIER -78.16 -23.32 47.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.046 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.698 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -85.85 -13.5 47.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 2.6 t30 -99.61 -43.8 6.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.499 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 5.8 m-85 -107.54 -41.09 5.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.619 ' CB ' ' HG ' ' A' ' 280' ' ' LEU . 0.8 OUTLIER -82.71 29.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 111.34 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.935 HD21 HD11 ' A' ' 304' ' ' LEU . 0.4 OUTLIER -166.77 38.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.528 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 69.8 p -153.12 178.55 9.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 291' ' ' GLU . 2.0 t70 -67.22 -14.87 63.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.334 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.636 ' HG2' ' NZ ' ' A' ' 26' ' ' LYS . 2.3 tt0 -78.51 -44.51 24.23 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -100.87 -42.86 2.37 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.035 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.52 -34.0 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 110.389 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 295' ' ' LYS . 71.1 mm-40 -78.01 -25.0 47.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.731 0.777 . . . . 0.0 111.11 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -78.75 -58.79 3.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.618 0.723 . . . . 0.0 111.282 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.24 -26.88 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 290' ' ' LEU . 16.8 t-20 -110.08 -3.48 16.4 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 122.388 -0.195 . . . . 0.0 110.681 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.893 ' HB3' ' O ' ' A' ' 291' ' ' GLU . 2.9 tttp -119.48 -18.87 8.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.896 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.762 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 21.7 t0 -56.32 -34.99 67.07 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.925 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.1 OUTLIER -163.32 137.02 4.51 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.01 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.855 ' HG2' HH12 ' A' ' 316' ' ' ARG . 60.9 Cg_endo -85.39 125.26 2.93 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.415 2.077 . . . . 0.0 112.425 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.925 HD22 ' HD2' ' A' ' 297' ' ' LYS . 0.7 OUTLIER -155.49 16.06 0.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.63 1.26 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.475 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.755 ' HB2' HG12 ' A' ' 317' ' ' ILE . . . -86.25 -178.73 6.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 304' ' ' LEU . 10.2 p -115.78 163.56 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.579 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.518 ' N ' HG22 ' A' ' 302' ' ' VAL . . . -83.0 49.85 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.935 HD11 HD21 ' A' ' 285' ' ' LEU . 0.1 OUTLIER -107.32 136.34 47.3 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -61.56 -56.75 16.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.57 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -39.64 94.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.437 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -70.38 -40.87 73.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.333 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.908 ' HA ' ' CD2' ' A' ' 311' ' ' LEU . 6.4 tt0 -63.69 -17.3 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.973 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.08 -30.51 34.69 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -89.9 -30.33 17.94 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 109.833 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 1.078 HD22 HG21 ' A' ' 317' ' ' ILE . 1.2 pp -50.67 -1.73 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.514 1.126 . . . . 0.0 113.811 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -62.88 -34.02 76.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -48.2 82.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.74 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 1.5 m-20 -60.41 139.35 92.18 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.776 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.704 ' HD2' ' HD2' ' A' ' 316' ' ' ARG . 3.3 Cg_endo -85.06 -19.98 3.65 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.433 2.755 . . . . 0.0 112.702 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.864 ' H ' ' HD2' ' A' ' 316' ' ' ARG . 0.6 OUTLIER -70.03 -59.52 2.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.595 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 1.078 HG21 HD22 ' A' ' 311' ' ' LEU . 1.9 mt -68.25 -36.86 76.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.061 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.68 -50.83 70.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.463 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.73 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.173 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.487 HG21 ' CG1' ' A' ' 110' ' ' VAL . 29.4 m -63.24 -35.66 81.08 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.009 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -31.24 69.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.66 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.47 -45.65 92.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.608 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.676 HD21 HG23 ' A' ' 246' ' ' VAL . 2.1 m-80 -75.88 -28.47 58.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.41 -45.02 85.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.607 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -26.02 62.73 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.369 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 0.8 OUTLIER -119.25 38.82 3.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.798 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -142.7 -178.19 18.4 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.893 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -127.07 157.97 38.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.999 0.428 . . . . 0.0 110.777 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 329' ' ' ILE . 0.5 OUTLIER -89.4 116.78 31.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.004 178.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.879 ' HB3' ' HB3' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -58.07 135.08 84.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.284 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 Cg_endo -75.59 -165.06 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.322 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.491 ' CG ' ' HA ' ' A' ' 65' ' ' ASP . 2.3 m-20 -133.36 74.11 1.55 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.231 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 335' ' ' GLN . 8.0 tt -132.36 125.91 20.01 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.932 -0.122 . . . . 0.0 111.268 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.68 -2.32 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.557 2.171 . . . . 0.0 113.13 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG12 ' A' ' 333' ' ' ILE . 0.9 OUTLIER -65.36 -21.27 66.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.709 0.29 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.426 ' O ' ' HD1' ' A' ' 339' ' ' PHE . 0.1 OUTLIER -54.87 -29.61 55.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.547 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -65.01 -24.59 67.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.935 0.398 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.5 ' HB1' ' CZ ' ' A' ' 341' ' ' TYR . . . -60.47 -28.8 68.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 158' ' ' TRP . 32.8 m-85 -53.66 -25.2 16.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.945 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.533 ' O ' ' HG2' ' A' ' 344' ' ' ARG . 0.2 OUTLIER -59.57 -56.84 16.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.869 0.366 . . . . 0.0 110.992 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.605 ' HA ' HH11 ' A' ' 344' ' ' ARG . 1.1 p90 -72.89 -16.44 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.556 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -82.2 -57.23 3.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 347' ' ' VAL . 13.8 p -59.43 -39.27 78.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.659 ' HA ' HD12 ' A' ' 348' ' ' ILE . 0.8 OUTLIER -63.13 -32.11 73.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.775 0.321 . . . . 0.0 111.484 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 12.4 m -81.43 -32.42 32.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 361' ' ' LEU . . . -75.12 -61.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 348' ' ' ILE . 29.5 m -80.13 -57.9 4.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 344' ' ' ARG . 22.0 mt -55.48 -53.38 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.751 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.6 m120 -62.0 -45.63 92.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.526 0.203 . . . . 0.0 111.373 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -68.3 -28.18 66.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.162 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.1 59.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 -50.9 47.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.883 0.373 . . . . 0.0 111.176 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 134.21 -4.48 4.53 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.791 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -136.83 38.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.828 0.314 . . . . 0.0 111.017 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.738 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 0.4 OUTLIER -147.01 119.79 8.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.758 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 358' ' ' ASP . 5.5 m -99.97 136.77 39.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.793 ' HB ' HD12 ' A' ' 361' ' ' LEU . 5.3 m -56.24 -26.62 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.526 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 356' ' ' THR . 6.0 t70 -61.62 -58.41 8.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.938 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -81.93 -43.73 17.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.24 0.543 . . . . 0.0 110.663 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -57.41 -48.4 79.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.601 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.793 HD12 ' HB ' ' A' ' 357' ' ' VAL . 59.3 mt -80.2 -42.65 22.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.753 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.6 OUTLIER -66.57 -55.88 13.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.0 111.747 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -61.33 -40.02 92.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.057 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 368' ' ' ILE . . . -56.93 -33.32 66.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.483 ' NE2' HG21 ' A' ' 181' ' ' VAL . 5.0 tm0? -67.53 -37.1 82.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 369' ' ' THR . 18.1 p -77.94 -29.9 50.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -34.97 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 364' ' ' ALA . 34.9 pt -71.58 -41.69 71.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 366' ' ' THR . 9.7 t -58.68 -27.24 64.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.58 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.666 0.27 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 2' ' ' THR . 7.8 t -106.17 76.06 1.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.929 0.395 . . . . 0.0 110.929 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -103.96 125.15 50.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HB3' ' OD1' ' A' ' 272' ' ' ASN . 0.2 OUTLIER -147.29 134.42 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.261 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 -38.88 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.325 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -150.67 157.76 43.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.433 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 36' ' ' THR . 1.4 mp -123.87 160.13 28.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.072 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.912 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 19.2 t -130.68 104.76 10.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.856 ' CG2' ' HA ' ' A' ' 37' ' ' VAL . 3.5 tt -91.45 159.67 2.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.374 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.816 ' O ' HG13 ' A' ' 60' ' ' ILE . 1.2 m0 -139.37 110.98 7.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.388 0.614 . . . . 0.0 110.349 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 13' ' ' GLY . 2.5 pp -157.39 151.03 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.213 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -89.62 40.94 1.02 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.664 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.65 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 115.07 -52.56 0.65 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.889 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' OD2' HD13 ' A' ' 11' ' ' ILE . 2.0 p30 54.43 11.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.688 0.395 . . . . 0.0 111.18 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HB3' ' H ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER 67.31 -131.69 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.428 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 30.24 79.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -61.39 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 111.469 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -28.4 57.87 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -56.11 22.53 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.156 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 23' ' ' VAL . 1.8 tp -73.35 -28.73 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.73 0.3 . . . . 0.0 111.76 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.05 85.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.369 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.39 -56.88 4.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.718 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 20' ' ' LEU . 14.7 p -47.82 -37.65 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.15 96.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.205 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -26.68 60.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.388 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -64.56 -31.59 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.273 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.945 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 1.7 m-85 -77.79 -59.36 2.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.168 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -48.76 -27.55 3.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.066 0.46 . . . . 0.0 110.566 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.89 59.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.228 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' THR . 0.4 OUTLIER -65.07 -57.94 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.53 36.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.641 176.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 156.29 43.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 118.037 -2.03 . . . . 0.0 115.813 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 1.8 mp -141.22 100.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 118.742 1.271 . . . . 0.0 112.288 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -130.34 125.75 35.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.956 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.18 122.9 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.555 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 9' ' ' ILE . 10.2 t -88.84 116.63 27.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.062 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.856 ' HA ' ' CG2' ' A' ' 9' ' ' ILE . 2.8 m -92.57 110.35 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.287 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.41 151.96 32.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.767 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -100.62 123.0 47.51 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.227 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 6.2 Cg_exo -77.83 107.64 2.39 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.664 2.242 . . . . 0.0 112.225 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.77 -46.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.707 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -0.72 11.65 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.13 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -63.73 -16.07 60.17 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.693 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -41.82 57.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.825 0.345 . . . . 0.0 111.604 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.4 -22.64 15.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.8 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.94 -32.4 63.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.471 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -49.17 -57.46 11.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.603 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.6 Cg_endo -57.98 -17.75 32.36 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.977 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.87 -52.57 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.865 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 46' ' ' LYS . 10.5 m -80.87 -22.38 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.32 -36.84 68.98 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.932 0.396 . . . . 0.0 110.863 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 53' ' ' THR . . . -53.33 -14.16 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.219 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 7.5 t 157.18 165.28 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.034 0.534 . . . . 0.0 110.16 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.82 -99.64 1.75 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.756 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.71 -71.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.183 0.516 . . . . 0.0 109.803 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 57' ' ' PRO . . . 70.67 50.53 24.66 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.229 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.912 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 25.6 Cg_exo -63.18 165.94 15.86 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.099 1.866 . . . . 0.0 111.364 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 59' ' ' ILE . 8.4 p-10 -155.89 39.07 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.129 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 58' ' ' ASP . 34.4 mm -138.82 110.06 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.943 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.816 HG13 ' O ' ' A' ' 10' ' ' TRP . 20.1 tt -156.9 139.76 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.378 . . . . 0.0 111.172 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HE2' HG21 ' A' ' 108' ' ' ILE . 23.2 m-85 -109.25 129.67 55.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.099 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.758 ' HD1' ' H ' ' A' ' 63' ' ' ALA . 1.2 t90 -161.12 163.91 31.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.758 ' H ' ' HD1' ' A' ' 62' ' ' TRP . . . -53.37 173.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.401 -0.187 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.944 ' HB2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -80.52 -29.55 37.24 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.66 -7.01 58.29 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.26 -6.29 9.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.049 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.944 ' CE2' ' HA2' ' A' ' 265' ' ' GLY . 38.3 t80 -115.0 -34.08 5.19 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.328 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.36 -9.63 86.85 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.627 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.78 -27.12 2.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -78.88 -48.44 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.807 0.337 . . . . 0.0 111.439 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.95 ' HB3' HD13 ' A' ' 76' ' ' LEU . . . -70.87 -25.09 62.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 33.9 tt0 -54.44 -31.8 56.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 t -91.43 -28.36 17.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.308 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 -84.8 1.4 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.485 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 4.1 mt -139.24 82.41 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.95 HD13 ' HB3' ' A' ' 71' ' ' ALA . 13.6 tp -120.15 110.99 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.996 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -99.71 136.93 38.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.934 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.9 157.16 24.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.411 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' CG2' HD13 ' A' ' 266' ' ' ILE . 1.1 pp -131.9 152.83 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.76 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.3 p -125.37 129.81 24.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.284 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.83 175.5 9.92 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.949 1.766 . . . . 0.0 111.946 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.01 -59.12 1.43 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.04 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 3.7 tttp -111.22 -20.04 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.497 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.28 -21.11 59.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.669 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -53.59 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -34.32 63.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.308 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.8 OUTLIER -49.34 -10.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 mptt 76.19 69.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.317 0.579 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HA ' ' HG ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -71.51 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.537 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.696 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 5.0 t80 -168.75 112.31 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.8 Cg_exo -53.15 -29.37 45.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.551 2.167 . . . . 0.0 112.894 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -79.7 -19.2 49.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.195 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 97' ' ' VAL . 10.8 m -86.98 -41.83 13.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.766 ' CE3' ' HA ' ' A' ' 91' ' ' PRO . 15.5 m0 -55.0 -50.02 70.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.78 -26.15 62.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.51 -22.55 35.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.445 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 93' ' ' THR . 16.8 m -95.56 42.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -126.17 117.13 22.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.839 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -131.82 92.93 3.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 111.813 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.2 m120 59.68 24.45 13.31 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.37 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.42 89.8 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.079 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.95 126.58 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 88.84 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.427 . . . . 0.0 110.526 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.842 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -120.48 39.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.597 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.32 100.27 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.564 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 263' ' ' SER . 28.3 t80 -100.01 117.98 62.39 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.053 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 83.4 Cg_endo -79.02 147.87 21.38 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.254 1.969 . . . . 0.0 112.504 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.65 ' O ' HG21 ' A' ' 302' ' ' VAL . 0.6 OUTLIER -161.92 39.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 179.41 125.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.959 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.677 HG23 ' CG1' ' A' ' 302' ' ' VAL . 33.8 t -106.42 116.67 50.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.509 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.639 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 2.5 pm0 -128.69 130.39 47.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.089 0.471 . . . . 0.0 110.781 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.77 -179.86 4.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.961 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.581 HD23 ' HA3' ' A' ' 228' ' ' GLY . 0.3 OUTLIER -111.85 160.64 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.839 ' HB3' HG23 ' A' ' 244' ' ' VAL . 29.0 m -120.24 172.05 8.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.348 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 247' ' ' LEU . 9.1 tt -104.02 121.8 43.93 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.856 HG21 ' OG1' ' A' ' 225' ' ' THR . 9.8 tp -72.65 127.15 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.917 0.865 . . . . 0.0 112.897 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.576 ' CD2' HD22 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.34 113.47 5.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.512 ' O ' HD12 ' A' ' 122' ' ' LEU . 32.5 p30 -158.86 -156.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER 65.18 109.07 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.556 0.693 . . . . 0.0 111.95 176.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.98 28.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.061 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 119' ' ' LYS . 3.3 pp -139.24 36.38 2.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.676 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.589 ' CD2' HD11 ' A' ' 139' ' ' LEU . 9.1 mt -126.7 143.91 48.09 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.879 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 135' ' ' LEU . 7.9 Cg_exo -71.29 160.74 47.92 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.418 2.078 . . . . 0.0 112.817 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.466 HD22 ' HD2' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -74.35 127.7 87.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.071 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' HD22 ' A' ' 124' ' ' ASN . 56.1 Cg_endo -72.32 136.86 27.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.121 1.881 . . . . 0.0 112.953 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.488 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 73.0 Cg_endo -77.19 -156.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.685 2.257 . . . . 0.0 111.612 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -99.73 7.32 45.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.393 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.6 p -122.28 140.57 52.48 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.311 0.577 . . . . 0.0 111.54 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.835 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.63 -29.92 65.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.912 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.902 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 20.6 mt-10 -52.41 -22.89 5.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.122 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 1.2 tp10 -59.35 -16.01 19.94 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.96 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 56.0 mt -55.21 -62.49 4.26 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.96 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 72.0 Cg_exo -52.04 -24.85 20.75 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.36 2.04 . . . . 0.0 112.72 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.69 -33.59 60.38 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' A' ' 123' ' ' PRO . 1.5 mm? -74.32 -25.82 59.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.831 0.348 . . . . 0.0 110.931 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.75 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 5.3 t70 -67.25 -33.11 74.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.402 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -35.9 57.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -51.88 10.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.467 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.832 HD12 ' HB2' ' A' ' 146' ' ' ALA . 14.1 mt -64.62 -38.12 89.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.313 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 10.0 tttt -68.17 -29.56 68.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.329 . . . . 0.0 110.591 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.78 -8.5 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.013 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.88 -56.2 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.064 0.459 . . . . 0.0 110.577 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . 160.12 39.44 0.02 OUTLIER Glycine 0 C--O 1.228 -0.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 44.3 mttt -165.66 176.69 7.85 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.986 0.422 . . . . 0.0 111.007 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.542 ' O ' HG22 ' A' ' 222' ' ' THR . 0.2 OUTLIER -124.89 161.97 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.287 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.832 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -103.63 -16.95 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 224' ' ' MET . 4.5 pp -147.19 144.71 29.13 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -174.91 120.05 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.221 0.534 . . . . 0.0 111.324 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CD2' ' CD1' ' A' ' 156' ' ' PHE . 9.6 t80 -143.65 178.21 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.656 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER -51.22 -26.25 6.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.617 0.246 . . . . 0.0 111.152 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.842 HD22 HG23 ' A' ' 199' ' ' ILE . 12.8 mt 76.52 -34.22 0.22 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.328 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -116.15 36.79 3.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.127 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 0.1 OUTLIER -119.69 137.72 25.92 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.203 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 3.6 Cg_exo -79.01 59.17 7.27 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.829 2.353 . . . . 0.0 111.96 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 6.7 m-85 -128.47 -15.83 4.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.272 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 157' ' ' THR . 35.7 p90 -125.64 -48.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.854 HG22 HD12 ' A' ' 195' ' ' LEU . 61.0 p -54.64 -52.45 62.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.173 -178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.769 ' HA ' HG12 ' A' ' 161' ' ' ILE . 1.9 t90 -63.7 -55.76 31.36 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 255' ' ' SER . 19.3 Cg_endo -58.11 -10.98 9.09 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.142 1.894 . . . . 0.0 112.95 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.419 HD11 ' NE1' ' A' ' 129' ' ' TRP . 0.3 OUTLIER -105.14 -35.47 7.59 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.695 0.283 . . . . 0.0 110.67 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 158' ' ' TRP . 3.5 pt -69.12 -9.91 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.26 -29.07 34.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 254' ' ' PRO . . . -72.61 14.52 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.646 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.8 -29.38 7.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.318 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 138.84 -3.96 2.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.909 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.45 107.61 3.03 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.502 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -95.89 162.34 13.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.607 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.79 -68.88 0.74 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.775 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -134.37 178.12 7.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.686 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.665 ' HD3' ' HB3' ' A' ' 180' ' ' ASP . 13.3 mtpp -126.42 126.04 43.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.57 ' OH ' ' HG2' ' A' ' 328' ' ' GLU . 26.8 p90 -139.13 132.95 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 174' ' ' GLY . 13.8 mp0 -119.05 117.44 28.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.452 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 71.23 -25.71 0.17 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.299 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 137.4 32.79 0.22 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.628 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 172' ' ' GLU . 12.0 pttt -147.74 140.25 24.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.416 . . . . 0.0 110.693 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -75.06 163.91 27.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.583 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -94.35 -80.68 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.785 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.853 HG13 ' H ' ' A' ' 179' ' ' LYS . 4.4 pt -158.9 -64.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 123.285 0.366 . . . . 0.0 111.173 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.853 ' H ' HG13 ' A' ' 178' ' ' ILE . 0.5 OUTLIER -152.89 26.06 0.55 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.704 0.287 . . . . 0.0 111.007 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.665 ' HB3' ' HD3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -66.07 98.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 110.944 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.82 146.85 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.511 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.643 HG21 ' OE1' ' A' ' 365' ' ' GLN . 6.4 m -109.07 -35.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -93.18 58.16 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.948 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.06 -175.64 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.813 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HA ' ' CE ' ' A' ' 189' ' ' LYS . . . -78.98 -28.72 43.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.31 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.73 -25.83 55.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.37 -34.59 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.552 ' CE ' ' HA ' ' A' ' 186' ' ' ALA . 14.8 pttt -63.25 -40.68 98.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.398 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -67.69 -37.67 82.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -66.74 -30.89 76.94 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.844 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -27.77 42.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.718 0.294 . . . . 0.0 111.401 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.5 m -78.76 -29.24 44.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.925 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -46.91 57.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.854 HD12 HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -59.11 -45.31 91.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.671 0.272 . . . . 0.0 111.466 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -61.64 -32.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.06 -32.01 63.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.978 0.418 . . . . 0.0 111.655 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -53.09 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.879 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.842 HG23 HD22 ' A' ' 151' ' ' LEU . 28.8 mt -61.85 -33.11 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.932 0.396 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 200' ' ' LYS . 2.5 ttpt -72.53 -20.6 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.424 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.7 12.89 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.087 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.05 -71.72 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.248 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -102.67 -26.24 13.26 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.208 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.4 ttt 63.23 21.18 12.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -157.65 -39.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.39 56.57 3.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.144 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.62 24.58 7.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.717 HG23 HG22 ' A' ' 212' ' ' ILE . 24.9 m -91.79 120.18 32.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.602 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.652 ' CG ' HG12 ' A' ' 212' ' ' ILE . 2.6 p30 -104.15 -145.98 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.606 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 4.3 m-85 -78.28 -54.14 6.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.3 m -62.92 -25.26 68.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.717 HG22 HG23 ' A' ' 208' ' ' THR . 33.1 mm -78.39 -58.97 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.71 0.291 . . . . 0.0 110.513 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.99 -28.95 66.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.232 0.539 . . . . 0.0 110.145 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.734 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 0.3 OUTLIER -55.08 -22.31 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.232 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.62 -56.51 9.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.09 -58.01 3.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 1.027 ' HD1' HG22 ' A' ' 225' ' ' THR . 73.5 t80 -44.46 -45.09 8.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.21 0.604 . . . . 0.0 111.932 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.734 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.0 OUTLIER -56.6 -39.25 73.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.645 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 5.45 29.1 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 36.15 38.57 0.25 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 114.092 0.397 . . . . 0.0 114.092 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.529 ' HB3' ' HZ3' ' A' ' 119' ' ' LYS . 79.3 mt-10 -80.4 34.29 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.74 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 145' ' ' SER . 19.2 p -157.43 138.74 13.69 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD13 ' A' ' 122' ' ' LEU . . . -71.39 38.16 0.06 Allowed 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.047 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.647 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -158.72 90.9 1.03 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.798 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 1.027 HG22 ' HD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -149.31 146.37 27.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.379 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 225' ' ' THR . 20.5 mm -129.02 116.39 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.628 ' OD1' ' HZ ' ' A' ' 217' ' ' PHE . 64.1 t30 -138.06 159.17 42.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.581 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -140.09 -139.9 3.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.853 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.632 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 41.7 Cg_endo -88.69 83.02 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.403 2.069 . . . . 0.0 112.559 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.91 -73.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 233' ' ' SER . . . -122.83 -42.69 2.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.512 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.5 t90 71.57 -18.64 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.597 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 231' ' ' ALA . 2.5 t 60.73 169.34 0.09 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.901 0.381 . . . . 0.0 111.058 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -174.39 165.36 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.222 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.603 ' N ' HD13 ' A' ' 235' ' ' ILE . 0.2 OUTLIER -153.2 179.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.015 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.83 -39.62 83.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -101.02 91.03 4.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.478 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 90.3 p -68.22 143.24 55.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.12 177.71 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.508 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.814 HG23 ' CE1' ' A' ' 242' ' ' TYR . 9.3 p -139.69 146.57 25.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.79 44.41 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.156 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.814 ' CE1' HG23 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -144.82 171.61 14.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.429 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 118' ' ' ASN . . . -132.07 144.05 15.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.763 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 114' ' ' SER . 11.5 p -113.05 123.24 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.69 0.281 . . . . 0.0 111.431 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 1.9 m -138.54 163.56 31.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.609 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.02 148.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.612 ' HG ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -58.8 146.8 74.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.161 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.49 ' HG2' ' CD2' ' A' ' 129' ' ' TRP . 92.7 Cg_endo -82.77 -149.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.299 2.0 . . . . 0.0 111.903 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 59.4 p -110.72 175.33 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.783 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.445 ' C ' ' H ' ' A' ' 252' ' ' GLY . 2.1 t80 -141.56 122.63 14.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.993 0.425 . . . . 0.0 110.66 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.83 -12.77 0.28 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.761 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 138.69 -9.21 3.4 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.047 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -127.89 136.85 29.62 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 117.005 0.402 . . . . 0.0 111.038 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.73 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 42.5 Cg_exo -58.06 175.8 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.883 2.388 . . . . 0.0 111.907 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.627 ' O ' ' HD3' ' A' ' 257' ' ' PRO . 12.1 p -99.46 146.8 25.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.58 0.229 . . . . 0.0 110.608 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.577 ' HZ1' ' C ' ' A' ' 327' ' ' GLY . 0.1 OUTLIER -106.2 86.11 1.93 Allowed Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' A' ' 255' ' ' SER . 65.9 Cg_endo -93.79 -154.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.284 2.656 . . . . 0.0 110.099 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.83 176.63 9.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.356 0.598 . . . . 0.0 112.365 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 260' ' ' GLY . 7.4 p -114.93 156.13 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.646 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -115.3 123.14 5.84 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.117 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.944 HG23 ' HB2' ' A' ' 64' ' ' HIS . 9.2 m -128.74 131.13 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.001 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -88.98 128.93 35.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.456 0.17 . . . . 0.0 111.385 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.642 ' HB2' ' CD2' ' A' ' 64' ' ' HIS . 4.1 t -99.6 134.63 42.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.72 151.89 41.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.584 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.944 ' HA2' ' CE2' ' A' ' 67' ' ' PHE . . . -103.18 116.41 5.44 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.539 -0.839 . . . . 0.0 114.451 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 266' ' ' ILE . 15.7 tt -142.46 95.13 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 2.9 m120 -56.54 163.13 1.89 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.996 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -77.99 3.68 14.12 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.962 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 271' ' ' PRO . . . -116.07 37.89 3.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.313 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 t -69.43 107.18 1.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 269' ' ' ALA . 37.9 Cg_exo -58.6 -25.17 73.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.398 2.066 . . . . 0.0 112.271 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.626 ' ND2' ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -129.89 79.2 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.992 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.811 ' O ' ' HD3' ' A' ' 277' ' ' LYS . 0.1 OUTLIER -59.74 -41.47 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.201 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.69 -29.51 63.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.626 ' HB2' ' ND2' ' A' ' 272' ' ' ASN . 1.6 tp -74.5 -42.69 58.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.061 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.89 -23.99 62.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.811 ' HD3' ' O ' ' A' ' 273' ' ' LYS . 0.6 OUTLIER -74.5 -48.57 26.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 7.6 pt-20 -73.77 -27.25 61.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.977 0.418 . . . . 0.0 111.444 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 2.1 t80 -67.47 -54.81 16.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.814 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.01 -20.99 40.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -96.1 -43.33 7.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.69 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 1.2 m-80 -87.61 4.35 44.16 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 0.2 OUTLIER -130.52 -52.38 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.15 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 39.95 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.307 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.492 HD11 ' CD1' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -158.79 28.78 0.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.234 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.2 p -155.25 172.92 17.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.342 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 4.0 p-10 -65.55 -8.74 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.396 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.52 -39.77 37.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.931 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -108.11 -52.78 0.67 Allowed Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.167 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.834 ' O ' ' HB2' ' A' ' 294' ' ' ASN . 0.3 OUTLIER -55.77 -31.74 62.84 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.563 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 1.078 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 0.5 OUTLIER -68.21 -23.74 64.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -81.12 -49.64 10.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.627 0.727 . . . . 0.0 110.491 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.474 HG13 HD22 ' A' ' 294' ' ' ASN . 14.7 p -83.24 -24.49 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 290' ' ' LEU . 1.4 m-80 -99.32 -15.94 18.64 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.415 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -98.01 -32.72 11.5 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 7.2 t70 -49.86 -41.1 44.57 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.87 136.33 0.48 Allowed Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.462 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.5 113.37 2.86 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.626 2.217 . . . . 0.0 112.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.774 ' HA ' ' NH1' ' A' ' 316' ' ' ARG . 0.4 OUTLIER -108.58 -67.36 0.98 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.328 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.737 ' H ' ' HG ' ' A' ' 299' ' ' LEU . . . -113.49 143.41 17.85 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.676 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.911 ' HB2' ' HA ' ' A' ' 317' ' ' ILE . . . -80.94 72.52 7.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 0.0 111.673 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.889 HG11 ' N ' ' A' ' 109' ' ' ALA . 13.1 m -139.33 116.14 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 290' ' ' LEU . . . 174.13 56.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 111.267 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.956 ' HG ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 60.38 153.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.752 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 0.0 OUTLIER -63.78 -15.33 58.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.24 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -49.03 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 303' ' ' ALA . 0.2 OUTLIER -79.11 -54.92 5.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -54.2 -19.69 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.183 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 0.0 OUTLIER -73.26 -28.72 62.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 312' ' ' ALA . 13.5 tt0 -75.55 -28.71 59.13 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.985 ' HB3' HG21 ' A' ' 317' ' ' ILE . 13.7 mt -48.87 -4.69 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.513 1.525 . . . . 0.0 113.504 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -50.82 -43.5 59.02 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -74.69 47.62 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.651 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.797 ' CB ' HD13 ' A' ' 317' ' ' ILE . 27.8 m-20 -146.95 153.77 46.16 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.695 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 314' ' ' ASP . 3.3 Cg_exo -77.31 -60.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.144 2.563 . . . . 0.0 112.711 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 299' ' ' LEU . 5.9 mtt85 -54.93 -51.89 64.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.418 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.985 HG21 ' HB3' ' A' ' 311' ' ' LEU . 5.3 mp -56.81 -55.85 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.59 -53.56 49.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.832 0.349 . . . . 0.0 111.674 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.535 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -51.13 -42.19 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.598 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.625 ' HA ' HD21 ' A' ' 323' ' ' ASN . 43.9 p -69.96 -43.83 70.74 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -22.65 67.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.94 -57.82 5.57 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.792 0.33 . . . . 0.0 111.27 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 320' ' ' THR . 6.2 p30 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.585 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.11 -23.31 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.086 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -73.08 -28.16 62.14 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.65 64.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.546 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.577 ' C ' ' HZ1' ' A' ' 256' ' ' LYS . . . -147.32 -172.87 17.94 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.854 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.57 ' HG2' ' OH ' ' A' ' 171' ' ' TYR . 4.8 tt0 -104.43 156.07 18.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.0 mm -85.09 130.36 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.67 ' CE ' ' HB3' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -56.23 111.54 3.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.845 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.12 -170.41 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.352 2.035 . . . . 0.0 112.267 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.86 85.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.895 HG13 ' HD2' ' A' ' 334' ' ' PRO . 0.5 OUTLIER -146.78 139.85 14.58 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.524 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.895 ' HD2' HG13 ' A' ' 333' ' ' ILE . 95.4 Cg_endo -76.48 -26.73 8.36 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.462 2.108 . . . . 0.0 112.885 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.553 ' NE2' HD11 ' A' ' 333' ' ' ILE . 38.5 mt-30 -63.51 -24.71 67.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.462 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.6 OUTLIER -56.88 -28.95 62.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.38 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.48 -24.96 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.918 0.39 . . . . 0.0 111.083 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -56.43 -26.58 54.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.994 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.1 OUTLIER -49.65 -24.92 2.47 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -42.11 89.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.776 0.322 . . . . 0.0 110.794 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -75.77 -22.76 56.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.84 -56.05 4.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.793 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 339' ' ' PHE . 30.4 m -56.69 -38.22 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.61 HH11 ' HG3' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -71.88 -44.11 64.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.646 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.804 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 17.9 m -72.48 -29.83 64.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 111.513 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -69.25 -61.06 1.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 12.3 t -77.32 -54.84 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 344' ' ' ARG . 14.8 mm -55.59 -52.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.804 ' HB2' ' O ' ' A' ' 345' ' ' THR . 3.0 m120 -67.8 -52.68 34.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -60.37 -36.17 77.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 111.515 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.13 -10.34 59.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.2 OUTLIER -67.41 -56.49 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.776 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 141.3 0.75 1.58 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.352 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 38.67 1.19 Allowed 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 117.048 0.424 . . . . 0.0 110.936 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.0 OUTLIER -143.32 114.55 7.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.347 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -86.78 164.33 16.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.699 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.4 -28.14 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 362' ' ' LYS . 3.4 p30 -69.97 -41.5 74.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.653 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.853 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 0.5 OUTLIER -79.19 -40.26 31.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.662 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.632 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -78.81 -55.24 5.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.43 HD13 ' C ' ' A' ' 361' ' ' LEU . 1.6 tm? -79.21 -57.37 3.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 358' ' ' ASP . 0.1 OUTLIER -57.19 -55.85 29.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 9.3 m-20 -57.95 -26.15 61.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 367' ' ' ARG . . . -66.38 -52.05 50.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.309 . . . . 0.0 111.434 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.701 ' HA ' HD12 ' A' ' 368' ' ' ILE . 23.5 tp60 -71.59 -30.7 66.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.456 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.621 ' OG1' ' HA ' ' A' ' 363' ' ' ASP . 2.0 p -61.29 -44.63 96.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.875 0.369 . . . . 0.0 111.502 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 1.101 ' HD2' HG13 ' A' ' 368' ' ' ILE . 0.1 OUTLIER -68.47 -34.24 75.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 -179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 1.101 HG13 ' HD2' ' A' ' 367' ' ' ARG . 12.1 mt -70.33 -43.8 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.091 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 370' ' ' LYS . 6.2 t -65.48 -45.46 83.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.159 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.413 ' N ' HG23 ' A' ' 369' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.037 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.787 0.327 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.3 p -131.68 148.02 52.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.92 116.95 32.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.153 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.56 -68.66 0.57 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.695 ' C ' HG23 ' A' ' 33' ' ' ILE . . . 104.9 64.84 0.67 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.997 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.824 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.3 mtmp? -155.31 154.87 32.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.584 0.23 . . . . 0.0 110.835 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 6' ' ' LYS . 1.4 mm? -142.12 118.41 10.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.091 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.962 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 23.1 t -97.39 134.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.733 ' CD1' HD21 ' A' ' 20' ' ' LEU . 29.9 mt -91.72 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 1.014 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -140.66 111.06 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.638 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.82 HD12 ' HB2' ' A' ' 14' ' ' ASP . 6.9 pt -156.38 160.91 2.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.528 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -126.96 82.72 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.13 67.55 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.852 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.82 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -100.09 13.86 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 0.0 110.934 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB2' HD11 ' A' ' 299' ' ' LEU . 3.3 mmtm 69.63 -145.48 0.09 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.171 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 15' ' ' LYS . . . 28.36 78.99 0.01 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -59.96 3.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.841 -0.679 . . . . 0.0 112.125 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -76.32 -28.27 56.86 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -53.43 44.95 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.723 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.733 HD21 ' CD1' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -74.14 -28.54 61.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.04 73.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -77.56 -56.7 4.31 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -50.58 -44.03 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.57 98.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.46 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.2 mmtt -76.02 -26.6 56.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.467 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 3.7 mttt -67.91 -33.19 74.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.005 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.764 ' HE2' ' HD1' ' A' ' 283' ' ' TYR . 12.7 m-85 -63.61 -61.17 2.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -34.24 65.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.936 0.874 . . . . 0.0 109.464 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -44.09 -23.38 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 113.773 -1.558 . . . . 0.0 113.719 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 31' ' ' THR . 5.5 m-20 -92.38 -57.3 2.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 118.149 -1.42 . . . . 0.0 110.954 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 158.27 47.63 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -178.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.32 -128.37 4.22 Favored Glycine 0 N--CA 1.414 -2.786 0 CA-C-N 112.321 -2.218 . . . . 0.0 113.416 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.695 HG23 ' C ' ' A' ' 5' ' ' GLY . 1.7 mp -116.02 148.31 18.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.0 -1.6 . . . . 0.0 113.069 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 6.6 tttt -101.03 129.94 46.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.091 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG22 ' HE1' ' A' ' 279' ' ' PHE . 20.6 t -97.56 126.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.295 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.633 ' HB ' HG13 ' A' ' 8' ' ' VAL . 1.2 m -101.73 137.22 40.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -104.17 112.69 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.39 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.37 163.59 30.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.137 0.494 . . . . 0.0 110.991 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -113.05 132.16 22.5 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.526 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.7 Cg_endo -81.25 -97.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.029 1.82 . . . . 0.0 112.893 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.3 t0 67.84 -68.55 0.16 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HE3' ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -94.63 -19.13 20.71 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.829 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 3.0 pp -90.97 0.83 57.43 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.07 -34.09 42.17 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 48' ' ' PRO . 24.6 tt0 -83.06 -12.71 56.91 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.704 0.288 . . . . 0.0 111.331 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.153 0.501 . . . . 0.0 111.299 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -39.92 -60.05 1.54 Allowed Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.147 -177.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 10.2 Cg_endo -52.23 -17.51 6.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.278 1.985 . . . . 0.0 112.767 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -55.44 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.661 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 55' ' ' ASP . 7.2 p -73.17 -30.46 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.691 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.22 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 53' ' ' THR . . . -48.26 -13.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 52' ' ' ALA . 2.6 p 90.07 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.291 0.636 . . . . 0.0 110.616 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.27 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.433 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' A' ' 50' ' ' VAL . 1.3 m-20 -50.82 -75.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.62 0.248 . . . . 0.0 111.436 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . 154.22 -52.52 0.46 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.185 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.962 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 11.7 Cg_endo -55.55 136.01 71.99 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.461 2.107 . . . . 0.0 112.308 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -160.61 40.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.644 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' CG1' HD12 ' A' ' 7' ' ' LEU . 39.9 mt -132.84 106.22 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.519 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.014 HG22 ' HB2' ' A' ' 10' ' ' TRP . 8.4 pt -130.41 141.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.969 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 264' ' ' ALA . 2.2 m-85 -110.8 129.09 55.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.503 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.0 OUTLIER -159.04 161.14 36.51 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.048 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -54.82 176.21 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.044 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.862 ' CD2' HG23 ' A' ' 261' ' ' VAL . 0.4 OUTLIER -77.65 -27.92 51.11 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.79 -49.36 70.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -88.8 2.3 53.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.016 ' HE2' ' HA ' ' A' ' 105' ' ' ALA . 40.5 t80 -98.04 -51.25 4.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 72' ' ' GLN . . . -77.98 -1.52 79.45 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.841 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.27 -37.13 1.38 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.375 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -87.56 -42.56 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 110.379 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 76' ' ' LEU . . . -75.59 -51.59 12.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.741 ' HG3' ' CD1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -52.34 -22.65 4.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.446 -178.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -98.75 -30.68 12.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' O ' HD22 ' A' ' 75' ' ' LEU . . . -77.69 -91.54 0.29 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.208 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -150.42 60.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.987 0.423 . . . . 0.0 110.435 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.838 HD13 ' HB1' ' A' ' 71' ' ' ALA . 23.1 tp -94.45 134.31 37.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.483 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.054 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -100.9 116.6 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.373 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HB3' HG22 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -58.55 161.32 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.681 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.82 126.1 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.0 t -93.62 140.05 22.99 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.33 179.29 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.521 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.28 -66.42 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.996 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -48.01 2.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.94 -23.27 12.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.442 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -80.07 -55.82 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -62.8 -26.02 68.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.462 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -48.63 -54.6 14.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.67 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.88 70.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.972 0.415 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD12 ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -99.53 133.15 44.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 0.2 OUTLIER -64.59 128.27 93.27 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.215 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 36.3 Cg_exo -61.17 -33.63 90.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.453 2.102 . . . . 0.0 112.436 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -59.43 -36.85 76.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 90' ' ' TYR . 15.3 p -70.14 -33.02 71.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.331 . . . . 0.0 110.958 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.66 ' NE1' HD12 ' A' ' 89' ' ' LEU . 36.7 m0 -65.57 -46.16 80.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.915 0.388 . . . . 0.0 110.856 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.02 -35.97 56.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.391 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.66 -40.14 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.914 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 97' ' ' VAL . 33.9 t -97.89 49.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 139.48 50.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.426 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -148.64 110.08 4.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.951 0.405 . . . . 0.0 111.252 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.25 26.3 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.85 22.09 76.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.711 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -133.26 143.07 48.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.59 85.42 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.065 0.459 . . . . 0.0 110.843 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.741 ' CD1' ' HG3' ' A' ' 72' ' ' GLN . 2.6 pp -104.4 39.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.142 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 1.016 ' HA ' ' HE2' ' A' ' 67' ' ' PHE . . . -170.24 127.06 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.616 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -114.17 112.83 46.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.865 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 90.5 Cg_endo -78.6 158.51 28.6 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.251 1.967 . . . . 0.0 112.163 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 108' ' ' ILE . 4.0 tp -179.03 39.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.143 0.497 . . . . 0.0 111.449 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.776 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -168.34 115.47 0.68 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.678 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 301' ' ' ALA . 25.1 t -102.25 107.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.434 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.89 127.39 53.38 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.788 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -169.24 177.57 4.72 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.936 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 227' ' ' ASN . 2.8 mp -132.65 172.05 13.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.736 ' HB3' HG23 ' A' ' 244' ' ' VAL . 6.1 m -117.68 171.56 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 247' ' ' LEU . 8.7 tp -102.52 110.73 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 225' ' ' THR . 32.9 mm -74.28 145.5 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.788 ' CZ ' ' HG3' ' A' ' 125' ' ' PRO . 0.5 OUTLIER -152.18 156.44 39.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.242 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -127.91 156.46 42.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 77.46 1.79 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.488 . . . . 0.0 111.916 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.53 -36.22 0.17 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.601 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.1 pp -156.26 45.55 0.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.456 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 139' ' ' LEU . 0.2 OUTLIER -152.06 131.86 7.02 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.633 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.37 159.78 50.62 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.091 1.86 . . . . 0.0 112.301 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 121.83 78.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.788 ' HG3' ' CZ ' ' A' ' 117' ' ' TYR . 73.9 Cg_endo -73.85 150.34 44.03 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.498 2.132 . . . . 0.0 112.552 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.52 ' HD3' ' HG2' ' A' ' 131' ' ' GLU . 96.4 Cg_endo -82.97 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.785 2.323 . . . . 0.0 112.299 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -95.84 17.48 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.284 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.09 140.19 53.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.847 0.356 . . . . 0.0 110.691 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.768 ' NE1' ' HD2' ' A' ' 248' ' ' PRO . 9.7 m95 -72.85 -31.77 64.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.569 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 13.1 tt0 -53.38 -21.99 6.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.05 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 126' ' ' PRO . 3.9 tp10 -73.46 -24.31 60.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.058 HG13 ' HD3' ' A' ' 133' ' ' PRO . 1.2 pp -68.62 -38.99 13.45 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 1.058 ' HD3' HG13 ' A' ' 132' ' ' ILE . 27.7 Cg_endo -64.98 -34.94 45.67 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.627 1.551 . . . . 0.0 112.545 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.758 ' O ' ' HG2' ' A' ' 137' ' ' LYS . . . -69.16 -27.01 65.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.574 HD23 HD12 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -72.15 -22.85 61.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -62.08 -33.43 74.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.398 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -74.48 -32.75 62.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.376 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -49.32 16.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.308 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.735 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.1 OUTLIER -65.43 -49.02 70.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.186 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.61 -27.69 69.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -64.65 -9.79 22.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.844 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -112.14 -56.12 2.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.08 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.29 39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.28 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 1.4 mttp -165.7 -177.41 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.431 ' O ' HG22 ' A' ' 222' ' ' THR . 5.8 m -131.36 157.85 42.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.899 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.735 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -93.36 -12.61 29.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -160.24 149.45 17.46 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.5 0.32 . . . . 0.0 111.706 -177.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.541 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.0 OUTLIER -179.31 127.34 0.09 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.113 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.38 176.59 12.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.42 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -171.33 0.0 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.73 0.3 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 mt -150.76 -29.3 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.38 32.72 1.7 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.689 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -120.2 143.83 36.56 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.49 0.186 . . . . 0.0 110.59 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.88 65.22 0.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.787 2.325 . . . . 0.0 113.917 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -140.51 0.61 1.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.644 ' CE2' ' HG ' ' A' ' 160' ' ' LEU . 48.5 t80 -123.95 -54.57 1.72 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.941 0.4 . . . . 0.0 112.025 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.755 ' O ' HG12 ' A' ' 161' ' ' ILE . 44.7 p -49.62 -48.79 48.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.749 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 3.3 t90 -57.0 -56.35 34.33 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 38.1 Cg_endo -67.76 -10.45 28.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.578 2.185 . . . . 0.0 112.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -96.86 -47.44 5.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.385 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 1.004 HG23 HD22 ' A' ' 195' ' ' LEU . 18.6 pt -82.61 -4.09 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 256' ' ' LYS . . . -78.99 -54.02 6.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.068 0.461 . . . . 0.0 110.602 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.663 ' CA ' ' HA ' ' A' ' 255' ' ' SER . . . 47.93 -160.57 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.721 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.56 ' OD2' ' HB3' ' A' ' 253' ' ' GLN . 2.0 t0 -105.75 31.35 5.08 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.904 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.88 -43.47 0.41 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.908 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.816 ' HA2' HD21 ' A' ' 185' ' ' ASN . . . -91.6 129.19 9.7 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.252 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.904 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 7.1 m-85 -102.73 170.23 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 111.034 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.18 -66.73 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.546 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 333' ' ' ILE . 98.8 m-85 -122.08 161.01 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -94.63 109.22 21.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 176' ' ' TYR . 2.2 p90 -134.32 116.76 15.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.259 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 4.5 pt-20 -121.26 120.49 35.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.425 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 70.5 -53.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.17 31.43 0.03 OUTLIER Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.336 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -133.77 124.29 26.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 0.0 110.378 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.893 ' CZ ' ' HB3' ' A' ' 331' ' ' PRO . 7.1 m-85 -85.68 171.6 11.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.173 0.511 . . . . 0.0 110.471 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 9.5 t70 -127.71 -166.02 1.56 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.135 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -153.7 -45.66 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 121.229 -0.189 . . . . 0.0 111.368 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -76.92 -9.7 58.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.639 0.256 . . . . 0.0 111.498 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.456 ' HB2' ' OD2' ' A' ' 177' ' ' ASP . 0.7 OUTLIER -110.44 118.98 37.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 0.0 111.003 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.55 147.13 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.93 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.54 49.45 0.93 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.443 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.431 HG12 HE22 ' A' ' 365' ' ' GLN . 9.9 p -89.28 -28.05 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.714 0.292 . . . . 0.0 111.145 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.627 ' OD2' ' HG3' ' A' ' 362' ' ' LYS . 4.4 t70 -114.24 64.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.115 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.816 HD21 ' HA2' ' A' ' 166' ' ' GLY . 19.2 p30 -104.13 -171.17 1.88 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.531 ' HA ' ' NZ ' ' A' ' 189' ' ' LYS . . . -63.26 -37.93 89.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.484 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.6 -22.02 75.97 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.737 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.43 71.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.531 ' NZ ' ' HA ' ' A' ' 186' ' ' ALA . 9.1 pttm -63.91 -46.77 83.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 189' ' ' LYS . . . -65.94 -36.55 83.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.26 -37.23 71.2 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.302 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.2 OUTLIER -75.25 -41.4 57.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.202 0.525 . . . . 0.0 110.743 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 p -60.8 -30.56 70.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.223 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.72 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 1.3 t80 -78.21 -46.13 21.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.638 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.004 HD22 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -59.25 -41.34 88.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.821 0.344 . . . . 0.0 111.645 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 192' ' ' LEU . 41.9 t -70.5 -57.22 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.24 -29.91 69.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.405 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 0.4 OUTLIER -63.48 -57.86 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.182 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.82 -35.75 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.616 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -58.66 -36.97 74.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.387 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -85.49 2.1 46.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.745 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 -60.25 1.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -79.07 -45.18 20.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.362 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 204' ' ' MET . 2.9 ttt 67.21 -2.85 1.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.2 -46.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.932 0.396 . . . . 0.0 110.228 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 64.11 66.18 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.16 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.19 27.36 9.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 p -77.35 136.45 38.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.439 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 3.7 m-20 -107.78 -167.98 1.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.82 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.725 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 17.7 t80 -78.23 -42.77 30.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.218 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 p -77.46 -24.24 50.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.904 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 23.7 mt -83.26 -48.11 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -73.43 -29.0 62.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.987 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.979 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -60.01 -45.17 93.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.11 33.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -58.32 3.05 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 1.045 ' HB2' HG23 ' A' ' 225' ' ' THR . 6.4 p90 -72.46 -39.49 67.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.72 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 1.9 t-20 -56.43 -37.88 70.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.864 0.364 . . . . 0.0 110.34 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -85.57 -8.44 58.28 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.212 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 42.96 52.64 5.65 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.761 -0.654 . . . . 0.0 114.287 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -111.01 34.03 4.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.472 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 145' ' ' SER . 68.7 p -158.7 149.54 20.24 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -72.03 38.21 0.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.222 -0.991 . . . . 0.0 113.623 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.76 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 3.4 tpt -157.22 98.98 1.76 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 1.045 HG23 ' HB2' ' A' ' 217' ' ' PHE . 1.7 m -147.38 124.11 11.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.06 -1.882 . . . . 0.0 109.763 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.513 HG22 HD22 ' A' ' 113' ' ' LEU . 29.3 mt -112.05 115.5 50.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.869 0.366 . . . . 0.0 110.466 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.705 ' C ' HD23 ' A' ' 113' ' ' LEU . 5.2 m120 -141.51 164.55 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -150.59 -153.43 6.13 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.62 85.29 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.467 2.111 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.204 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -161.52 85.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 111.417 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.55 -37.76 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.836 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.1 t 61.47 160.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -136.91 165.68 25.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.503 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 235' ' ' ILE . 0.9 OUTLIER -168.23 117.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -123.36 67.49 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -140.93 -57.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.45 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.05 51.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.36 116.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.975 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.57 126.1 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -171.33 120.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.881 0.372 . . . . 0.0 111.09 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -139.5 142.65 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -106.57 136.35 13.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.694 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 114' ' ' SER . 8.5 p -121.57 119.01 57.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.88 163.41 32.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.111 0.481 . . . . 0.0 110.989 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.32 151.38 4.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.592 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' ' 115' ' ' LEU . 1.6 mp -57.34 144.97 69.42 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.883 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.768 ' HD2' ' NE1' ' A' ' 129' ' ' TRP . 3.2 Cg_exo -78.33 -158.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.846 2.364 . . . . 0.0 111.665 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.876 HG22 ' HD3' ' A' ' 254' ' ' PRO . 17.2 p -91.43 171.74 9.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.023 0.44 . . . . 0.0 111.149 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.646 ' O ' ' HG3' ' A' ' 251' ' ' LYS . 49.5 t80 -142.84 116.35 9.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.646 ' HG3' ' O ' ' A' ' 250' ' ' PHE . 0.1 OUTLIER 53.8 12.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.235 -179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 253' ' ' GLN . . . 145.38 -33.78 1.55 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.435 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.56 ' HB3' ' OD2' ' A' ' 164' ' ' ASP . 7.5 mt-30 -152.8 158.72 33.02 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 111.238 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 249' ' ' THR . 19.2 Cg_endo -59.11 170.17 3.11 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.628 2.219 . . . . 0.0 112.449 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.663 ' HA ' ' CA ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -88.23 176.66 7.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.484 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -122.06 91.81 48.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -96.27 -142.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.407 2.738 . . . . 0.0 110.225 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.656 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 28.9 p90 -150.46 168.63 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.522 -0.871 . . . . 0.0 113.189 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.34 156.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.516 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -112.78 118.05 4.48 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.522 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.862 HG23 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -129.94 131.44 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.478 0.18 . . . . 0.0 110.867 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.048 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 6.7 mp -106.34 137.81 43.65 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 16.9 m -109.11 136.52 48.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.719 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . . . -74.28 137.0 42.64 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.166 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.954 ' HA2' ' CE1' ' A' ' 67' ' ' PHE . . . -86.61 133.37 11.75 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.418 -0.896 . . . . 0.0 114.804 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 266' ' ' ILE . 9.5 tt -134.41 106.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 111.09 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -61.55 154.83 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.129 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 1.054 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -83.51 28.8 0.54 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.734 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 271' ' ' PRO . . . -43.67 -24.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.991 ' HB3' ' HD3' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 84.6 -85.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.769 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 270' ' ' SER . 31.6 Cg_exo -57.82 -25.6 69.8 Favored 'Trans proline' 0 C--N 1.366 1.461 0 CA-C-N 121.33 1.511 . . . . 0.0 112.635 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -73.63 6.09 3.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.873 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 0.8 OUTLIER -60.3 -44.42 95.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.75 -45.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 111.023 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.54 -49.95 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.54 -37.67 88.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 273' ' ' LYS . 0.1 OUTLIER -62.27 -41.71 98.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.922 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.05 -27.72 60.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 111.28 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.789 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.2 OUTLIER -60.54 -57.9 10.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.579 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.79 -34.39 52.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.0 OUTLIER -59.91 -24.52 64.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.419 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -115.99 -9.19 11.79 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.789 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -81.11 -71.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.952 0.405 . . . . 0.0 111.009 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.91 60.99 0.74 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.807 HD13 HD11 ' A' ' 304' ' ' LEU . 0.2 OUTLIER -167.48 29.44 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 4.9 t -153.59 169.11 24.05 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.847 0.356 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 291' ' ' GLU . 3.6 t70 -69.58 -29.19 66.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.221 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.13 -31.02 49.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.94 0.4 . . . . 0.0 111.444 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -98.93 -50.11 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.041 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 294' ' ' ASN . 0.2 OUTLIER -59.78 -32.4 70.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.303 . . . . 0.0 110.652 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 1.078 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . 0.0 OUTLIER -67.75 -24.86 65.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.606 0.717 . . . . 0.0 110.737 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 296' ' ' ASP . . . -79.95 -59.79 2.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.781 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.3 t -87.01 -26.81 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.832 ' CB ' HD23 ' A' ' 290' ' ' LEU . 56.1 t30 -108.26 -4.53 17.46 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 1.078 ' HB2' ' HA ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -120.91 -20.05 7.04 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.357 -178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.789 ' HB2' ' O ' ' A' ' 292' ' ' ALA . 3.3 t70 -54.63 -29.96 53.66 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.634 ' HG2' ' HD2' ' A' ' 298' ' ' PRO . 4.4 tttp -168.38 138.58 2.06 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.427 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.634 ' HD2' ' HG2' ' A' ' 297' ' ' LYS . 45.5 Cg_exo -56.92 143.64 91.28 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.102 1.868 . . . . 0.0 112.725 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -134.23 -62.37 0.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -166.42 -158.42 11.09 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.746 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.856 ' HB3' HG21 ' A' ' 110' ' ' VAL . . . -80.05 174.85 11.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.637 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.79 146.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.301 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -79.26 55.71 1.92 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.807 HD11 HD13 ' A' ' 285' ' ' LEU . 48.0 mt -155.49 120.55 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.756 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 309' ' ' GLU . 16.9 mttp -69.07 -21.27 64.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.251 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -52.87 48.24 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.578 ' CE2' HD13 ' A' ' 290' ' ' LEU . 35.2 m-85 -80.13 -37.44 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.75 0.31 . . . . 0.0 110.924 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.941 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.5 OUTLIER -69.89 -18.74 63.42 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.55 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.712 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.8 tt0 -64.84 -43.11 94.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 312' ' ' ALA . 1.7 mt-10 -82.3 -29.38 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.941 ' HB2' ' HA ' ' A' ' 308' ' ' GLU . 0.0 OUTLIER -44.79 -6.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.238 1.415 . . . . 0.0 114.281 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 310' ' ' GLU . . . -54.97 -19.88 7.8 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.992 -0.442 . . . . 0.0 111.619 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -40.83 85.58 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.621 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -90.59 141.35 27.06 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.112 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -91.86 -2.43 4.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.74 2.294 . . . . 0.0 113.572 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -63.3 -60.75 2.98 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.005 0.431 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.659 HG21 ' CD2' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -59.09 -28.86 40.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.39 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.628 ' H ' HD13 ' A' ' 317' ' ' ILE . . . -71.58 -45.19 62.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.36 74.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.496 HG21 ' CG1' ' A' ' 110' ' ' VAL . 2.9 m -62.35 -34.4 76.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.174 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -23.11 67.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.323 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.05 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 320' ' ' THR . 4.2 p-10 -74.31 -32.72 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.433 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.07 96.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -80.64 -12.28 59.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.592 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.642 ' HD3' ' HG3' ' A' ' 254' ' ' PRO . 22.0 mttm -131.07 46.8 2.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.6 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -154.75 -165.61 14.21 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.354 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.795 ' HG3' ' NZ ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -123.25 146.62 47.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.863 0.363 . . . . 0.0 111.475 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.1 mt -94.72 124.08 47.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.9 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.46 112.72 4.79 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.685 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.893 ' HB3' ' CZ ' ' A' ' 176' ' ' TYR . 71.6 Cg_endo -77.15 -168.72 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.219 1.946 . . . . 0.0 112.773 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -121.25 68.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 336' ' ' MET . 0.6 OUTLIER -118.62 131.22 24.37 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.15 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 333' ' ' ILE . 18.2 Cg_exo -66.84 -29.9 41.26 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.609 2.206 . . . . 0.0 112.392 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.563 HE22 HG13 ' A' ' 368' ' ' ILE . 0.6 OUTLIER -63.97 -23.93 67.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.524 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.712 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -56.86 -27.94 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.573 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -26.32 65.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.849 0.357 . . . . 0.0 110.97 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.96 -27.15 69.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 336' ' ' MET . 1.6 m-85 -53.38 -31.07 43.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.344 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -34.31 77.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.63 -20.55 56.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.368 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.93 -57.38 3.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.693 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 344' ' ' ARG . 27.0 m -55.45 -46.85 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.16 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.646 ' HD3' HG13 ' A' ' 348' ' ' ILE . 2.8 mmt85 -56.97 -54.98 40.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.944 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.979 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 71.2 p -67.21 -27.11 66.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 111.6 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -74.84 -61.02 2.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.889 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.5 t -80.86 -52.41 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.646 HG13 ' HD3' ' A' ' 344' ' ' ARG . 21.2 mm -72.39 -57.95 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.979 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 1.3 m120 -59.43 -44.84 92.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.663 ' HA ' ' CB ' ' A' ' 355' ' ' GLN . . . -68.36 -27.63 66.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.748 0.309 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -79.1 -11.19 59.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.462 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 35.0 t -70.57 -54.71 11.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.659 0.266 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 147.59 -15.09 1.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.121 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -126.3 41.44 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.704 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.856 ' HG3' ' HB3' ' A' ' 349' ' ' ASN . 4.7 mm100 -148.17 119.13 7.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.739 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 m -102.99 143.34 32.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.273 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.4 m -57.3 -27.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.803 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.98 -56.97 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.724 0.297 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.35 -26.61 58.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -77.99 -54.67 6.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -57.61 3.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.627 ' HG3' ' OD2' ' A' ' 184' ' ' ASP . 3.0 tttt -55.87 -56.68 17.69 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -29.57 45.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.48 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.42 87.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.384 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.523 ' HA ' HG22 ' A' ' 368' ' ' ILE . 9.0 tp60 -60.96 -43.83 98.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 111.513 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -36.64 84.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -73.1 -34.27 66.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.442 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.563 HG13 HE22 ' A' ' 335' ' ' GLN . 0.9 OUTLIER -80.28 -37.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 111.167 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 365' ' ' GLN . 16.9 p -60.92 -49.2 78.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.727 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.555 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.894 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.059 0.457 . . . . 0.0 111.421 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -85.79 169.24 13.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.27 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.66 151.91 37.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.39 76.37 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.771 ' C ' HG23 ' A' ' 33' ' ' ILE . . . -110.35 62.88 0.28 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.271 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -150.65 158.99 44.8 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.702 0.287 . . . . 0.0 111.26 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -153.54 135.94 15.02 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.28 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.129 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 21.5 t -109.68 129.2 64.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-O 121.081 0.467 . . . . 0.0 111.222 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.972 HG13 ' HA ' ' A' ' 37' ' ' VAL . 1.1 pt -90.61 158.57 2.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.064 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.716 ' HB3' HG23 ' A' ' 60' ' ' ILE . 1.3 m0 -140.79 111.0 6.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.435 0.159 . . . . 0.0 110.598 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -162.74 161.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.16 0.505 . . . . 0.0 111.644 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -134.92 146.88 49.58 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.644 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.62 -9.4 10.72 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.518 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.23 31.02 3.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.55 53.46 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' O ' ' HB2' ' A' ' 20' ' ' LEU . . . 32.03 76.08 0.04 OUTLIER Glycine 0 C--O 1.224 -0.525 0 N-CA-C 115.437 0.935 . . . . 0.0 115.437 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -78.07 -50.24 12.44 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.555 0.217 . . . . 0.0 110.758 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.9 -35.94 59.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.59 -52.77 28.05 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.69 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 1.8 mt -66.27 -31.41 72.2 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.554 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -76.54 -56.91 4.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.969 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 20' ' ' LEU . 15.8 m -49.05 -46.12 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.61 -50.72 59.14 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.295 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.753 ' HD2' ' HE3' ' A' ' 34' ' ' LYS . 3.8 tttt -76.83 -25.68 53.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.435 0.16 . . . . 0.0 110.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -56.13 -35.85 67.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.335 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -72.0 -59.58 2.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.273 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -54.84 -34.53 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.751 0.786 . . . . 0.0 110.309 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -46.61 -24.51 0.55 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.412 -177.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 t70 -93.64 -57.51 2.55 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.768 1.27 . . . . 0.0 109.176 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 165.22 43.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.607 -2.542 . . . . 0.0 105.511 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.44 5.7 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 112.511 -2.131 . . . . 0.0 113.075 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.771 HG23 ' C ' ' A' ' 5' ' ' GLY . 7.9 mt -129.77 152.11 36.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 113.208 -1.496 . . . . 0.0 113.15 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.753 ' HE3' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -111.49 139.16 47.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.4 178.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 t -109.38 140.2 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.327 0.584 . . . . 0.0 111.837 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.676 ' OG1' HG22 ' A' ' 8' ' ' VAL . 14.4 p -101.56 118.89 37.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.972 ' HA ' HG13 ' A' ' 9' ' ' ILE . 11.8 p -76.95 109.84 11.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.835 0.35 . . . . 0.0 111.719 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.1 mt-10 -125.54 153.11 44.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -120.98 122.26 28.42 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.136 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 11' ' ' ILE . 57.3 Cg_endo -70.49 136.14 30.38 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.391 2.061 . . . . 0.0 112.446 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.83 -59.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.086 0.47 . . . . 0.0 110.927 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -105.17 -2.96 23.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 1.3 mp -92.7 -0.32 57.3 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -51.52 68.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.978 0.418 . . . . 0.0 111.049 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 48' ' ' PRO . 9.0 mt-10 -84.18 -23.13 30.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.204 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 37.3 mttt -68.58 -25.04 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.45 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.24 -60.24 5.14 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 18.2 Cg_endo -59.16 -14.72 25.03 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.31 2.007 . . . . 0.0 113.021 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.63 -52.52 4.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 46' ' ' LYS . 30.2 m -80.14 -16.56 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.326 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.82 83.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -46.77 -19.65 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.928 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -42.02 6.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.658 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 37.95 4.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.314 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.32 56.38 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 110.93 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.17 167.73 23.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.283 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 1.129 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 40.9 Cg_exo -59.26 171.82 2.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 59' ' ' ILE . 5.7 m-20 -143.16 35.38 1.35 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.219 -0.593 . . . . 0.0 112.261 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 11.4 mm -148.47 114.37 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.712 0.291 . . . . 0.0 110.852 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.716 HG23 ' HB3' ' A' ' 10' ' ' TRP . 8.8 mt -139.29 144.2 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 112.117 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB2' HG23 ' A' ' 11' ' ' ILE . 30.1 m-85 -126.46 128.32 46.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.055 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.785 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.0 OUTLIER -160.86 174.16 14.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -53.11 165.79 0.29 Allowed 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.062 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 16.3 t-80 -78.57 -28.29 45.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.5 -48.29 14.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.717 ' HD2' ' CD1' ' A' ' 62' ' ' TRP . 2.6 ptp180 -81.15 -8.62 59.8 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.73 ' CZ ' ' HA3' ' A' ' 265' ' ' GLY . 0.6 OUTLIER -102.37 -55.77 2.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.991 0.424 . . . . 0.0 109.96 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 104' ' ' ILE . . . -80.81 -0.25 87.8 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.31 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.89 -57.0 0.74 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.021 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -40.96 54.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.606 0.241 . . . . 0.0 111.186 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.974 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -61.7 -40.63 95.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.988 0.423 . . . . 0.0 110.636 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.854 HE21 HG21 ' A' ' 104' ' ' ILE . 1.2 tt0 -51.76 -10.89 0.12 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.59 -30.15 6.92 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.794 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.05 -77.79 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.864 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.25 62.13 1.17 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.949 0.404 . . . . 0.0 110.904 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.974 HD23 ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.63 124.07 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.617 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 268' ' ' ALA . . . -97.05 160.38 14.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.756 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.79 ' HG3' HG22 ' A' ' 104' ' ' ILE . 10.7 mp0 -73.68 154.71 39.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 103' ' ' LEU . 11.3 tt -130.05 138.66 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.105 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -135.89 131.16 18.88 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.926 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -87.12 176.05 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.523 2.149 . . . . 0.0 112.627 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.32 -38.06 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 8.3 mtpt -85.72 -43.12 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.614 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.691 ' HA ' ' HB2' ' A' ' 87' ' ' ASP . . . -61.05 -22.02 64.18 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.723 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.497 ' CZ ' ' HH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER -63.55 -59.93 3.99 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -75.34 -27.98 59.42 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -52.08 -9.29 0.09 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.092 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.33 71.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD23 ' HB1' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -78.77 142.45 36.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.951 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.874 ' HD2' ' HB2' ' A' ' 92' ' ' PHE . 2.2 t80 -67.78 125.31 91.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.291 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 24.3 Cg_exo -60.12 -21.6 66.5 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.149 1.899 . . . . 0.0 112.165 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.874 ' HB2' ' HD2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -58.75 -38.19 77.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 90' ' ' TYR . 9.4 t -87.65 -26.22 23.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.192 0.52 . . . . 0.0 110.268 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 2.0 m95 -75.48 -31.48 60.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.66 -36.2 32.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.725 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -46.55 14.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.956 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 97' ' ' VAL . 22.2 t -79.39 42.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.014 0.435 . . . . 0.0 110.592 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.21 115.02 24.5 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.419 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HD2' HD21 ' A' ' 332' ' ' ASN . 33.1 t80 -110.89 98.55 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.743 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 t30 70.14 -64.28 0.36 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.46 25.2 0.05 OUTLIER Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.691 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -145.51 167.3 23.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -106.54 92.07 3.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.854 HG21 HE21 ' A' ' 72' ' ' GLN . 2.6 pp -100.08 41.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.593 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB1' ' OG ' ' A' ' 263' ' ' SER . . . 178.06 -177.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.602 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.612 ' CD1' ' HD2' ' A' ' 107' ' ' PRO . 13.7 t80 -147.39 141.5 15.86 Favored Pre-proline 0 C--O 1.224 -0.277 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.853 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.612 ' HD2' ' CD1' ' A' ' 106' ' ' TYR . 98.3 Cg_endo -79.49 138.98 14.13 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.503 2.135 . . . . 0.0 112.516 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.011 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 39.2 mm -126.21 -128.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 122.879 0.472 . . . . 0.0 110.026 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.741 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -77.91 -175.37 3.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.162 0.585 . . . . 0.0 112.021 -177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 12.4 p -121.35 129.47 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.517 ' HG2' ' HZ3' ' A' ' 230' ' ' TRP . 1.8 mt-10 -113.86 127.46 56.0 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.361 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -170.32 -179.85 3.19 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 226' ' ' ILE . 4.5 mm? -121.08 169.38 10.57 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.29 162.8 19.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.262 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.78 HD23 HG23 ' A' ' 245' ' ' THR . 19.5 tp -105.19 115.65 30.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.915 HG22 ' H ' ' A' ' 225' ' ' THR . 1.3 tp -72.51 140.34 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.406 ' OH ' HD12 ' A' ' 122' ' ' LEU . 69.0 t80 -135.35 143.02 45.87 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.69 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.05 137.11 52.38 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -106.07 60.68 0.65 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.477 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.64 ' HB3' HD22 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -175.16 -37.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 120' ' ' ASP . 1.8 mm? -124.22 44.56 2.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.117 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 223' ' ' ALA . 0.5 OUTLIER -148.77 107.99 3.5 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.549 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.639 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 11.9 Cg_exo -71.09 160.49 49.04 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.766 2.311 . . . . 0.0 111.593 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -65.09 103.3 0.41 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 57.0 Cg_endo -93.38 158.69 2.49 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.849 2.366 . . . . 0.0 112.689 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 131' ' ' GLU . 56.5 Cg_endo -72.0 -155.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.684 2.256 . . . . 0.0 111.954 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -116.03 34.14 5.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.319 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -124.28 140.66 52.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.489 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.874 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -70.17 -38.83 75.5 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.347 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -54.45 -24.47 20.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CD ' ' A' ' 126' ' ' PRO . 3.5 tp10 -83.94 -32.76 24.89 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 129' ' ' TRP . 1.4 tt -53.55 -37.12 47.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.765 ' HD3' ' O ' ' A' ' 129' ' ' TRP . 12.4 Cg_exo -71.76 -26.57 19.11 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.273 1.982 . . . . 0.0 112.519 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.48 69.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.572 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 139' ' ' LEU . 4.9 mt -65.72 -28.88 69.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.939 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.559 ' OD2' ' HE2' ' A' ' 202' ' ' LYS . 19.6 t0 -65.06 -42.22 94.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.926 0.393 . . . . 0.0 110.604 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -33.54 75.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.957 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.77 55.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.064 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.002 HD23 ' HG3' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -69.82 -45.63 67.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -31.69 72.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.284 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.41 -8.06 1.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.938 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.58 -61.58 1.64 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.058 0.456 . . . . 0.0 110.282 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.67 40.54 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.839 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 1.002 ' HG3' HD23 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -160.96 -174.55 4.45 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.495 0.664 . . . . 0.0 111.654 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.771 ' C ' HD22 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -144.4 162.48 36.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.426 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.928 ' HB2' HD13 ' A' ' 139' ' ' LEU . . . -109.49 -6.86 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.972 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.915 HD23 ' HG3' ' A' ' 224' ' ' MET . 0.4 OUTLIER -147.08 138.94 24.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 ttt -161.9 115.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.461 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CD2' ' CD2' ' A' ' 156' ' ' PHE . 25.5 p90 -139.08 177.24 8.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.301 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -54.81 178.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -52.12 0.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.222 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -97.22 36.5 1.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.53 145.85 58.65 Favored Pre-proline 0 N--CA 1.464 0.238 0 O-C-N 122.216 -0.302 . . . . 0.0 110.545 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.54 53.59 2.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.578 2.185 . . . . 0.0 112.614 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 1.9 t80 -113.66 -11.78 12.92 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.093 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.766 ' HZ ' HD11 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -123.85 -55.52 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.258 0.551 . . . . 0.0 111.896 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.493 HG22 ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -47.43 -48.8 26.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.779 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -61.55 -54.96 47.25 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.174 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.742 ' HD2' ' C ' ' A' ' 156' ' ' PHE . 16.7 Cg_exo -65.71 -10.71 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.467 2.111 . . . . 0.0 112.533 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -91.2 -52.02 5.03 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.022 0.439 . . . . 0.0 110.711 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 1.103 HG23 ' HA3' ' A' ' 191' ' ' GLY . 8.2 mt -66.22 -12.16 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB1' ' HG3' ' A' ' 256' ' ' LYS . . . -72.61 -33.98 67.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.796 0.331 . . . . 0.0 110.493 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.894 ' HB2' ' HB3' ' A' ' 255' ' ' SER . . . -66.14 -15.77 63.4 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.83 -29.55 23.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 128.49 17.0 1.99 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.364 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.63 112.8 3.72 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.541 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.607 ' HA ' ' NZ ' ' A' ' 256' ' ' LYS . 3.1 m-85 -97.24 156.22 16.51 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 111.572 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.77 -68.47 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.244 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.7 165.62 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.058 0.456 . . . . 0.0 111.194 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' HD2' ' OD2' ' A' ' 180' ' ' ASP . 0.1 OUTLIER -107.06 127.22 53.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.28 134.08 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.7 OUTLIER -132.88 125.72 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.537 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 17.8 m-80 71.77 -52.4 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 158.95 44.98 0.02 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -134.24 160.57 37.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.607 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -98.13 151.81 20.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.961 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 180' ' ' ASP . 19.3 p30 -90.33 -167.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.77 -50.93 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.997 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' LYS . 1.6 ttmp? -125.52 5.63 7.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.644 ' OD2' ' HD2' ' A' ' 170' ' ' LYS . 2.4 m-20 -75.1 98.02 3.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.729 0.3 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.47 149.43 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.77 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -135.24 40.87 1.5 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.314 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.786 ' CG2' ' HG3' ' A' ' 365' ' ' GLN . 0.0 OUTLIER -85.63 -31.81 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.699 ' OD2' ' HA ' ' A' ' 362' ' ' LYS . 0.3 OUTLIER -102.78 60.92 0.8 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.296 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.75 165.85 14.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.689 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.34 70.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.077 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -44.5 55.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.893 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.41 -28.55 59.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.245 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -65.04 -51.11 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.83 -27.57 67.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.31 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 1.103 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.38 -27.2 66.23 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.414 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -90.27 -29.92 17.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.742 0.306 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.534 ' O ' HG12 ' A' ' 196' ' ' VAL . 6.6 m -70.27 -36.65 74.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.401 . . . . 0.0 110.775 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.657 ' HA ' ' OD2' ' A' ' 197' ' ' ASP . 15.7 m-85 -77.05 -37.15 55.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 157' ' ' THR . 0.6 OUTLIER -59.06 -33.32 70.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.15 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 193' ' ' THR . 14.4 p -77.22 -43.43 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.559 0.218 . . . . 0.0 111.583 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.706 ' HA ' ' CD ' ' A' ' 200' ' ' LYS . 3.1 p30 -73.07 -31.1 64.17 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.09 -47.43 85.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.737 HG13 ' H ' ' A' ' 200' ' ' LYS . 28.8 pt -64.63 -54.96 24.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.0 111.418 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.737 ' H ' HG13 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -58.58 -15.76 12.83 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.955 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -98.99 0.02 43.03 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.428 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.559 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 6.9 mtpt -107.17 -71.18 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.666 0.27 . . . . 0.0 110.46 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.485 ' HD2' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -86.41 -29.41 22.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.358 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.737 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 0.1 OUTLIER 60.3 27.83 17.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.046 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.521 ' HB3' ' OD2' ' A' ' 207' ' ' ASP . 24.3 m120 -143.3 -42.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 61.57 28.14 17.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.521 ' OD2' ' HB3' ' A' ' 205' ' ' ASN . 3.6 p30 -103.46 30.31 5.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 203' ' ' HIS . 1.3 p -82.16 126.05 31.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.465 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.635 ' HB2' HG12 ' A' ' 212' ' ' ILE . 1.8 m-20 -107.04 -159.51 0.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.691 -0.232 . . . . 0.0 110.709 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.836 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 0.3 OUTLIER -77.02 -48.61 17.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 110.032 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 90.3 p -70.95 -23.07 62.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.755 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 209' ' ' ASP . 17.9 mm -78.22 -54.22 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.98 -29.15 65.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.84 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.836 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 8.3 tt0 -58.96 -24.74 62.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.523 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.01 -57.55 12.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -82.7 -34.16 27.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.976 ' CD1' HG23 ' A' ' 225' ' ' THR . 13.1 t80 -64.66 -58.62 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.205 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 214' ' ' GLU . 0.7 OUTLIER -61.25 -44.01 97.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -82.27 -5.02 58.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.34 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.59 38.56 1.54 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.339 0.496 . . . . 0.0 114.339 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.87 35.14 0.56 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.746 0.773 . . . . 0.0 110.168 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.534 ' HB ' ' CA ' ' A' ' 146' ' ' ALA . 8.4 p -160.03 145.5 15.28 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.92 37.89 0.07 Allowed 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.604 -170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.915 ' HG3' HD23 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -156.46 92.26 1.3 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 176.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.976 HG23 ' CD1' ' A' ' 217' ' ' PHE . 96.1 m -149.35 148.01 29.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.011 -1.45 . . . . 0.0 108.922 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 225' ' ' THR . 0.3 OUTLIER -123.25 116.3 48.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.6 HD22 HG22 ' A' ' 225' ' ' THR . 3.9 m-80 -128.48 146.23 50.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.026 0.441 . . . . 0.0 111.86 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.44 -148.39 7.4 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.429 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.5 ' HB2' HD21 ' A' ' 299' ' ' LEU . 71.0 Cg_endo -85.2 -7.89 8.96 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.755 2.303 . . . . 0.0 112.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.517 ' HZ3' ' HG2' ' A' ' 111' ' ' GLU . 22.4 p90 -108.07 15.48 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 111.179 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -138.03 32.97 2.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -122.93 110.97 16.07 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 110.49 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.3 p -126.41 165.37 19.19 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.013 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.24 147.87 45.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.76 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 235' ' ' ILE . 0.8 OUTLIER -156.12 78.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 111.069 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.09 28.03 15.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.938 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.39 -179.58 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 91.0 p -168.6 -32.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.313 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -148.79 132.09 16.52 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.764 0.316 . . . . 0.0 111.235 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.8 t -143.26 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -91.29 90.78 7.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.313 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -123.05 127.15 48.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.89 129.86 9.17 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.224 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 24.5 m -101.49 134.29 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.534 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 HD23 ' A' ' 115' ' ' LEU . 8.9 t -142.56 165.34 27.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.67 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.9 148.9 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 111.792 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.06 144.17 83.02 Favored Pre-proline 0 C--N 1.334 -0.085 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.176 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HG2' ' HD1' ' A' ' 129' ' ' TRP . 94.9 Cg_endo -82.58 -144.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.025 2.483 . . . . 0.0 111.539 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 32.5 p -111.0 164.49 12.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.733 0.301 . . . . 0.0 111.209 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 160' ' ' LEU . 4.4 t80 -128.01 117.05 20.99 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.832 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.6 mttt 71.35 -15.11 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.5 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 250' ' ' PHE . . . 144.77 -9.4 1.83 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.945 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.445 ' HG2' ' HD2' ' A' ' 254' ' ' PRO . 32.5 tt0 -140.35 139.28 20.38 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.964 0.382 . . . . 0.0 110.846 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 23.8 Cg_exo -60.93 173.89 2.06 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.227 1.952 . . . . 0.0 112.221 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.894 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 3.0 p -103.04 162.59 12.81 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.585 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.923 ' HG3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -121.22 98.82 46.63 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -176.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -97.61 -138.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.833 3.022 . . . . 0.0 110.079 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 5.6 p90 -135.38 166.83 22.23 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.91 151.78 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.162 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.805 ' O ' ' HA ' ' A' ' 110' ' ' VAL . . . -106.99 120.7 6.29 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.089 -1.053 . . . . 0.0 113.957 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 64' ' ' HIS . 7.8 p -131.0 117.01 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -76.52 132.68 39.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.418 -178.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 8.3 t -103.0 124.28 48.2 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.166 0.508 . . . . 0.0 110.222 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.37 154.96 39.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -116.57 114.78 3.13 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.478 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 266' ' ' ILE . 17.5 tt -129.95 93.48 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -66.41 157.25 32.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.844 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . . . -71.7 -1.24 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.3 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.69 24.1 5.61 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 271' ' ' PRO . 60.6 p -91.9 101.72 5.03 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 270' ' ' SER . 11.6 Cg_endo -54.2 141.83 69.05 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.468 2.112 . . . . 0.0 112.061 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 61.08 84.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -25.13 67.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.032 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -34.25 62.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.961 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -34.67 63.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.63 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.37 94.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.401 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 5.6 mm-40 -67.26 -29.37 68.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.129 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -72.08 -41.75 66.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 111.664 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.735 HD13 ' CB ' ' A' ' 284' ' ' LEU . 0.1 OUTLIER -81.96 -20.57 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.588 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 0.5 OUTLIER -99.14 -14.07 19.51 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 0.7 OUTLIER -110.07 -5.04 15.5 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.441 ' C ' ' H ' ' A' ' 285' ' ' LEU . 1.3 m-85 -135.23 -59.0 0.79 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.735 ' CB ' HD13 ' A' ' 280' ' ' LEU . 2.8 mm? -75.42 37.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.868 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 106' ' ' TYR . 2.4 mt -174.64 35.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 15.9 p -145.93 174.07 11.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.051 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.924 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 p-10 -76.95 -1.77 30.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.943 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -77.85 -43.58 29.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 293' ' ' VAL . . . -116.66 -57.86 0.31 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.924 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -53.03 -27.92 21.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.948 0.404 . . . . 0.0 111.783 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.924 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 25.1 tt0 -75.76 -38.01 58.75 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 295' ' ' LYS . . . -78.0 -24.34 48.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.158 0.583 . . . . 0.0 110.721 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 289' ' ' GLY . 28.0 t -75.72 -25.32 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.554 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 297' ' ' LYS . 9.9 t-20 -104.8 -10.19 17.57 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.882 ' HB2' ' O ' ' A' ' 291' ' ' GLU . 0.0 OUTLIER -85.44 -46.05 11.27 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.695 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -56.08 -44.32 78.85 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -154.4 131.45 6.01 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.765 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.41 84.33 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.024 2.483 . . . . 0.0 111.91 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -88.86 -73.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 111.603 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' A' ' 317' ' ' ILE . . . -150.08 171.93 29.99 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.497 ' H ' HD12 ' A' ' 317' ' ' ILE . . . -170.01 120.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 110.808 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.452 ' HA ' ' OE2' ' A' ' 308' ' ' GLU . 2.6 m -149.09 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.85 -131.85 0.26 Allowed 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 306' ' ' SER . 0.6 OUTLIER -44.13 147.38 0.53 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.461 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -74.21 -25.75 59.86 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.683 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -56.84 -37.52 71.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.226 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 -28.5 35.04 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.134 0.493 . . . . 0.0 109.999 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.807 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 0.8 OUTLIER -71.37 -26.32 62.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.819 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -40.63 88.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 312' ' ' ALA . 3.9 tt0 -79.61 -28.56 40.99 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 1.114 HD21 HG21 ' A' ' 317' ' ' ILE . 12.6 tp -43.66 -8.48 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.501 1.52 . . . . 0.0 114.463 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -65.89 -19.47 65.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.193 0.451 . . . . 0.0 112.04 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.08 33.28 3.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.172 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 317' ' ' ILE . 0.1 OUTLIER -101.7 140.95 21.65 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.749 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.26 -54.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.168 1.912 . . . . 0.0 112.601 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -58.67 5.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.02 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 1.114 HG21 HD21 ' A' ' 311' ' ' LEU . 1.7 mm -53.79 -31.85 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -65.59 -53.94 34.78 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.622 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.17 74.13 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.854 0.359 . . . . 0.0 110.71 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 110' ' ' VAL . 3.8 m -70.15 -39.27 75.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.9 mtt -64.53 -26.69 68.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.999 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -55.79 16.73 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.909 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.39 -27.7 52.56 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.95 -22.69 50.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -24.98 63.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.779 0.324 . . . . 0.0 111.751 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -136.12 33.12 2.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.162 0.506 . . . . 0.0 109.686 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.08 155.14 19.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 258' ' ' PHE . 0.6 OUTLIER -101.0 136.94 40.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.981 0.42 . . . . 0.0 110.616 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.2 132.1 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 258' ' ' PHE . 0.7 OUTLIER -60.27 152.07 65.05 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 120.502 0.191 . . . . 0.0 111.274 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.93 -170.69 0.81 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.551 2.167 . . . . 0.0 112.268 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.515 HD21 ' HD2' ' A' ' 99' ' ' TYR . 19.7 p-10 -157.81 43.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 111.259 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.598 ' O ' ' HG2' ' A' ' 336' ' ' MET . 25.8 pt -125.72 161.76 48.98 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 73.0 Cg_endo -76.93 -18.05 15.01 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.364 2.042 . . . . 0.0 112.687 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -60.92 -21.82 63.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.459 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 333' ' ' ILE . 0.4 OUTLIER -56.63 -24.86 51.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.303 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.8 t -62.3 -33.33 74.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 111.217 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -58.05 -30.18 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.819 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.23 -27.87 62.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.795 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 344' ' ' ARG . 20.8 m95 -59.97 -42.95 95.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.247 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -70.81 -20.89 62.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.383 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.29 -56.98 3.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.839 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.6 p -60.09 -37.78 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.438 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 340' ' ' TRP . 0.0 OUTLIER -54.79 -60.96 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.824 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 56.8 p -65.68 -26.29 67.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.902 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.07 -60.0 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 15.7 t -80.19 -57.71 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.0 mm -53.4 -44.27 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.721 ' HB2' ' O ' ' A' ' 345' ' ' THR . 1.8 m-80 -76.92 -46.71 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -63.72 -30.92 71.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.643 0.258 . . . . 0.0 111.53 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -84.57 -11.04 56.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 53.5 p -66.0 -55.31 17.38 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.502 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 140.33 -1.43 2.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.904 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.76 38.44 1.82 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.828 0.314 . . . . 0.0 110.973 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 350' ' ' ALA . 4.4 tp60 -136.14 123.73 22.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.767 0.318 . . . . 0.0 110.946 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 359' ' ' GLU . 6.8 t -98.19 133.95 41.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.0 t -51.99 -27.16 8.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.889 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.56 -58.36 6.58 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 30.0 mt-10 -80.6 -26.61 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 355' ' ' GLN . . . -79.43 -55.21 5.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 361' ' ' LEU . 3.7 tt -78.06 -56.34 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.699 ' HA ' ' OD2' ' A' ' 184' ' ' ASP . 0.0 OUTLIER -56.98 -56.45 21.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.2 OUTLIER -59.6 -27.02 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.06 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.47 -48.03 76.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.786 ' HG3' ' CG2' ' A' ' 183' ' ' VAL . 5.3 tt0 -61.33 -32.97 72.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 32.1 m -61.44 -37.75 84.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.157 0.503 . . . . 0.0 110.046 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 367' ' ' ARG . 0.0 OUTLIER -66.87 -19.69 65.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.656 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 365' ' ' GLN . 18.1 mm -75.86 -44.51 38.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.12 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 4.1 t -70.24 -27.12 64.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.023 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.461 ' HG3' ' OXT' ' A' ' 370' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.818 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.805 0.336 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.5 p -130.94 -176.75 4.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.683 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.13 166.85 10.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -134.95 -75.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.449 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.98 28.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.065 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.8 156.13 42.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.741 0.305 . . . . 0.0 110.747 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.848 HD22 HD11 ' A' ' 59' ' ' ILE . 6.0 mt -140.77 144.93 35.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.495 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.807 HG11 ' HB3' ' A' ' 57' ' ' PRO . 3.8 t -110.13 112.57 41.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 121.212 0.53 . . . . 0.0 111.619 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.877 ' CG1' ' HA ' ' A' ' 37' ' ' VAL . 1.9 pp -91.49 157.69 2.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.402 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.678 ' HE3' ' HD3' ' A' ' 40' ' ' PRO . 31.2 m95 -135.15 111.49 9.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.863 0.364 . . . . 0.0 110.575 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 pt -150.17 138.53 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.544 HD21 ' HZ3' ' A' ' 62' ' ' TRP . 1.6 p30 -132.81 46.33 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.06 -26.39 7.05 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.208 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.82 42.84 3.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.196 0.522 . . . . 0.0 111.214 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HD2' HD22 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -114.7 -178.11 3.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.307 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 31.02 81.1 0.01 OUTLIER Glycine 0 C--N 1.33 0.225 0 N-CA-C 115.671 1.028 . . . . 0.0 115.671 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 1.2 t80 -81.22 -60.14 2.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.779 -0.711 . . . . 0.0 111.548 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -54.76 -44.73 80.6 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.721 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.2 tt -77.48 -23.47 50.33 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 110.746 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 17' ' ' TYR . . . -73.75 -41.9 61.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.1 -57.99 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.614 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 19' ' ' GLY . 14.5 m -45.26 -34.08 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.903 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.09 -48.28 48.18 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.96 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -69.07 -33.31 73.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.901 0.381 . . . . 0.0 111.112 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -56.15 -28.05 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.67 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 19.9 m-85 -75.83 -58.68 3.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.697 0.284 . . . . 0.0 111.475 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.664 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -51.78 -27.42 12.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.369 0.604 . . . . 0.0 110.419 179.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -58.66 -34.83 71.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.64 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.676 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -59.02 -57.71 11.85 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 10.3 t 157.34 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.06 176.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.67 45.06 0.02 OUTLIER Glycine 0 C--N 1.339 0.724 0 C-N-CA 118.436 -1.84 . . . . 0.0 115.716 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 27' ' ' PHE . 7.1 mt -139.89 94.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 118.196 0.998 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 6.8 mtpp -121.07 122.83 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.485 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' CG2' HG23 ' A' ' 9' ' ' ILE . 12.1 p -120.04 139.25 47.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.352 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 8' ' ' VAL . 1.5 t -107.24 109.87 21.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.814 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.877 ' HA ' ' CG1' ' A' ' 9' ' ' ILE . 5.3 m -74.31 111.24 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 2.4 tp10 -99.94 152.55 20.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 111.577 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -126.72 96.1 36.1 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.886 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.678 ' HD3' ' HE3' ' A' ' 10' ' ' TRP . 94.4 Cg_endo -82.31 166.68 16.02 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.701 2.268 . . . . 0.0 112.445 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -154.22 -54.25 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.194 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -0.19 26.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.842 HD12 ' HE3' ' A' ' 46' ' ' LYS . 6.6 tp -63.22 -15.13 56.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.514 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -36.68 77.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.952 0.406 . . . . 0.0 110.731 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.26 -23.56 18.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.842 ' HE3' HD12 ' A' ' 43' ' ' LEU . 31.6 mtmt -77.71 -22.67 50.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.18 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -42.06 -54.81 6.95 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 19.1 Cg_endo -58.36 -17.39 33.19 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.607 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.35 -55.29 3.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.732 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.09 -14.09 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.859 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.24 64.49 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.195 -0.315 . . . . 0.0 111.674 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.69 -14.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -94.5 -174.96 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.15 -2.03 37.66 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.518 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.36 95.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.15 -52.53 52.75 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.906 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.807 ' HB3' HG11 ' A' ' 8' ' ' VAL . 92.9 Cg_endo -80.04 152.45 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.343 2.029 . . . . 0.0 111.701 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.814 ' OD2' ' HB2' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -142.84 37.69 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.257 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 7' ' ' LEU . 36.0 mt -155.27 109.09 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.76 0.314 . . . . 0.0 111.339 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.607 HD12 ' CB ' ' A' ' 10' ' ' TRP . 4.1 tt -144.27 142.75 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 121.132 0.491 . . . . 0.0 112.252 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -113.42 123.89 51.14 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.773 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.914 ' HB3' ' HD2' ' A' ' 67' ' ' PHE . 2.8 t-105 -143.15 174.78 10.4 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 67' ' ' PHE . . . -68.59 162.91 24.83 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 263' ' ' SER . 0.3 OUTLIER -77.96 -28.02 49.36 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.23 -58.7 6.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 7.0 mtp85 -96.47 21.72 8.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.914 ' HD2' ' HB3' ' A' ' 62' ' ' TRP . 1.5 t80 -109.71 -47.6 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.883 0.373 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.39 -3.56 82.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.371 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.47 -55.92 0.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.146 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 35.0 m-85 -65.16 -46.87 79.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.83 ' HB1' ' CD2' ' A' ' 76' ' ' LEU . . . -64.13 -36.74 85.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.916 0.388 . . . . 0.0 110.618 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.62 ' NE2' ' HE3' ' A' ' 102' ' ' LYS . 5.0 tp60 -55.42 -10.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 p -113.26 -28.01 7.76 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.685 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' C ' HD13 ' A' ' 75' ' ' LEU . . . -68.55 -96.89 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.463 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.622 ' CD2' HD22 ' A' ' 267' ' ' ASN . 0.0 OUTLIER -155.05 49.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.83 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 2.3 mm? -91.49 116.88 29.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.29 141.65 28.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . 10.4 pt-20 -87.36 162.03 17.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.861 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -114.16 172.45 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.733 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.07 154.77 37.14 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.641 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.733 ' HD2' HG22 ' A' ' 80' ' ' THR . 6.0 Cg_exo -79.34 167.36 21.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.3 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.58 ' OD2' ' HB3' ' A' ' 84' ' ' ALA . 4.4 p-10 -153.86 -167.87 2.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.56 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -79.1 -29.66 43.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.779 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.58 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . -68.01 -23.01 64.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.574 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.557 ' HE1' ' HH ' ' A' ' 106' ' ' TYR . 1.5 m-85 -76.16 -50.99 13.09 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -24.39 67.87 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.475 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -83.64 -55.09 4.47 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -176.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -10.61 30.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -174.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB3' ' NE1' ' A' ' 94' ' ' TRP . 0.2 OUTLIER -117.51 147.75 42.47 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -105.55 164.03 15.89 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 120.456 0.169 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.06 -29.3 82.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.002 1.801 . . . . 0.0 111.592 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -55.48 -32.53 62.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.368 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.812 ' O ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -83.4 -45.23 13.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.533 ' HZ2' ' O ' ' A' ' 85' ' ' PHE . 11.0 m0 -65.47 -26.56 67.99 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.0 t70 -65.99 -28.17 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.28 -44.12 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.117 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 93' ' ' THR . 11.8 m -80.85 39.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 3.4 ptm85 -112.0 118.69 36.14 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.8 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 4.1 t80 -126.94 96.72 4.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.03 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 74.9 m-20 69.57 -66.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 27.2 0.1 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.62 ' HE3' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -137.34 156.06 48.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.926 0.393 . . . . 0.0 111.205 -179.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.4 57.36 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.685 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 0.9 OUTLIER -87.11 54.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.452 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.2 103.56 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.613 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.601 ' HD1' ' HD2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -87.52 148.58 44.54 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.664 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.601 ' HD2' ' HD1' ' A' ' 106' ' ' TYR . 9.3 Cg_endo -85.01 129.87 4.0 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.664 2.242 . . . . 0.0 111.832 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 38.2 mm -119.31 -130.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.787 ' H ' HG22 ' A' ' 108' ' ' ILE . . . -81.98 156.76 24.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.046 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 260' ' ' GLY . 5.1 t -97.03 123.83 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.987 ' HG2' ' HG2' ' A' ' 229' ' ' PRO . 12.5 tm-20 -125.67 126.66 45.03 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.206 0.527 . . . . 0.0 110.683 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -170.81 -177.18 2.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.552 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 154.33 19.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 1.093 ' HB3' HG23 ' A' ' 244' ' ' VAL . 0.8 OUTLIER -118.12 157.31 27.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.814 177.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.668 HD12 ' HA ' ' A' ' 247' ' ' LEU . 1.2 tt -94.53 130.16 41.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 174.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 225' ' ' THR . 8.9 tp -72.05 136.18 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.944 -176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -143.9 129.98 19.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.856 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.18 133.22 53.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' N ' HD22 ' A' ' 118' ' ' ASN . 7.7 tttt -97.58 64.82 1.84 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -164.63 -34.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.33 39.53 2.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.077 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -136.66 108.37 9.24 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.622 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.659 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 60.8 Cg_endo -73.11 160.68 45.03 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.278 1.986 . . . . 0.0 111.571 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.18 103.51 0.44 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.203 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 123' ' ' PRO . 63.0 Cg_endo -91.02 160.01 3.91 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.839 2.359 . . . . 0.0 112.614 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.732 ' CG ' ' HG3' ' A' ' 131' ' ' GLU . 83.6 Cg_endo -77.25 -158.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.211 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 33.32 4.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.871 0.367 . . . . 0.0 111.146 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.63 ' HB ' ' HG2' ' A' ' 130' ' ' GLU . 26.2 p -127.56 141.1 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.591 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.735 ' HE1' ' HD2' ' A' ' 248' ' ' PRO . 0.4 OUTLIER -66.69 -31.22 71.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.817 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.63 ' HG2' ' HB ' ' A' ' 128' ' ' THR . 10.8 pt-20 -48.26 -29.03 3.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.732 ' HG3' ' CG ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -71.19 -27.39 63.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.662 0.268 . . . . 0.0 111.462 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.899 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 19.6 mm -58.66 -60.28 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.899 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 48.2 Cg_exo -54.26 -36.79 87.5 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.202 1.935 . . . . 0.0 112.083 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -28.0 64.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -24.44 67.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.582 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.978 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 5.8 m-20 -70.5 -40.92 73.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 12.5 mttt -57.75 -29.4 64.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.69 -46.03 14.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 145' ' ' SER . 1.9 mp -72.67 -50.62 23.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.664 0.268 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.978 ' HD2' ' HB3' ' A' ' 136' ' ' ASP . 13.0 mtpt -56.49 -40.22 74.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.25 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -49.89 -18.76 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -56.23 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.958 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.76 42.16 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -177.83 5.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.704 0.287 . . . . 0.0 111.413 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.465 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.9 OUTLIER -135.56 145.57 47.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.509 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -90.51 -10.51 43.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.885 ' HB2' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER -156.3 148.84 23.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.526 0.203 . . . . 0.0 110.544 -177.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.945 ' H ' ' HB3' ' A' ' 224' ' ' MET . 0.9 OUTLIER -177.84 114.55 0.08 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.618 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' ' CE2' ' A' ' 156' ' ' PHE . 1.9 p90 -143.59 177.89 8.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 153' ' ' GLU . 0.4 OUTLIER -52.12 -177.6 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -135.33 -32.73 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.855 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -125.06 37.14 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.711 -0.796 . . . . 0.0 113.067 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.531 ' HG3' ' OD1' ' A' ' 150' ' ' ASN . 3.5 mt-10 -117.89 159.49 42.47 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 120.655 0.264 . . . . 0.0 111.518 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 156' ' ' PHE . 6.6 Cg_endo -86.7 -156.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.136 2.558 . . . . 0.0 112.634 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.652 ' O ' ' HG3' ' A' ' 159' ' ' PRO . 53.2 m-85 64.94 -7.54 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.875 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.525 ' O ' ' HG2' ' A' ' 159' ' ' PRO . 6.2 t80 -123.12 -57.79 1.67 Allowed 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 121.469 0.652 . . . . 0.0 111.491 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.493 ' O ' HG13 ' A' ' 161' ' ' ILE . 10.9 p -47.14 -51.5 17.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.892 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 13.3 t-105 -63.3 -52.73 59.01 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.652 ' HG3' ' O ' ' A' ' 155' ' ' TYR . 33.4 Cg_endo -63.7 -9.17 17.52 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.781 2.321 . . . . 0.0 113.779 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -57.44 2.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 157' ' ' THR . 1.7 pp -74.95 15.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -94.67 -50.87 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.518 0.675 . . . . 0.0 110.339 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . 48.19 -168.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.55 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -93.37 27.75 2.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -116.72 -42.82 0.65 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.36 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.58 120.94 5.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 150.88 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 111.266 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 181' ' ' VAL . . . -99.07 -70.04 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 331' ' ' PRO . 53.6 p90 -136.07 175.1 9.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 122.1 45.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 0.0 111.356 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.655 ' CE1' ' HA2' ' A' ' 174' ' ' GLY . 3.9 t80 -137.03 111.13 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.216 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 0.0 OUTLIER -126.05 136.14 52.6 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.227 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 2.2 m-80 69.3 -67.47 0.22 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.34 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.655 ' HA2' ' CE1' ' A' ' 171' ' ' TYR . . . 173.84 37.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.247 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -131.1 157.65 42.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.671 0.272 . . . . 0.0 110.946 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -105.09 158.0 16.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.49 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -132.59 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.56 ' O ' HG23 ' A' ' 178' ' ' ILE . 8.0 tp 179.75 105.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.168 0.509 . . . . 0.0 110.231 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 369' ' ' THR . 9.9 mmtt 68.67 24.28 6.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.203 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.42 117.57 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.584 ' CG2' HG23 ' A' ' 183' ' ' VAL . 8.4 p -147.77 138.36 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.096 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -128.43 52.37 0.83 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.852 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.584 HG23 ' CG2' ' A' ' 181' ' ' VAL . 20.7 t -89.24 -19.73 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.738 0.304 . . . . 0.0 111.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.658 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 4.3 p30 -102.81 51.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -114.86 -173.57 2.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.28 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.86 -33.42 52.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.99 -45.38 95.74 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.587 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.36 63.81 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.824 0.345 . . . . 0.0 111.358 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -33.41 75.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.302 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.5 -33.34 72.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.96 -41.8 80.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.788 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -34.86 73.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.89 0.376 . . . . 0.0 111.097 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.4 m -59.53 -46.06 89.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.11 -26.8 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.368 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -60.23 -54.86 40.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.096 0.474 . . . . 0.0 111.341 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.696 ' O ' ' HB2' ' A' ' 200' ' ' LYS . 17.3 m -75.63 -35.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.708 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.06 -28.07 69.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -45.26 25.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.727 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 200' ' ' LYS . 38.6 pt -74.56 -38.8 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.531 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 0.0 OUTLIER -59.81 -23.63 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.898 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.28 5.34 29.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.31 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.47 -66.31 1.1 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 204' ' ' MET . 0.5 OUTLIER -89.83 -47.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.578 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 203' ' ' HIS . 28.6 mmm 73.23 -25.46 0.19 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.853 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' HIS . 5.6 p30 -129.34 109.22 10.92 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.944 0.402 . . . . 0.0 109.985 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -79.12 55.01 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.525 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.16 25.59 10.98 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 213' ' ' ALA . 1.7 m -79.25 136.15 36.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.593 ' HB2' HG13 ' A' ' 212' ' ' ILE . 2.1 m-20 -105.32 -169.13 1.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.806 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.817 ' O ' ' HB2' ' A' ' 214' ' ' GLU . 95.3 m-85 -79.02 -41.96 27.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.175 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 m -74.9 -25.55 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' ' 209' ' ' ASP . 12.0 mt -81.96 -54.05 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.143 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -64.76 -28.95 69.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.904 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 1.011 ' HG3' ' HB2' ' A' ' 218' ' ' ASN . 0.7 OUTLIER -51.0 -23.31 2.83 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.59 -179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 219' ' ' LYS . . . -58.83 -56.37 23.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.733 0.301 . . . . 0.0 111.69 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 148' ' ' MET . . . -82.84 -39.08 22.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -68.0 -59.04 3.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.159 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 1.011 ' HB2' ' HG3' ' A' ' 214' ' ' GLU . 20.5 t-20 -64.59 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.734 0.302 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -92.0 -5.06 53.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.048 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 37.77 26.42 0.03 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 219' ' ' LYS . 0.1 OUTLIER -79.81 37.14 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.839 0.82 . . . . 0.0 110.072 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 145' ' ' SER . 16.9 p -159.87 149.54 18.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 122' ' ' LEU . . . -72.35 37.72 0.07 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.868 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.945 ' HB3' ' H ' ' A' ' 148' ' ' MET . 5.7 tpt -153.81 95.19 1.85 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.665 ' H ' HG22 ' A' ' 116' ' ' ILE . 2.5 m -149.04 137.84 21.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.297 -1.774 . . . . 0.0 109.763 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.435 HG13 ' CD1' ' A' ' 156' ' ' PHE . 21.3 mm -115.33 115.53 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.25 159.89 42.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.933 0.397 . . . . 0.0 111.253 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -143.14 -171.85 13.78 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.317 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.4 Cg_endo -74.14 69.98 4.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.208 1.938 . . . . 0.0 111.894 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.655 ' CE3' ' HA ' ' A' ' 230' ' ' TRP . 0.0 OUTLIER -168.64 -37.38 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.039 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.22 103.04 11.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.42 155.58 48.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.6 t -99.42 -38.35 8.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.025 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.3 m120 61.15 118.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.87 -38.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.613 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.12 115.1 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.156 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m 59.92 167.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.67 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 21.1 m 70.8 -56.55 0.61 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.664 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -141.8 113.47 7.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.866 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.1 m -152.87 29.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.37 100.66 11.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -136.06 138.7 42.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.319 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -107.78 141.31 15.68 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.786 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 1.093 HG23 ' HB3' ' A' ' 114' ' ' SER . 6.5 p -120.84 109.98 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.62 0.247 . . . . 0.0 110.499 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 19.5 p -127.5 160.45 31.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.177 0.513 . . . . 0.0 110.91 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.526 HG23 ' ND2' ' A' ' 323' ' ' ASN . 11.8 p -92.85 151.24 3.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.381 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.668 ' HA ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -58.81 141.09 85.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.321 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.735 ' HD2' ' HE1' ' A' ' 129' ' ' TRP . 2.4 Cg_endo -80.02 -148.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.399 2.733 . . . . 0.0 111.869 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.932 HG22 ' HD3' ' A' ' 254' ' ' PRO . 62.8 p -121.61 170.12 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' ' 255' ' ' SER . 0.1 OUTLIER -153.5 131.66 11.88 Favored 'General case' 0 CA--C 1.526 0.05 0 CA-C-O 121.021 0.438 . . . . 0.0 110.576 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 1.6 mttt 70.16 -12.19 0.52 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.429 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.448 ' C ' ' HG2' ' A' ' 253' ' ' GLN . . . 150.11 -30.51 1.09 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.185 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.457 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 25.7 mm-40 -147.9 159.02 41.47 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.181 0.49 . . . . 0.0 111.339 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.932 ' HD3' HG22 ' A' ' 249' ' ' THR . 61.0 Cg_endo -70.78 -165.5 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.389 2.059 . . . . 0.0 111.608 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 4.1 t -110.48 -178.39 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -120.53 99.41 47.76 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -95.35 -140.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.997 2.465 . . . . 0.0 110.252 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 328' ' ' GLU . 51.7 p90 -153.18 166.04 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.33 0.968 . . . . 0.0 112.798 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' A' ' 324' ' ' ALA . 7.7 p -89.77 154.02 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.058 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 111' ' ' GLU . . . -124.76 108.49 1.12 Allowed Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.809 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 21.4 t -130.21 134.96 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.895 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 5.6 mp -86.01 138.24 32.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.692 ' HB2' ' HA ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -101.79 125.45 48.46 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.631 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 108' ' ' ILE . . . -74.22 152.26 39.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.695 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.404 ' HA3' ' HZ ' ' A' ' 67' ' ' PHE . . . -118.12 130.73 8.88 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.856 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.446 ' H ' ' CD1' ' A' ' 76' ' ' LEU . 33.4 mm -129.24 95.79 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.2 0.524 . . . . 0.0 110.269 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.814 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 13.6 m120 -55.06 140.82 36.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.807 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.51 4.1 1.52 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.39 -37.29 57.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.738 0.304 . . . . 0.0 111.464 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.35 90.71 7.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.25 -73.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.197 1.932 . . . . 0.0 112.019 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.945 HD22 HD13 ' A' ' 275' ' ' LEU . 15.1 m120 55.82 70.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 110.7 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 277' ' ' LYS . 8.6 ptpt -65.32 -41.95 93.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -73.34 -37.73 66.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.71 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.945 HD13 HD22 ' A' ' 272' ' ' ASN . 1.1 mp -76.25 -56.32 4.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.573 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 280' ' ' LEU . . . -59.68 -32.91 70.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 281' ' ' GLU . 6.2 ttmm -77.71 -30.11 51.65 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.3 -50.18 13.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.494 ' HD1' ' CE2' ' A' ' 27' ' ' PHE . 92.3 m-85 -70.82 -51.71 25.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.347 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -60.13 -49.69 76.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.845 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 277' ' ' LYS . 8.3 mt-10 -61.54 -13.85 24.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.404 ' HA ' ' HB ' ' A' ' 286' ' ' THR . 65.3 m-20 -118.71 3.09 11.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.742 ' HD1' HD23 ' A' ' 284' ' ' LEU . 6.4 t80 -101.26 -75.32 0.59 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 111.139 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.742 HD23 ' HD1' ' A' ' 283' ' ' TYR . 1.5 mm? -110.12 39.25 2.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.73 39.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.278 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 289' ' ' GLY . 5.8 t -131.84 168.97 16.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.973 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.786 ' O ' ' HG2' ' A' ' 291' ' ' GLU . 9.2 t0 -62.42 -25.32 67.9 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -78.85 -51.27 9.95 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.707 ' H ' HG23 ' A' ' 286' ' ' THR . . . -82.71 -61.24 1.98 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.163 -0.541 . . . . 0.0 114.055 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.4 OUTLIER -45.75 -26.77 0.7 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.921 ' HA ' HD21 ' A' ' 294' ' ' ASN . 0.0 OUTLIER -79.72 -27.14 40.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 295' ' ' LYS . . . -78.23 -25.97 47.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.094 0.557 . . . . 0.0 112.142 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.68 -24.98 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.664 0.745 . . . . 0.0 111.119 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.921 HD21 ' HA ' ' A' ' 291' ' ' GLU . 12.7 p30 -100.21 -16.39 17.77 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.746 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 292' ' ' ALA . 0.0 OUTLIER -81.67 -43.54 18.38 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -58.49 -56.82 17.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 175.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.727 ' HG3' ' O ' ' A' ' 296' ' ' ASP . 0.0 OUTLIER -164.33 113.39 0.92 Allowed Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 113.567 -1.651 . . . . 0.0 111.13 -178.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . 50.7 Cg_endo -67.52 112.03 2.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.916 1.744 . . . . 0.0 111.543 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 300' ' ' GLY . 0.6 OUTLIER -110.58 -79.89 0.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.753 ' HA2' HG13 ' A' ' 317' ' ' ILE . . . -177.49 124.31 0.94 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.204 -0.522 . . . . 0.0 113.084 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.597 ' HA ' ' H ' ' A' ' 110' ' ' VAL . . . 163.12 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.27 0.628 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.54 ' CG2' HG21 ' A' ' 317' ' ' ILE . 16.2 m -145.27 94.18 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 110.998 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.4 ' N ' HD23 ' A' ' 304' ' ' LEU . . . -101.76 39.33 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.783 HD12 ' OG ' ' A' ' 306' ' ' SER . 1.2 pt? -163.83 133.74 4.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -24.45 66.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.783 ' OG ' HD12 ' A' ' 304' ' ' LEU . 4.4 p -58.54 -44.25 89.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -81.17 -34.39 32.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.262 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 311' ' ' LEU . 2.9 tt0 -63.62 -26.91 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.335 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' SER . 0.2 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.027 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 312' ' ' ALA . 1.1 tp10 -79.86 -28.4 40.02 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 315' ' ' PRO . 3.2 tp -46.14 -8.14 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.864 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 310' ' ' GLU . . . -80.53 -29.05 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.081 0.467 . . . . 0.0 111.933 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -55.94 -78.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.153 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.67 ' N ' ' HD3' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -164.26 45.44 0.13 Allowed Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.508 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 318' ' ' ALA . 12.1 Cg_endo -91.1 146.36 3.6 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.149 1.899 . . . . 0.0 112.417 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -53.89 -26.79 26.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.79 179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.753 HG13 ' HA2' ' A' ' 300' ' ' GLY . 3.7 mp -75.85 -24.71 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.972 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.745 ' HB2' ' HD2' ' A' ' 315' ' ' PRO . . . -56.58 -45.95 81.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.51 15.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.544 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -59.79 -33.91 72.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.399 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.58 ' HG3' ' HG2' ' A' ' 325' ' ' GLN . 12.4 tpt -68.85 -23.74 64.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.875 0.369 . . . . 0.0 111.109 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -37.72 88.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.324 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.526 ' ND2' HG23 ' A' ' 246' ' ' VAL . 12.4 m120 -68.91 -47.93 64.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.971 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 259' ' ' VAL . . . -71.76 -31.33 66.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.536 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.58 ' HG2' ' HG3' ' A' ' 321' ' ' MET . 5.2 mm100 -62.38 -46.66 87.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -113.9 66.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.508 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -151.32 -151.94 5.73 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.356 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.682 ' HG3' ' HG2' ' A' ' 256' ' ' LYS . 0.3 OUTLIER -104.34 135.65 45.39 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.763 0.316 . . . . 0.0 110.546 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.6 tp -81.63 138.54 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.725 0.297 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 330' ' ' MET . 3.9 tmm? -48.32 119.94 8.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.217 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.55 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 49.8 Cg_endo -67.9 -168.13 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.714 2.276 . . . . 0.0 112.958 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -145.25 47.18 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.122 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 333' ' ' ILE . 18.9 tt -138.01 115.55 9.43 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.864 0.364 . . . . 0.0 111.621 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.52 -25.59 74.81 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.391 2.061 . . . . 0.0 111.812 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -21.7 63.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.346 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -61.08 -27.1 68.11 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 111.207 -179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . 0.477 ' HA ' ' CE1' ' A' ' 339' ' ' PHE . 71.6 p -58.49 -20.4 45.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.926 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -55.12 -26.82 40.85 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 337' ' ' SER . 0.1 OUTLIER -52.93 -24.66 9.78 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -48.25 71.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.833 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -21.16 65.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.701 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -80.92 -57.38 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 10.1 p -49.04 -32.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.404 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -52.79 64.09 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 349' ' ' ASN . 5.8 t -74.32 -26.79 60.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 350' ' ' ALA . . . -75.85 -52.82 9.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.137 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.03 -54.16 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -76.09 -59.23 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 345' ' ' THR . 0.4 OUTLIER -54.57 -46.61 73.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 346' ' ' ALA . . . -64.92 -29.21 70.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.64 -10.4 59.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.82 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.2 m -67.48 -56.14 10.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.227 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 142.11 -2.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.743 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 38.95 2.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.893 0.378 . . . . 0.0 110.246 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.66 ' HB2' ' O ' ' A' ' 349' ' ' ASN . 0.0 OUTLIER -147.65 106.42 3.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.259 0.552 . . . . 0.0 111.029 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 63.6 p -91.6 146.21 23.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.516 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 9.0 p -56.55 -29.64 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.772 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.849 ' O ' ' HB2' ' A' ' 362' ' ' LYS . 7.0 t70 -66.93 -57.32 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.978 0.418 . . . . 0.0 111.316 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.792 ' O ' ' HB2' ' A' ' 363' ' ' ASP . 1.2 tp10 -76.26 -28.02 56.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.158 0.504 . . . . 0.0 110.79 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.506 ' HB2' ' NE2' ' A' ' 355' ' ' GLN . . . -77.43 -50.61 12.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.945 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 357' ' ' VAL . 0.1 OUTLIER -78.95 -55.16 5.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.849 ' HB2' ' O ' ' A' ' 358' ' ' ASP . 3.6 mmtp -59.16 -55.68 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.792 ' HB2' ' O ' ' A' ' 359' ' ' GLU . 0.1 OUTLIER -62.51 -29.44 70.55 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.755 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -75.79 -26.72 57.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.658 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.9 mm100 -74.9 -30.9 61.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 21.5 p -67.88 -42.9 80.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 110.787 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 364' ' ' ALA . 0.0 OUTLIER -64.84 -29.46 70.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.755 HG12 ' O ' ' A' ' 364' ' ' ALA . 28.9 mm -64.65 -39.43 85.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.784 0.326 . . . . 0.0 111.387 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 4.0 m -74.26 -36.45 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.161 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.791 -179.691 . . . . . . . . 1 1 . 1 stop_ save_